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Summary-
Physiological parameters may be recorded non-invasively to gain information on 
cardiovascular function which can then characterise populations with various 
pathologies. Physical exercise produces specific autonomic nervous system (ANS) 
changes. There has been no comprehensive profiling of cardiovascular function 
during exercise or simultaneous characterisation of the influence of exercise on 
cardiac ventricular function and electrical activity. This work aims to address that, 
using a combination of physiological parameters.
Between-lead agreement for ambulatory electrocardiographic (ECG) 
depolarisation-repolarisation (QT) interval was quantified during rest and exercise. 
In contrast to cardiac interval (RR) data, between-lead bias and limits of agreement 
for QT interval data should be quantified when reporting results from an 
ambulatory ECG system and between-gender QT differences should also be 
accounted for. ECG electrode location appears to significantly affect QT-RR 
hysteresis, the shortening of the post-exercise QT interval relative to that at 
similar heart rates during exercise or pre-exercise rest, further emphasising the 
need for standardisation of ECG electrode placement.
Sample entropy (SampEn) measures data complexity. Few studies have compared 
SampEn of RR data (SampEn-RR) during exercise, whilst none have examined 
SampEn for the corresponding QT interval (SampEn-QT). Fractal analysis assesses 
data correlation and scaling structures. Detrended fluctuation analysis (DFA) 
provides a scaling exponent (a) which describes these properties. This has not been 
quantified for RR interval data during post-exercise recovery and has not been 
reported for QT interval data. Differences in a  magnitudes for RR and QT data 
suggest that these quantities have different fractal properties.
Exercise perturbs the resting QT-RR relationship via hysteresis. The QT variability 
index (QTVI) quantifies the relative autonomic influence on the atrial and 
ventricular myocardium during rest and exercise. QTVI is a consistent measure of 
cardiac ventricular function and as such appears to be a more useful index than 
other parameters based on RR or QT interval alone.
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Chapter 1 Thesis overview
1.1 Introduction
The main theme of this thesis is the investigation and characterisation of cardiac 
and haemodynamic responses to physical exercise. In a normal physiologically 
and neurally intact heart, successive cardiac cycles (RR intervals) are non- 
uniformly separated in the time domain. Investigation of this temporal variability 
in RR interval data is commonly referred to as heart rate variability (HRV) 
analysis. Frequency domain techniques, including those based on Fourier or 
wavelet transformation, can be used to separate the HRV signal into band-limited 
components. The “power” of a signal can be estimated within a finite frequency 
range by calculating its “power spectral density” (PSD), and the PSD may be 
integrated to determine the power within a defined bandwidth.
Hyndman etal. (1971), Sayers (1973) and Kitney & Rompelman (1980) were 
among the first to implement power spectral analysis for the investigation of 
HRV and other haemodynamic parameters. Since then, the Task Force of the 
European Society of Cardiology and The North American Society of Pacing and 
Electrophysiology has published guidelines for the measurement, physiological 
explanation and clinical interpretation of HRV (Task Force ESC & NAPSE 1996). 
These guidelines suggest three bandwidths are of importance in the power spectra 
of adult HRV data, each having association with different heart rate modulation 
mechanisms.
Neural regulation of the heart rate takes place as a result of the interplay between 
sympathetic and parasympathetic modulation of the electrical activity of the 
sinoatrial (SA) node. These two branches of the autonomic nervous system (ANS) 
demonstrate a reciprocal activity relationship(Malliani etal. 1994). A
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fundamental hypothesis suggesting the use of spectral analysis in HRV studies is 
that the two branches of the ANS influence the heart rate in a frequency- 
dependent way. Information about the contribution of each system to the main 
power spectral components has been obtained using neuropharmacological 
techniques (Randall etal. 1991). These studies have suggested that: (i) High 
frequency (HF) components of the HRV signal are mediated via the 
parasympathetic system, the sympathetic system being too slow to respond at 
these frequencies, and (ii) HRV components in the low frequency (LF) range are 
mediated via both sympathetic and parasympathetic systems (Akselrod et al. 
1981,1985). Additionally, it has been suggested that the relative power of the LF 
and HF components (the LF/HF ratio) might provide an accurate index of 
sympathovagalbalance(Pagani etal. 1986).
Equivocal findings have been reported from investigations comparing the 
distribution of HRV power during rest with that during dynamic exercise. 
Bemardi etal. (1990) and Rimoldi etal. (1992) reported an increase in LF power 
and a decrease in HF power during low intensity exercise hence implying an 
increase in the LF/HF ratio during low intensity exercise, a trend similarly 
described by Tulppo etal. (2001). However, several authors (Casadei etal. 1995, 
Perini etal. 1990) have described reductions in LF power at higher exercise 
intensities whilst at yet higher exercise intensities Arai etal. (1989) and Bemardi 
etal. (1990) documented increased HF power. Variations in both the mode and 
the relative intensity of exercise employed in different HRV studies have made it 
difficult to reliably compare their results.
The experimental work forming the basis of this thesis is presented as five studies 
which are detailed in chapters 3, 4 and 5, an overview of these chapters is 
provided below. Subjects were selected from two separate cohorts owing to time
2
restrictions and subject availability, however all subjects were broadly from the 
same population, that is physically active young adults. All studies discussed in 
chapters 3 and 4 contain data from a single cohort, the two studies which form 
chapter 5 however use data taken from different cohorts.
1.2 Chapter 3 Investigating the relationship between QT and RR time-series 
during rest and exercise
Following physical exercise, the electrocardiographic ventricular depolarisation- 
repolarisation (QT) interval is shortened relative to that at similar heart rates 
during exercise or pre-exercise rest. This lag in QT adaptation to the recovering 
heart rate has been described as “hysteresis” (Ahnve & Vallin 1982). Multi-lead 
ambulatory electrocardiogram (ECG) recording offers recognised advantages for 
QT interval analysis, especially during physical exercise. However, data are 
usually reported for a single lead and do not quantify between-lead variability, 
leading to possible misinterpretation. Prior to undertaking a quantification of QT- 
RR hysteresis, it is essential to understand whether the choice of electrode (lead) 
position influences the magnitude of either the RR or QT intervals (for example, 
owing to either technical artifact or differences in physiological information 
content). No previous study has quantified the influence of ECG electrode 
placement on the magnitude and temporal variation of QT-RR hysteresis 
following physical exercise. In the preliminary study, quantification of the 
between-lead agreement for QT and RR time-series data recorded during rest and 
during dynamic exercise was sought, prior to the subsequent analysis of QT-RR 
hysteresis.
A three-lead Holter ECG was recorded continuously during pre-exercise rest, 
exercise and recovery for male and female subjects undertaking a progressive sub-
3
maximal bicycle ergometer exercise test. Beat-to-beat cardiac cycle (RR) and QTa 
(Q_wave end to T wave apex) data were measured for each sinus beat following 
observation which indicated that the QTa interval provided a reliable measure of 
ventricular depolarisation and repolarisation. Bland-Altman analysis (Bland & 
Altman 1999) was used to quantify between-lead agreement for RR and QT 
intervals. Mean between-lead difference (bias) was significantly (pclO'6) greater 
for QT compared with RR and in males the between-lead limits of agreement 
(LOA) for QT were significantly (pelO'6) greater than for RR. Relative to mean 
parameter values, the between-lead LOA for RR was low, with maximal values 
(% of mean) of 0.1% (male) and 0.3% (female). Paired-lead bias for RR was also 
relatively low (5.0% and 6.7%), but paired-lead bias for QT (8.3% and 6.9%) and 
paired-lead LOA for QT (13.1% and 12.8%) were notably larger. These results 
indicate that the between-lead bias and LOA for QT interval data should be 
quantified when reporting results from a multi-lead ambulatory ECG system. 
Interpretation of the results of such studies should take account of between-lead 
and between-gender QT differences, and should note the physiological conditions 
during recording. This type of analysis however, does not necessarily indicate 
that any one lead is better than another.
QTa-RR hysteresis was subsequently calculated as the difference in QTa 
magnitude at identical heart rates during the pre-exercise rest or exercise period 
and the post-exercise recovery period. The results of this analysis indicated some 
significant (p<0.05) between-lead and between-gender differences in the 
calculated hysteresis values. Hysteresis was generally greatest during the second 
or third minute post-exercise and in males. Hysteresis was significantly 
diminished during late recovery and in males, and was significantly diminished 
during late recovery compared with early recovery periods (p<0.05). QTa-RR 
hysteresis is significantly affected by the locations of the electrodes used to record
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the surface ECG, emphasising the need for standardisation of ECG electrode 
placement in future investigations.
1.3 Chapter 4 Complexity of electrocardiographic RR and QT time-series data 
during rest and exercise
Sample entropy (SampEn) is a measure of data complexity. Few studies have 
compared the SampEn of RR data (SampEn-RR) during differing physiological 
states and none have examined SampEn for the corresponding QT interval 
(SampEn-QT). Chapter 4 details the quantification of SampEn-RR and SampEn- 
QT during rest and for a range of exercise workloads. The utility of SampEn for 
discriminating between physiological states, and the relationship of SampEn-RR 
with traditional measures of HRV is assessed. Twelve males of similar age, mass 
and aerobic fitness participated. A three-lead ECG was recorded continuously 
during pre-exercise, progressive bicycle exercise and recovery, and beat-to-beat 
RR and QT intervals were quantified for sinus beats. SampEn and HRV were 
calculated within consecutive one-minute periods throughout. Consistent 
estimation of SampEn-RR and SampEn-QT was possible with an appropriate 
choice of SampEn parameters. SampEn-RR was sensitive to differing 
physiological conditions but its discriminating ability was poorer than that of 
linear HRV indices. SampEn-RR was also negatively correlated with normalised 
LF and LF/HF parameters. Changes in SampEn for RR and QT data were 
interpreted in terms of the altered ANS control of either the atrial or ventricular 
myocardium (or both) during discrete physiological states. It is speculated that 
the observed greater complexity in QT data might be explained by a direct ANS 
influence on the ventricular myocardium.
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Fractal analysis assesses the correlation and scaling structure within data. 
Detrended fluctuation analysis (DFA) provides a scaling exponent (a) that 
describes these properties. Previous studies have quantified a  for RR data during 
rest and exercise, but not during recovery. The influence of age and physical 
fitness on a  during exercise has not been considered. Furthermore, a  has not 
been reported for QT interval data. The further aim of this chapter was to 
investigate short-term (ai) and long-term (0 2 ) scaling exponents for RR and QT 
data using DFA during rest and physical exercise. This was specifically 
approached by comparing 0 0  and 0 2 , thereby examining their relationships with 
HRV parameters, and assessing their sensitivities to differing physiological states. 
A three-lead ECG was recorded continuously during rest, progressive bicycle 
exercise and recovery. Beat-to-beat RR and QT intervals were quantified and ai 
and ot2 were quantified using DFA during each physiological state. Short-term ai 
(for RR) was the only exponent sensitive to differing physiological conditions, but 
its discriminating ability was poorer than most HRV indices, ai and 0 2  (for RR) 
correlated with various indices of HRV, confirming that the fractal characteristic 
of RR data is associated with ANS activity. Differences in scaling exponent 
magnitudes for RR and QT data indicates that these quantities have dissimilar 
fractal properties. This is possibly a reflection of differing mechanisms of 
temporal modulation for these two markers of cardiac electrical activity.
1.4 Chapter 5 Investigation of QT interval variability and its association with 
ventricular function in healthy adults during rest and exercise
1.4.1 Study 1
The QT interval is known to vary in part as a function of heart rate (HR) or RR 
interval, although previous studies have indicated a substantial HR-independent 
component in resting QT interval variability (Porta etal. 1998, Almeida etal. 
2006). There have been few studies of the influence of dynamic physical exercise
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on the QT interval or of the QT-RR relationship during these conditions. 
However it has been shown that QT shortening during exercise is in part 
independent of heart rate (Rickards & Norman 1981). It has since been suggested 
that the ANS has a direct influence on the ventricular myocardium, and this 
might affect cardiac repolarisation independently of heart rate modulation via the 
SA node (Shimizu etal. 1994, Magnano etal. 2002). To date there have been no 
reports of the quantification of HR-dependent and HR-independent influences on 
the atrial and ventricular myocardium during physical exercise. The QT 
variability index (QTVI) introduced by Berger etal. (1997) quantifies the relative 
magnitude of temporal variability in QT and RR intervals and can be interpreted 
with regard to the relative autonomic modulation of these two parameters. 
Previous studies have suggested that the magnitude of QTVI is a risk factor for 
arrhythmia (Berger etal. 1997, Atiga etal. 1998,2000). QTVI might therefore be a 
useful index for delineating the relative autonomic influences on the atrial and 
ventricular myocardium, and this might be linked to the potential risk of cardiac 
arrhythmia.
The aim of this study was to quantify the relationship between QT and RR 
interval variabilities during rest, exercise and subsequent recovery. After 
establishing that the data provided evidence of a HR-independent component of 
QT variability, quantification of the QTVI index during these conditions was 
sought. It was postulated that the temporal variation of QTVI during exercise 
reflects the differential autonomic regulation of electrical activity in the atrial and 
ventricular myocardium, and might reflect the risk of cardiac arrhythmia during 
exercise. The data collected from the different leads of a clinical Holter ECG 
system was also compared, and the differences in the results for males and 
females were examined.
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A three-lead Holter ECG was recorded continuously during pre-exercise, exercise 
and recovery for subjects undertaking a progressive bicycle ergometer exercise 
test. Mean values of RR, QT, QTc (QT interval corrected for heart rate), QTVI and 
mean-normalised QT variance (QTVN) were determined. At the onset of exercise 
QTVI increased rapidly compared with pre-exercise rest and remained 
significantly elevated throughout exercise and recovery. There were significant 
differences between QTaVI and QTeVI (QT interval measured from Qwave onset 
to T wave apex (QTa) and T wave end (QTe), respectively) throughout the 
experimental protocol, however, detection of T wave apex was considered more 
accurate than T wave end. QTVI was significantly reduced in males compared 
with females prior to exercise but was similar thereafter, possibly owing to QT 
intervals being longer in females than males. The results suggest a simultaneous 
withdrawal of ANS modulation of the atrial myocardium and an accentuation of 
ANS modulation of the ventricular myocardium during exercise. Hence QT 
variability is possibly modulated by an autonomic influence on heart rate, as the 
QT interval is partly heart rate dependent, along with the influence of ion 
(calcium) channel modification.
1.4.2 Study 2
Ultimately, HRV or QT variability only have value with regard to their clinical 
utility and it would be of use for clinicians to understand how these variables are 
related to more familiar clinical indicators (such as left ventricular function, as 
assessed by left ventricular ejection fraction and stroke volume). To date there has 
been no simultaneous characterisation of the influence of physical exercise on 
cardiac ventricular function and cardiac electrical conduction variability. 
Consequently little is known about the relationship between ventricular function 
and either HRV or QT variability. Subsequent to the analysis of QTVI during
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exercise, an assessment of the relationship between QTVI and ventricular 
function was sought.
A three-lead Holter ECG was recorded continuously during pre-exercise, exercise 
and recovery for subjects undertaking a progressive bicycle ergometer exercise 
test. Mean values of RR and QT, their variabilities (RMSSD and SDNN (section 
2.5.4.2.1)) and their relative variability (QTVI) were determined. Traditional 
indices of ventricular function: stroke volume index (SVI), cardiac output index 
(Cl), left ventricular ejection time (LVET), end diastolic volume index (EDVI), 
ejection fraction (EF), index of contractility and acceleration index (IC and ACI, 
both of which are measures of the inotropic state of the myocardium), total 
peripheral resistance (TPRI), left ventricular work index (LVWI), systolic and 
diastolic blood pressure (BP) and pulse pressure (PP) were determined on a beat- 
to-beat basis via impedance cardiography. Beat-to-beat blood pressure was 
recorded simultaneously using a technique employing photoplethysmography 
and vascular unloading.
Multiple linear regression analysis using the Stepwise method resulted in 
significant models for each of the dependent variables (RR, QT, RR and QT 
variabilities, QTVI) using indices of ventricular function as predictor variables. 
Notably QTVI reflected both SVI and ACI (which are measures of cardiac 
‘output’ per contraction and the force of contraction, respectively), hence 
indicating that QTVI was strongly related to measures of cardiac pumping 
efficiency. This relationship was largely unperturbed by physical exercise, in 
contrast with the results for all other dependent variables. This work suggests 
that QTVI is a consistent measure of cardiac ventricular function, and as such is a 
more useful index than other parameters based on RR or QT interval alone.
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Chapter 2 Autonomic nervous system control of the cardiovascular system
2.1 The peripheral nervous system
The peripheral nervous system (PNS) consists of all nerves and neurons which do 
not lie within the central nervous system (CNS) (Appendix I), but extend 
outward serving the limbs and organs. It provides a nerve supply to the rest of the 
body and relays messages to and from the CNS. It consists of 12 pairs of cranial 
nerves which originate in the brain and 31 pairs of spinal nerves which originate 
at the spinal cord. The spinal nerve pairs are subdivided into 8  pairs of cervical 
nerves, 12 pairs of thoracic nerves, 5 pairs of lumbar nerves, 5 pairs of sacral 
nerves and 1 pair of coccygeal nerves, corresponding to the vertebrae to which 
they are connected.
Unlike the CNS, the PNS is not protected by bone or the blood-brain barrier (the 
endothelial cells which protect the brain from blood chemicals) leaving it 
vulnerable to toxins and injury. The PNS consists of the somatic nervous system 
(SNS), the enteric nervous system (ENS) and the autonomic nervous system 
(ANS). Each of the 43 nerve pairs of the PNS belong to one or more of these 
systems.
2.1.1 The somatic nervous system
The somatic nervous system is responsible for coordinating bodily movement. It 
is that part of the PNS associated with volitional control through the recruitment 
of skeletal muscle and with the reception of external stimuli, hence it regulates 
the body within its surroundings through the senses. The SNS therefore includes 
all the neurons connected with muscle, skin and the sensory organs. The SNS 
however also provides an automatic and involuntary reaction to a stimulus,
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examples being the patellar reflex, the aversion reflex and correction in response 
to postural imbalance.
2.1.2 The enteric nervous system
The enteric nervous system manages all aspects of digestion, from the oesophagus 
to the stomach, small intestine and colon. There are more neurons in the ENS 
than there are in the spinal cord, the system having immense intricacy. The ENS 
is responsible for the complex behaviour of the bowel propulsive peristaltic 
movement, and other motions which result in digestive mixing. The ENS also 
regulates intestinal blood supply, mucosal epithelial water and electrolyte 
transport. The ENS is capable of autonomous behaviour including the 
coordination of reflexes, as it receives considerable innervation from the ANS and 
thus is often considered to be part of it.
2.1.3 The autonomic nervous system
It was noted by Gaskell in 1886 following demonstration of the complete 
structural and functional relationships of the ANS, that some nerves provide 
inhibitory and excitatory function. The ANS is the part of the PNS that controls 
homeostasis, the constancy of the content in tissues of gasses, ions and nutrients 
and the maintenance of heart rate and blood pressure (Cannon 1932). It does so 
largely by controlling cardiovascular and respiratory functions, but also 
salivation, perspiration, pupil diameter, genitourinary function and secretions 
from exocrine and endocrine glands, by supplying nerves to all internal organs 
and to blood vessels. It may therefore be considered predominantly an efferent 
system (Freeman etal. 2006). The ANS is controlled by the hypothalamus and so 
its actions are not controlled by the brain but are involuntary and reflex in 
nature.
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Autonomic nerves constitute all efferent fibres which leave the CNS, with the 
exception of those which innervate skeletal muscle. There are however some 
afferent autonomic fibres which mediate visceral sensation and regulate 
vasomotor and respiratory reflexes, examples being the baroreceptors and 
chemoreceptors in the carotid sinus and aortic arch (section 2 .6 ) which are 
concerned with the control of heart rate, blood pressure and respiratory activity. 
Signals from these afferent fibres are usually carried to the CNS by major 
autonomic nerves such as the vagus, splanchnic or pelvic nerves, although 
afferent pain fibres from blood vessels may be carried by somatic nerves. Motor 
neurons of the ANS belong to one of three categories that have specific effects on 
their target organs: sympathetic, parasympathetic or enteric.
2.1.3.1 The sympathetic nervous supply
The term sympathetic originated in the second century A.D. when Galen 
suggested that “sympathy” exists between all parts of the body. The sympathetic 
nervous system consists of ganglia which are anterior to the vertebral column and 
travel the length of the body from thoracic vertebra T1 through to lumbar 
vertebra L2. The system is therefore known as the thoraco-lumbar outflow 
(Freeman etal. 2006). The sympathetic nervous system responds to impending 
danger or stress and enables the body to be prepared for “fight or flight”. Its 
primary function is to increase cardiac output during episodes of stress.
Other sympathetic responses include diversion of blood flow from the skin and 
splanchnic vessels (vessels supplying and draining the viscera) to those supplying 
skeletal muscle, raised heart rate and blood pressure, increased pupil dilation and 
lens relaxation allowing more light to enter the eyes, bronchiolar dilation, 
contraction of sphincters and metabolic changes such as the mobilisation of fat
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and glycogen, along with the sense of excitement one feels owing to the increase 
of noradrenaline (Section 2.4) in the vascular system.
2.1.3.2 The parasympathetic nervous supply
Parasympathetic nervous fibres exit the brain stem and sacral segments of the 
spinal cord and supply the thorax, abdomen and pelvic regions via the vagus, 
oculomotor, facial and glossopharyngeal nerves (these are cranial nerves X, III,
VII and EX respectively) and also via the spinal nerves that exit the cord from the 
sacral vertebrae S2 through to S4. The sacral neural fibres form pelvic plexuses 
which innervate the distal colon, rectum, bladder and reproductive organs; the 
system is therefore described as the craniosacral outflow (Freeman etal. 2006). 
Parasympathetic influence is evident when one is resting and feels relaxed and is 
responsible for pupil constriction, lowering of heart rate, dilation of the blood 
vessels, and stimulation of the digestive system (salivary gland secretion and 
acceleration of intestinal peristalsis) and genitourinary system. In keeping with 
the “rest and digest” functions, parasympathetic activity mediates digestion of 
food and indirectly, the absorption of nutrients and excretion of waste material.
2.1.3.3 Pharmacology: Cholinergic effects
Autonomic pre-ganglionic neurons in the CNS and all parasympathetic post­
ganglionic neurons release acetylcholine (ACh). They are termed cholinergic 
neurons and ACh release is followed by increased parasympathetic mediation of 
target-organ function. The specific ACh receptors have been subdivided 
pharmacologically according to the actions of the alkaloids muscarine and 
nicotine. The actions of ACh at pre-ganglionic regions in both the 
parasympathetic and sympathetic systems are mimicked by nicotine and all 
autonomic ganglia are therefore termed nicotinic. Nicotinic transmission also
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occurs at the neuromuscular junction, in the CNS, the adrenal medulla and at 
some sympathetic post-ganglionic sites. However, the action of ACh at the 
parasympathetic post-ganglionic nerve endings is mimicked by muscarine. 
Muscarinic transmission also occurs at certain sites in the CNS.
2.1.3.4 Pharmacology: Adrenergic effects
Norepinephrine (noradrenaline) and epinephrine (adrenaline) are hormones 
classed as catecholamines. The majority of sympathetic post-ganglionic neurons 
release norepinephrine and so are termed adrenergic; that is, they are strongly 
influenced by sensory inputs from somatic and visceral sources. Exceptions to this 
classification are limited to populations of sympathetic neurons innervating sweat 
glands, which are cholinergic. The adrenal medulla are the central cores of the 
adrenal glands, which are under the control of the hypothalamus; they are 
innervated by sympathetic pre-ganglionic neurons and respond to nervous 
impulses, thereby releasing adrenaline and noradrenaline into the blood stream, 
although the majority of noradrenaline is synthesised to adrenaline. In situations 
involving physical or psychological stress, secretion rate is markedly increased, 
producing a widespread increase in sympathetic activity.
The actions of catecholamines are mediated by specific postsynaptic cell surface 
receptors. Pharmacological subdivision of these receptors into two groups (a and 
P) was first suggested by Ahlquist (1948), based upon the effects of adrenaline at 
peripheral sympathetic sites. These have since been further subdivided on 
functional and anatomical grounds. Thus Pi-adrenoceptor mediated effects in the 
heart (increased force and rate of contraction) have been differentiated from 
those which produce smooth muscle relaxation in the bronchi and blood vessels 
(P2-adrenoceptor effects). Similarly, a-adrenoceptor mediated effects such as
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vasoconstriction have been termed ai-effects, to differentiate them from the 
feedback inhibition by noradrenaline on its own release from pre-synaptic 
terminals, which is mediated by a  2-adrenoceptors.
However, the classification is more complex. Many organs have both 0i and 02 
adrenoceptors; for example, the heart has one 0 2-adrenoceptor for every three 01- 
adrenoceptors. The receptors also show differing responses to adrenaline and 
noradrenaline. At 0i adrenoceptors in the heart, adrenaline and noradrenaline 
appear to have an equal effect, whereas 02 adrenoceptors in smooth muscle are 
more sensitive to circulating adrenaline than noradrenaline.
2.2 Electrical activity of the heart
The heart is the major organ of the cardiovascular system, causing blood to flow 
to all extremities of the body through the vasculature by repeated, rhythmic 
contractions which establish blood pressure. The sympathetic and 
parasympathetic nervous systems continuously moderate the inherent 
rhythmicity of the heart via their action on specific parts of it, with the final pace 
of the heart being defined by the balance between these two branches of the 
ANS.
The cardiac wall consists of three main layers. The epicardium is the outer layer 
of the wall and consists of connective tissue covered by epithelium. Beneath the 
epicardium lies the myocardium. The myocardium is composed of specialist 
cardiac muscle cells with the unique ability to carry action potentials as well as to 
contract, similar to neurons in nerve fibres. Some myocardial cells also have the 
property of automaticity, that is the ability to spontaneously generate an
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electrical action potential, and these particular myocytes are described as 
myogenic. The myocardium is subject to two opposed electrical control 
mechanisms. First-order electrical control is via the sinoatrial (SA) node and 
arises from sympathetic discharge in the region of the SA node. Second-order 
electrical control comes via parasympathetic influence from the spinal vertebral 
ganglia and vagus nerves. The innermost layer of the cardiac wall is the 
endocardium which lines the chambers of the heart, covers the heart valves and 
is continuous with the inner lining of the blood vessels. Purkinje fibres are also 
located in the endocardium, which participate in the electrical conduction and 
contraction of the cardiac ventricles.
Under normal conditions in a healthy heart, the SA node exhibits total control of 
the cardiac cycle, as its action potentials are initiated most frequently, exciting 
other cells to generate their own synchronised action potentials. The spontaneous 
depolarisation of the SA node is continuously modulated by sympathetic and 
parasympathetic neural input, sympathetic via the superior, middle and inferior 
nerves and parasympathetic via the vagus nerve. Sympathetic and 
parasympathetic nerve fibres terminate at the SA node, the atria, the ventricles 
and the coronary vessels and parasympathetic nerve fibres also terminate at the 
AV node.
2.3 Electrocardiography and haemodynamic monitoring
An electrocardiograph (ECG) is an expression of the ionic cellular changes 
generated during the myocardial depolarisation-repolarisation cycle and provides 
information on cardiac integrity via both its morphological and temporal 
characteristics. Although elaborate and sophisticated imaging facilities are used 
for assessing heart and circulation morphology and function, the ECG remains
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the first-step approach in patient evaluation (Passino & Emdin 2008) and is the 
single most commonly performed clinical investigation (Bayes de Luna etal. 
2006). The spread of electrical impulses (electrical depolarisation-repolarisation 
wavefront) that constitutes the heart beat is externally measurable by electrodes 
attached to the skin. Placed either side of the heart, these measure potential 
differences and hence electrical activity within different regions of the heart. An 
ECG therefore enables measurement and diagnosis of abnormal conduction and 
rhythm, particularly those caused by conductive tissue damage. Techniques based 
on temporal analysis of the ECG have been used as markers of autonomic 
modulation of the heart. These have included HRV, QT interval variability and 
heart rate turbulence analyses.
Whereas a 12-lead ECG provides a representation of cardiac electrical activity, 
typically of short duration and used for morphological diagnosis, a Holter or 
ambulatory monitor allows the recording and subsequent temporal analysis of 
cardiac rhythm over 24 hours or more, which has particular value for individuals 
with arrhythmias. Holter monitors usually employ between 3 and 8  leads 
connected to a small recorder which is typically attached to the individual’s 
clothing.
Einthoven in 1895 identified the primary topographic features of the ECG 
waveform now known as the PQRST waveform; these are:
• The P wave, representing atrial depolarisation which is of low amplitude 
and therefore at times masked by the QRS complex
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• The PR interval, representing the time taken for the electrical impulse to 
pass from the SA node and through the AV node and the His-Purkinje 
system, thereby initiating ventricular contraction
• The QRS complex, representing ventricular depolarisation
• The T wave, representing the recovery of ventricular cells to pre­
excitation potentials
A typical cardiac waveform is illustrated in Figure 2.1.
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Figure 2.1 A typical cardiac waveform (http://campus-
llamaquique.uniovi.es/virtual/docencia/teleco/4.aplicaciones/biomedica/bio.htm)
2.3.1 Temporal ECG parameters: RR interval
The RR interval is the time elapsed between two adjacent R waves on the ECG. 
Strictly, as the P wave represents atrial depolarisation and is therefore the 
beginning of the cardiac cycle, a full cycle is represented by the PP interval, but 
as the R wave is more easily identifiable on the ECG owing to difficulties in
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precisely verifying P wave onset, the RR interval is used as a surrogate and more 
accurate index of cardiac cycle duration.
2.3.2 Temporal ECG measurements: QT interval
The QT interval is measured from the beginning of the QRS complex to the end 
of the T wave and therefore represents the time for both ventricular 
depolarisation and repolarisation to occur. There is no distinct atrial 
repolarisation wave represented in the ECG waveform as it occurs during 
ventricular depolarisation, and since it has small amplitude it is masked by the 
larger ventricular-generated QRS complex. The QT interval on the standard 12- 
lead ECG is influenced by a variety of physiological and pathological factors such 
as heart rate, autonomic balance, hormonal concentration, drugs, heart disease, 
ventricular dysfunction and electrolyte disturbances (Sredniawa et al. 2005) and 
also genes and gene products (Moss 2006) that can modify the function of specific 
cardiac ion channels.
The QT interval and its variability have diagnostic and screening relevance with 
regard to pro-arrhythmic potential. Recently the importance of careful 
assessment of all drugs for pro arrhythmic effects has been recognised (Sheridan 
2000, Shah 2002). Drugs that have the potential to alter cardiac ion channel 
activity resulting in delayed conduction or repolarisation (hence a prolonged QT 
interval) are routinely screened in the preclinical and clinical settings (Berger et 
al. 2005). Additionally, congenital long QT syndrome (LQTS) is an abnormality of 
cardiac repolarisation that can cause syncope and sudden death (Levine etal. 
2008). It was first described (Jervell & Lange-Nielsen 1957) in a family of four 
children with congenital deafness, syncope and QT interval prolongation, three 
of whom died suddenly. There are ten distinct genetic LQTS phenotypes, each
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with a specific ion channel abnormality (Levine etal. 2008). Notably, individuals 
with the LQT1 phenotype (a potassium channel abnormality; Chiang & Roden
(2 0 0 0 )) are most likely to experience a cardiac event during exercise, particularly 
and for as yet unexplained reasons, when swimming (Schwartz etal. 2001).
Detection of mean QT interval increases of the order of several milliseconds is 
subject to various difficulties such as improper lead placement, electrode noise, or 
an incorrect choice of leads. Notably QT prolongation is more evident in some 
leads than others (owing to both physiological and technical reasons) and 
different ECG machines can present varying values of QT interval for the same 
subject owing to the use of differing detection algorithms. In addition, incorrect 
choices for the start of the Q_wave and end of the T wave can occur owing to the 
relatively low amplitudes of these waves. Methodologically it is easier to measure 
from Q  onset to Ta (Tapex, the peak of the T wave) than to Te (Tend, the end of the T 
wave, where it meets the ECG baseline) (Davey 1999), although it remains 
unclear whether QT interval variability within the Ta-Te interval has importance. 
In support of the use of QTa interval is the finding that in normal resting subjects, 
most inter- and intra-individual QT interval variability occurs in the R to Ta 
portion of the QTe interval (Merri etal. 1989).
Ambulatory ECG (Holter) monitoring has allowed the assessment of dynamic QT 
under differing physiological states such as exercise and rest, and has facilitated 
beat-to-beat analysis over extended periods. Assessment of the QT interval and its 
relationship with the corresponding RR interval during various conditions (such 
as rest and exercise) is not, contrary to what might be expected, fixed or uniform. 
Quantification of the QT-RR relationship under different physiological 
conditions holds promise as a tool for identifying individuals at increased risk of
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arrhythmic events and for studying the effects of drugs on ventricular 
repolarisation (Sredniawa etal. 2005).
Throughout the subsequent sections of this chapter, QT interval adaptation is 
discussed where appropriate, in parallel with HRV in a range of 
pathophysiological conditions.
2.3.2.1 Heart rate correction of the QT interval
The QT interval typically needs correction for the influence of heart rate owing 
to the negative correlation between heart rate and QT interval. Slower heart rates 
are associated with longer QT intervals and vice versa. This can be problematic 
when attempting to distinguish between, for example, QT interval changes that 
are drug-induced and those caused by natural physiological processes. Heart rate 
correction aims to provide a standardised value that would have been measured 
in the same subject had the heart rate been 60 beats per minute and allows 
comparison between QT intervals recorded at different heart rates. Corrected QT 
interval (QTc) is commonly based around formulae proposed by Bazett (1920) and 
Fridericia (1920) (Equations 1 & 2) although there are many other formulae 
utilising logarithms, exponentials and regression.
Equation 1 (Bazett): QTc =
Equation 2 (Friderica): QTc =
To assess the performance of a particular heart rate correction formula, the 
correlation between QTc intervals calculated using the formula and the RR
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intervals can be assessed. If it differs from zero, the correction formula is not truly 
successful (Sredniawa etal. 2005).
Previous work has suggested that a specific correction formula may work well for 
a specific data set but might not be universally applicable (Malik 2001) as the 
formulae do not account for age, gender and levels of aerobic training. The 
reasons for this high inter-individual variability include environmental influence 
and inherent genetically determined differences in the QT-RR relationship 
(Batchvarov etal. 2002). In addition, females have longer QTc intervals than 
males (Genovesi et al. 2007) and the QT interval is prolonged during sleep 
(Extramiana etal. 2005). An ideal approach would be for each individual to have 
a personalised correction derived from different heart rates. A d  hoc correction 
which may be sufficient in clinical practice is too simplistic and inaccurate to be 
used in precise drug studies (Malik 2004), although there is no evidence that such 
individual rate correction would improve discrimination of diseases such as 
hereditary LQTS (Toivonen 2002). Bazett’s formula has been questioned as it 
over-corrects QT at high heart rates and under-corrects at low heart rates which 
can hide the pro-arrhythmic toxicity of drugs slowing the heart rate (Yash & Toal 
2003). The cube root correction of Friderica accounts for this but is not reliable at 
high heart rates. It is thought that Bazett’s formula can only be applied to correct 
the QT interval within a range of heart rates between 50 and 90 beats per minute, 
the same limitation applying to Fridericia’s formula although to a lesser degree 
(Sredniawa etal. 2005).
The alternative use of the so-called “bin method” that matches heart rates of on- 
drug and off-drug data is linked to other potential difficulties (Malik 2005). The 
“bin method” compares QT intervals recorded at closely matched heart rates 
before and after intervention (either mechanical or pharmaceutical). Pairs of RR
22
and QT intervals are distributed into groups (bins) according to the immediately 
preceding RR value. Post intervention pairs are collected at the same value of RR, 
but with new, altered QT interval values and compared with the baseline pairs. 
The bin method has particular importance in infants (as this group has higher 
heart rates owing to smaller ventricular size and greater metabolic needs), in 
individuals with slow or high heart rates and when investigating drugs which 
induce significant changes in heart rate (Sredniawa etal. 2005), as it allows the 
comparison of QT interval for any RR interval. The bin method has limitations in 
that there are not always sufficient numbers of recorded QT intervals available 
for analysis and owing to autonomic tone, QT interval may be different at 
identical heart rates, (the phenomenon of “hysteresis”). It should also be noted 
that heart rate correction ignores the dynamicity of QT-RR relationship (Yash & 
Toal 2003).
23.2.2 QT-RR hysteresis
It has been observed that QT changes lag several minutes behind heart rate 
changes, a phenomenon referred to as “QT-RR hysteresis” (Ahnve & Vallin 1982). 
Simply, the QT interval does not adapt to heart rate changes quickly, taking a 
number of beats to adjust in response to changes in heart rate. This lag has been 
shown in cellular and pacing studies (Franz etal. 1988, Lau etal. 1988, Lee etal.
1999) to have two components:
1. An immediate rapid component with a very short time-constant that 
acts over 1 - 2  cardiac cycles
2. A delayed component with a time constant of the order of 1 minute or 
greater
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Toivonen (2002) has since noted that full adaptation of the QT interval to a 
change in heart rate takes between one and three minutes. New methods of QT 
dynamics assessment that take into account these phenomena have been 
proposed (Sredniawa etal. 2005). These methods include the computation of 
linear regressions between QT and RR intervals and measures of the regression 
gradient, this defining the percentage of QT interval change per unit of RR 
interval change. Using these methods, dynamic QT changes have been observed 
in relation to ischemic heart disease, advanced heart failure and cardiac arrest.
Pueyo et al. (2003) used a global optimisation algorithm to estimate the lag 
between RR and QT changes. They found that on average, 140 seconds of the 
preceding RR data have an influence on the QT interval. Benatar & Decraene
(2001) quantified RR, QT and QTc in children at rest, during high-intensity 
physical exercise, and during six minutes of post-exercise recovery. They 
observed that lengthening of the QT interval in response to decreasing heart rate 
began only after two minutes of recovery. Notably, Chauhan et al. (2002) 
observed that QT hysteresis values at one and two minutes post-exercise were 
significantly greater in women than in men, which suggests that the 
cardiovascular response to exercise and exercise training may be different in 
males and females (Genovesi etal. 2007). These authors suggest that females in 
particular may benefit from intervention aimed at increasing physical activity as a 
tool for prevention of cardiovascular morbidity and mortality.
2.3.2.3 The QT variability index
The QT variability index (QTVI) suggested by Berger etal. (1997) quantifies the 
relative magnitudes of temporal variability in QT and RR intervals and has been 
interpreted as an indirect measure of autonomic regulation of cardiac ventricular
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electrophysiology, although this hypothesis has never been directly tested (Malik 
2008). QTVI is the base 10 log ratio of QT variability (QTv) normalised for mean 
QT interval (QTm) squared and heart rate variability (RRv) normalised for mean 
heart rate (RRm) squared:
The QTVI therefore compares the magnitude of temporal variability in QT and 
RR time-series. The ability to assess ANS influence at the ventricular level is 
appealing as it is there that ventricular arrhythmias originate (Malik 2008).
Several previous studies have indicated an association between changes in QTVI 
and altered ANS activity. QTVI is decreased after postural tilt in healthy subjects 
(Piccirillo etal. 2001) and is increased in individuals with chronic renal failure, 
this being associated with diabetes and coronary disease (Johansson et al. 2004) 
and in individuals with congestive heart failure (Raghunandan etal. 2005). 
Moreover increased QTVI is a risk factor for sudden cardiac death (Atiga et al. 
1998), indicates a greater susceptibility for malignant ventricular arrhythmias 
(Berger etal. 1997, Atiga etal. 1998) and is associated with an independent risk 
for ventricular tachycardia or ventricular fibrillation (Haigney etal. 2004). In 
asymptomatic individuals with congestive heart failure and mild ventricular 
systolic dysfunction, the QTVI could be helpful in stratifying the risk of sudden 
cardiac death (Piccirillo etal. 2007). Furthermore, the combination of a high 
QTVI and low RR variability is associated with an increased risk of primary 
cardiac arrest among individuals without clinically recognised heart disease 
(Whitsel etal. 2001). It is also notable that Atiga etal. (1998) suggested a non­
exercise QTVI value of 0.1 or greater to be a discriminator for higher risk of 
arrhythmic events. QTVI and its association with ventricular function in healthy 
adults during rest and exercise is detailed in chapter 5.
(QTv)/(QTm)
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The first study (Baumert et al. 2008a) of the relationship between QT variability 
and cardiac norepinephrine spillover (measuring cardiac sympathetic activity, the 
direct “gold-standard”), conducted in individuals with depression and panic 
disorder, was unable to find any correlation between the variables. This resulted 
from two facets of QTVI being problematic. Firstly, QT interval measurements 
neglect hysteresis and secondly, exact QT interval duration in any selected ECG 
lead does not provide a consistent measure of the overall duration of ventricular 
repolarisation (Malik 2008).
2.3.3 Haemodynamic monitoring
Critical care patients regularly require determination of their cardiac output 
(CO), typically expressed as the volume of blood ejected into systemic circulation 
from the left ventricle per minute (De Maria & Raisinghani 2000). The primary 
aim of haemodynamic monitoring is the determination of the adequacy of oxygen 
delivery to the tissues (Summers etal. 2003). Whilst determination of blood 
pressure, heart rate, respiratory rate and oxygen saturation is clinically readily 
available, the application of these measurements to provide an assessment of the 
true haemodynamic state is difficult, as blood pressure and heart rate are not well 
correlated with blood flow in acute clinical conditions (Wo etal. 1993).
2.3.3.1 Traditional indices of cardiac output
CO is commonly determined via a thermodilution pulmonary artery balloon 
flotation Swan-Ganz catheter (Engoren & Barbee 2005) although the process has 
been associated with complications related to its invasiveness, such as 
pneumothorax, arterial puncture, arrhythmias and bacteremia, hence questions 
remain regarding the efficacy of catheter use (Levett & Replogle 1979, Stetz etal. 
1982, Nishikawa & Dohi 1993, Connors etal. 1996, Kern & Shoemaker 2002,
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Sandham etal. 2003). Clinicians do not yet have a “gold standard” for the 
measurement of CO (De Maria & Raisinghani 2000, Chakravarthy 2008). 
However, traditional standards remain: the dye dilution method which is 
similarly invasive and is unable to measure beat-to-beat changes (Spiering et al. 
1998); or the Fick method (Engoren & Barbee 2005) which has limited use in 
individuals with lung abnormalities (Light 1988, Takala etal. 1989) as it relies on 
the analysis of inspired and expired gases. In current practice however, gas 
analysis is not routinely conducted, hence thermodilution has replaced the Fick 
method as the reference standard for CO measurement (Albert et al. 2004).
2.3.3.2 Impedance cardiography
Impedance cardiography (ICG) is a non-invasive technique for the evaluation of 
haemodynamic parameters (Strobeck & Silver 2004) and also records the 
electrical activity in the myocardium as a non-diagnostic ECG which is used as 
part of the ICG calculation process (De Maria & Raisinghani 2000). It allows the 
state of the circulatory system and trends in changes in haemodynamic 
parameters to be assessed easily, quickly and cheaply through the specific 
characterisation of stroke volume (SV) (the volume of blood pumped from the 
heart with each beat) and hence stroke volume index (SVI) (stroke volume 
normalised for body surface area to account for different body sizes and hence 
heart sizes) derived from the impedance waveform and the ECG using specific 
algorithms (De Maria & Raisinghani 2000). It also allows assessment of the 
following (adapted from Sodolski & Kutarski 2007):
• Total peripheral resistance (TPR) (the sum of the resistance of all 
peripheral vasculature)
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• Contractility -  the measurement of acceleration index (ACI) (a measure of 
the inotropic state of the myocardium)
• Left ventricular ejection time (LVET) (the time for ejection of blood from 
the left ventricle)
• End diastolic volume (EDV) (the blood volume in a ventricle at the end of 
diastole)
• Ejection fraction (EF) (the fraction of the end diastolic volume pumped 
out of a ventricle per heat)
• Left ventricular work index (LVWI) (the work the left ventricle does in 
pumping blood each minute)
• Thoracic fluid content (TFC) (a reflection of the total (intravascular and 
extravascular) fluid volume contained within the thorax)
• Systolic and diastolic blood pressures (BP)
• Pulse pressure (PP) (the change in BP over a cardiac cycle)
One new device for the non-invasive monitoring of haemodynamic function is 
the Task Force Haemodynamic Monitor (TFM) (CNSystems Medizintechnik 
GMBH, Austria), which allows the beat-to-beat analysis of SV and CO along with 
beat-to-beat BP analysis and the derivation of TPR (Fortin etal. 1997, Fortin etal. 
1998, Gratze etal. 1998).
2.3.3.3 The theory of impedance cardiography
The thorax is predominantly muscle, lung, fat, skin, bone and air, all of which 
have a high resistivity, and blood, which has a low resistivity resulting from its 
electrolytic fluid base (Summers etal. 2003). It can be postulated therefore that 
the majority of any electrical current applied to the thorax would flow through 
the blood filled aorta and vena cava as they offer the paths of least impedance. 
Kubicek etal. (1966) considered that observed impedance alterations occurring
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within this thoracic conductor would reflect changes in the volume of the great 
vessels. In the ICG method, low amplitude, high frequency alternating current is 
transmitted through the thorax and seeks the low impedance path of the aorta 
(Albert etal. 2004); each cardiac cycle alters the blood volume and velocity 
within the aorta which therefore alters its impedance. The ICG measures the 
baseline thoracic impedance and compares it with the dynamic impedance 
changes that occur through each cardiac cycle, providing a measure of CO. 
Typically, sensors are placed each side of the neck and thorax providing outer and 
inner “circuits”. The outer sensors provide the electrical field and the inner 
sensors measure thoracic impedance.
From Ohm’s law, the impedance (z) between two points is equal to the ratio of 
the potential difference (E ) between the points and the size of the electrical 
current (/) flowing between the points:
Z = E /I
Furthermore, if impedance is dependent on the cross-sectional area (A), length 
(L) and resistivity (p) of the conductor, then:
Z = p{L/A)
Changes in impedance can be related to changes in volume (F) (where V — A x  
L) leading to:
Z = p(L2/V)
Hence, when applied to the body, the impedance (Z) of the thorax is inversely 
proportional to the content of fluid (V) within the thoracic cavity and this result 
is the fundamental principle behind the concept of ICG (Summers etal. 2003). 
ICG was pioneered by Nyboer etal. (1940) who used the technique to evaluate 
the flow of blood in limbs (Sodolski & Kutarski 2007). Their technique recorded a
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proportional impedance response to volumetric changes in the arm and related 
impedance change (8Z/8t ) to original base impedance (Z0) and volume change 
(8v/8t)  as follows:
6 V /8 t  =  -p{L2/ Z 2) 5Z/5t
The technique was then furthered by Kubicek etal. (1966) by the definition of a 
new equation determining SV which incorporated the maximum value of the first 
derivative of the impedance waveform [(8Z/8t )max] and LVET. The inclusion of 
(8Z/ 8t)max overcame the limitations of signal artifact produced by respiration, 
which prevented accurate assessment of ejection time, and magnitude of 
impedance change attributable to blood volume change in the aorta, hence 
(where SV represents 8V and LVET represents St):
57 = p(L2/ Z 02) (SZ /  8t)max LVET
Sramek (1982) refined the technique through the use of a truncated cone model 
of the thorax rather than the previous cylindrical model and proposed the length 
of the thorax to be 17% of the patient height. Bernstein (1986) modified it further 
by accounting for the mass of the individual in an attempt to more accurately 
define the thoracic volume.
The TFM utilises a combination of refined hardware and software based on the 
Kubicek and Sramek modifications detailed above and a novel set of shorthand 
electrodes which combine ease of application and reproducibility by creating a 
particularly homogeneous electrical field in the thorax (Fortin etal. 2006).
2.3.3.4 Clinical application of impedance cardiography
ICG is used in the diagnosis and treatment of hypertensive patients (Sharman et 
al. 2004, Strobeck & Silver 2004, Ferrario 2005, Ventura et al. 2005) as
hypertension is associated with abnormal CO and arterial distensibility which can 
be calculated via the relationship between SV and PP (Sodolski & Kutarski 2007). 
It has also had utility in therapeutic decision making in dyspnoea (Springfield et 
al. 2004, Strobeck & Silver 2004), coronary artery bypass surgery recuperative 
care (Kaukinen etal. 2003, Van De Water etal. 2003, Kokkonen etal. 2005), in 
intensive care (Neath etal. 2005, Veale etal. 2005), in dialysis patients (Yoshii et 
al. 2005, Wynne etal. 2006), in the optimisation of cardiac pacemaker 
programming (Belott 1999, Tse etal. 2003, Gimbel 2005) and in heart failure 
(Yancy & Abraham 2003, Vijayaraghavan etal. 2004), although it should be noted 
that a recent study (Kieback etal. 2009) found poor correlation between the ICG 
and thermodilution methods in measuring SVI in this group of individuals. 
Furthermore, ICG has been used in monitoring circulatory system changes during 
pregnancy (Heethaar etal. 1995, van Oppen etal. 1996).
2.3.3.5 Comparison of cardiac output determination methods
Early generation ICG showed inconsistent performance (Belardinelli et al. 1996, 
Marik etal. 1997) as there was consistent overestimation of CO (De Maria & 
Raisinghani 2000). Despite the algorithmic improvements made by Sramek (1982) 
and Bernstein (1986), results were weakly correlated with thermodilution and the 
Fick method (Yakimets & Jensen 1995) and it appeared therefore that ICG would 
have little useful clinical application (Marik etal. 1997, De Maria & Raisinghani
2000). However, improvements in signal processing, software, hardware and 
algorithmic calculation have led to ICG becoming a valuable investigative tool 
(Sodolski & Kutarski 2007). Current generation devices are able to provide 
precise, repeatable results (Sodolski & Kutarski 2007) which are comparable with 
results obtained from invasive methods as confirmed in multiple comparative 
studies (De Maria & Raisinghani 2000, Greenberg et al. 2000, Strobeck et al. 2000, 
Drazner etal. 2002, Sageman etal. 2002, Van De Water etal. 2003, Strobeck &
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Silver 2004) and the trends of ICG-derived CO changes closely match CO changes 
assessed by thermodilution (Shoemaker etal. 1998). Thermodilution is known to 
have a variation of up to 20% in individual measurements (De Maria & 
Raisinghani 2000) which is improved to 10% variation by averaging over three 
measurements (Fortin etal. 2006). However, the available data would not yet 
support ICG replacing invasive methods in the critical care setting (Bayram & 
Yancy 2009). Notably, ICG can now be used to record beat-to-beat measurements 
and to electronically mark events in relation to postural changes and changes in 
exercise workload (De Maria & Raisinghani 2000).
Specifically for the TFM however, the variation of CO is smaller and hence the 
reproducibility of results is better when compared with thermodilution, even in 
individuals with severe heart failure (Fortin et al. 2006). Fortin et al. (2006) 
attributed this to the modified algorithm used and the new electrode array 
producing a stable electrical field. They concluded that the TFM appears suitable 
for monitoring intensive care cardiac patients.
2.3.3.6 Limitations of impedance cardiography
ICG results are considered unreliable when there is consistent aortic 
insufficiency, septic shock or hypertension, in individuals of height less than 120 
cm or over 230 cm and of mass less than 30 kg or over 155 kg (Sodolski &
Kutarski 2007). Specifically for the TFM, inaccurate CO values have been found 
in the presence of cardiac shunt, in individuals with heart valve insufficiency or 
stenosis and in individuals with high levels of thoracic fluid accumulation (Fortin 
etal. 2006).
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2.4 Chronotropic effects on the heart
Heart rate regulation is a highly intricate process controlled by components of the 
CNS and PNS through positive and negative feedback loops, giving rise to very 
complicated dynamics (Kanters etal. 1996). Physically, cardiac control is 
overseen by:
• The medulla oblongata processing sensory information from the ANS
• The higher somatomotor centres of the brain constantly updating the 
medulla oblongata with neural information to regulate cardiac output
• The hypothalamus which transmits physical expressions of emotion via 
the ANS
• Sensory receptors providing peripheral input from the viscera leading to 
neurochemical release
• Renal control of blood volume and the renin-angiotensin system (section 
2.4.2)
• Further endocrine factors including thyroxin and reproductive hormones
• Respiratory influence including the respiratory sinus arrhythmia (RSA) 
(section 2.5.4.2.4)
Chronotropic effects on the heart are exerted by the following physiological 
parameters: blood pressure, blood composition, temperature, breathing rate and 
breath amplitude. These influences are achieved via the release of chemical 
substances which act on the heart to cause a positive or negative chronotropic 
effect as shown in Table 2.1.
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Table 2.1 Chemical substances which chronotropically affect the heart
Chemical Released By Chronotropic effect
Noradrenaline
(norepinephrine) Sympathetic ANS fibres positive
Adrenaline
(epinephrine) Adrenal medulla positive
Acetylcholine Parasympathetic ANS fibres negative
2.4.1 Chronotropic influences of the ANS
Sympathetic activity increases the rate of atrial depolarisation via the release of 
noradrenaline at the SA node, leading to tachycardia and decreased HRV. The 
tendency toward sympathetic influence exists even during conditions of 
equilibrium. Parasympathetic stimulation favours the liberation of acetylcholine, 
which reduces the rate of depolarisation of the SA node leading to bradycardia 
and increased HRV. There also exists a tendency towards parasympathetic 
influence during equilibrium, hence the constantly modulating antagonistic 
nature of the two branches of the ANS (Lewis 2005). Additionally, this 
modulatory process is governed by the CNS with a closed loop control system.
The CNS receives input stimuli and uses the ANS to send the appropriate signal to 
the heart. This signal then alters heart rate as well as other heart rate-dependent 
cardiovascular variables such as blood pressure and information about these 
changes is fed back to the CNS (Garcfa-Sanchez etal ' 2006). Added to this is the 
input from other sensory feedback systems, lending immense complexity to 
overall heart rate modulation.
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2.4.2 The renin-angiotensin-aldosterone system
The renin-angiotensin-aldosterone system is an endocrine system that influences 
cardiac output through the regulation of blood volume, vascular resistance and 
hence blood pressure. This occurs via the formation of angiotensin I in blood and 
tissues which is synthesised from angiotensinogen, released by the liver. This is 
further synthesised by the angiotensin converting enzyme (ACE) to angiotensin 
II, which in turn stimulates the release of aldosterone from the adrenal cortex 
which acts to maintain fluid and sodium levels in the kidneys. Angiotensin II also 
constricts blood vessels hence increasing systemic vascular resistance and arterial 
pressure. There is widespread involvement of angiotensin II in the 
pathophysiology of cardiovascular diseases as well as diabetic nephropathy 
(Ferrario 2006). Angiotensin II also exerts several actions on the sympathetic 
nervous system and also on central baroreflex modulation (section 2.6.3), 
accounting for its ability to increase blood pressure without a reflex bradycardia 
(Reid 1992).
2.5 Heart rate variability
2.5.1 History and origins
The fluctuation of haemodynamic parameters on a beat-to-beat basis was 
reported although not described by Hales (1733) following the initial 
measurement of quantitative blood pressure through the insertion of a glass 
capillary tube into the carotid artery of a horse to view the blood level, “it would 
rise and fall at and after each pulse two, three, or four inches; and sometimes it 
would fall twelve or fourteen inches.” However, the Chinese physician Wang 
Shuhe wrote in the third century A.D. “If the pattern of the heart beat becomes 
as regular as the tapping of a woodpecker or the dripping of rain from the roof, 
the patient will be dead in four days” (Cheng 2000). The modem clinical
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relevance of HRV was identified when it was recognised that RR interval 
alterations preceded foetal distress and before a critical change in heart rate 
became apparent following possible hypoxia (Hon & Lee 1965). This relevance 
was furthered during the 1980s when HRV became a strong indicator of 
mortality following myocardial infarction (MI). This section will provide an 
overview of the standards, methods and relevance of HRV analysis.
2.5.2. What is heart rate variability?
Heart rate variability is the change in duration of cardiac cycles that is observed 
on a beat-to-beat basis in living organisms. HRV is commonly determined non- 
invasively via the ECG. Theoretically this would be achieved by measuring the 
time interval between the initial deflections of the P waves, or the intervals 
between this point and the end of the T wave, for consecutive cardiac cycles. 
However, technical difficulties render this method unrealistic and consequently, 
as previously discussed, an alternative proxy measure of cardiac cycle length, the 
“RR interval” (the duration between two adjacent R wave peaks) is used. 
Measurement of the RR interval thus allows calculation of heart rate (heart rate 
(beats per minute) = 60/RR (seconds)), and different authors have variously used 
either RR interval or heart rate as the basis of HRV investigations. HRV analysis 
therefore quantifies the amount by which the RR interval (or heart rate) changes 
from one cardiac cycle to the next.
2.5.3 General interpretation of HRV
HRV analysis provides a versatile, non-invasive clinical method for assessing the 
integrity of the cardiovascular control system in a variety of disease states 
(Akselrod etal. 1981). HRV is generally interpreted as a marker of the balance 
which exists between the influence of the sympathetic and parasympathetic
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influences of the ANS on the SA node of the heart (To reiterate: release of 
epinephrine and norepinephrine by the sympathetic nervous system and 
acetylcholine released by the parasympathetic nervous system (Malpas 2002)). 
Significantly altered HRV can be found not only in cardiac diseases but also in a 
wide variety of pathophysiological disorders characterised by disturbance of ANS 
function (Several of these disorders are detailed in Appendix II).
In the young and/or healthy individual, the physiological variability of the ANS is 
reflected by the pattern (variability and structural complexity) of HRV. With 
progressing age or disease, HRV becomes more regular with a marked loss of 
variability and complexity. Greater variability of heart rate indicates greater 
integrity of physiological control mechanisms and as a general rule, higher values 
of HRV are associated with more functionally efficient cardiac autonomic control 
mechanisms (Lewis 2005).
The relationship between the ANS and cardiac mortality has been widely 
investigated, with HRV acknowledged as one of the most sensitive markers of 
this relationship. Clinical data based on numerous studies since the early 1990s 
has generally considered decreased global HRV as a strong predictor of increased 
all-cause cardiac and/or arrhythmic mortality (Sztajzel 2004). Despite the 
intensive research on various aspects of HRV, it has not been definitively 
established why altered (reduced) HRV has been associated with early death 
(Huikuri etal. 1999). This is largely because conventional measures of HRV 
permit high risk group definition but without the specificity to identify 
individuals with elevated sudden cardiac death (SCD) risk (Kanters etal. 1996).
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2.5.4 Technical measurement of HRV
HRV assessment is, in general, performed to provide some form of evaluation of 
ANS function. There are two common settings in which HRV is measured 
(Kleiger etal. 2005). The first is assessment under controlled laboratory 
conditions with short-term measurements designed to challenge the ANS via 
certain manoeuvres (section 2.5.4.3.4). The second is the determination of HRV 
from 24-hour ECG recordings taken whilst subjects perform their usual daily 
activities. This method has been particularly useful for risk stratification in 
various pathologies and also for quantifying autonomic dysfunction (Eckberg 
1980, Billman & Hoskins 1986, Bigger etal. 1988).
2.5.4.1 Standards and guidelines for HRV assessment and interpretation
The establishment of the Task Force by the European Society of Cardiology and 
the North American Society of Pacing and Electrophysiology (Task Force ESC & 
NASPE 1996) led to the development and application of appropriate guidelines 
for the standardisation of HRV measurement and analysis. The specific goals of 
the Task Force were to:
• Standardise nomenclature and develop definitions of terms
• Specify standards of measurement
• Define physiological and pathophysiological correlates
• Describe currently appropriate clinical applications
• Identify areas for future research
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Cerutti etal. (2006) suggested another Task Force initiative would be appropriate 
to update current thinking and understanding, to take account of results obtained 
over the time since the initial Task Force.
2.5.4.2 Quantification of HRV
The Task Force guidelines (Task Force ESC & NASPE 1996) detail the 
quantification of HRV using statistical and geometrical methods in the time and 
frequency domains. HRV has been assessed in numerous ways, including both 
linear and non-linear methods, which are detailed below.
2.5.4.2.1 Linear time-domain methods
Time domain analysis gives a measure of the magnitude of HRV but little detail 
about the underlying rhythms which cause the variability, as the temporal 
sequence of individual RR intervals is lost during averaging. However, time 
domain indices are simple to calculate using statistics derived from the intervals 
between RR complexes on an ECG. For example, the standard deviation of all the 
RR intervals in a given period is referred to as SDNN. “NN” refers to normal-to- 
normal intervals, or adjacent beats originating at the SA node. SDNN is the square 
root of variance and as variance mathematically equates to the total power of 
spectral analysis, SDNN reflects all cyclic components responsible for variability 
over the recording period (Task Force ESC & NASPE 1996). SDNN is considered 
an estimate of overall HRV, encompassing sympathetic and parasympathetic 
influences (Piestrzeniewicz etal. 2008).
A further interval based measurement, SDANN, expresses the standard deviation 
of the average of RR intervals over segments (usually 5 minutes) of the total
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monitoring period and is considered to represent variation resulting from 
circadian rhythms (Freeman etal. 2006). SDANN provides a “smoothed out” 
version of SDNN by measuring long term fluctuations (Bigger etal. 1988) which 
result from mainly sympathetic output (Piestrzeniewicz et al. 2008). SDANN is 
less subject to errors caused by artifact than SDNN as the averaging process 
minimises the effects of missed beats and ectopic complexity, hence it is much 
less affected by abnormal rhythm and may even permit risk stratification in atrial 
fibrillation (Kleiger etal. 2005). Further time domain measures include RMSSD, 
the square root of the mean squared differences of successive RR intervals, NN50, 
the number of interval differences of successive RR intervals >50ms and pNN50, 
the proportion derived by dividing NN50 by the total number of RR intervals 
(Task Force ESC & NASPE 1996). The latter three indices are generally thought 
to reflect vagal modulation of the SA node (Freeman etal. 2006).
2.5A2.2 Geometric methods
The Task Force guidelines (Task Force ESC & NASPE 1996) suggested several 
time domain geometric measures of HRV such as the HRV triangular index, the 
differential index and the Poincar£ plot which is a method to assess complex non­
linear behaviour in physiological signals. In HRV analysis it presents a graphical 
representation of temporal correlations within the RR intervals (Woo etal. 1992). 
It is a scatter plot of an RR interval time-series plotted against the same series 
delayed by one cardiac interval. In the Poincare plot, the dispersion of points 
perpendicular to the line of identity (the “width” of the scatterplot) reflects the 
level of short-term variability (Brennan etal. 2002). This dispersion can be 
quantified by the standard deviation of the distances of the points from the line of 
identity and is equivalent to RMSSDNN. The standard deviation of points along 
the line of identity (the “length” of the scatterplot) reflects the standard deviation 
of the RR intervals (SDNN). A major advantage of Poincare plots is their ability to
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identify beat-to-beat cycles and patterns in data that are difficult to identify with 
spectral analysis (Brennan et al. 2002).
2.5.4.2.3 Further non-linear methods
Non-linear properties of RR time series have been investigated as linear statistical 
HRV measures do not describe complex dynamic RR interval time series (Meyer 
& Stiedl 2003). Non-linear measures make no assumption of uniformity (as 
required by linear descriptive statistical methods) and quantify dynamic aspects 
of heart rate control whilst maintaining the information on cardiac function 
(Komatsu etal. 1997). These non-linear methods differ from linear methods in 
that they measure the correlation properties of time series data, rather than their 
variability (Galaska etal. 2008). Such techniques have included measures of both 
the complexity or predictability of data (such as entropy, which indicates the 
logarithmic likelihood that the patterns of the data that are close to each other 
will remain close for the next comparison within a longer pattern (Khandoker et 
al. 2009)) and of the structure of data (such as self-similarity or scaling 
descriptions). For example, RR time series possess a strong 1/fP type scaling 
component (Kobayashi & Musha 1982, Peng etal. 1995), suggesting that RR time- 
series have the property of self-similarity, which can be determined from fractal 
analysis (Mandelbrot 1982, Meyer etal. 1998a,1998b). A mono-fractal process is 
characterised by a single scaling exponent throughout its duration. Several 
methods exist for the estimation of fractal properties in data, including power 
spectral density analysis, detrended fluctuation analysis (DFA), rescaled range 
analysis, dispersional analysis, maximum likelihood estimation and scaled 
windowed variance methods.
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Prior to selecting a fractal analysis method, an informed choice for the most 
appropriate descriptive model of the data under investigation is necessary, since 
each technique may perform differently for different model assumptions. The 
DFA technique introduced by Peng etal. (1995) yields a scaling exponent (a) that 
can be used to describe the correlation structure of data. In this way it is possible 
to distinguish between data that possess long-range power-law correlations (0.5< 
a  <ri.O) and those that have correlation structure but not in the form of a power- 
law (a >1.0). The specific cases of a  = 0.5, a  = 1.0 and a  = 1.5 indicate, 
respectively, data that are uncorrelated (white noise), data that have the 
correlation characteristics of 1/f noise, and data that have the correlation 
characteristics of Brown noise (the integral of white noise). Previous studies have 
shown that DFA can be used to estimate fractal properties in data assumed to 
follow either fractional Brownian motion (FBM) or fractional Gaussian noise 
(FGN) models (Eke etal. 2000,2002). DFA has an important advantage in that it 
avoids spurious detection of long-range correlations resulting from non- 
stationary conditions (Peng etal. 1995, Eke etal. 2000, Ivanov etal. 1999). It has 
also previously been asserted that the accuracy of estimating fractal properties 
depends on the length of the analysed data set, and that reliable determination 
requires at least 212 data points (Eke etal. 2000,2002). However, Delignieres etal. 
(2006) showed that DFA (and most other techniques) provide acceptable 
estimates of the scaling exponent for both FBM and FGN data sets consisting of 
128 or more points.
Several studies have associated the fractal characteristic of RR data with cardiac 
integrity, a lack of fractal structure being associated with pathology (Peng etal. 
1995, Iyengar etal. 1996, Pikkujamsa etal. 1999, Perkiomaki etal. 2003). 
Investigations of the effects of physical exercise on the fractal properties of RR 
data have also shown that the mono-fractal scaling exponent is influenced by
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physical stress (Tulppo etal. 2001, Hautala etal. 2003). The DFA a  scaling 
exponents for RR data have been shown to have clinical utility. For example, 
Makikallio etal. (1998) found that, of all the HRV indices assessed in that study, 
ai (short-term scaling exponent) was the strongest independent predictor in 
differentiating between patients with coronary artery disease (CAD) and healthy 
subjects (ai being significantly greater in patients). Jokinen etal. (2001) noted 
that cxi was more sensitive than traditional HRV measures in detecting age-related 
changes in HRV in patients with CAD. Recently Baumert et al. (2007) observed 
an increase in a  prior to the onset of ventricular fibrillation in patients with 
severe congestive heart failure (CHF).
However, there is some evidence that RR time-series are too complex to be 
adequately described by a single scaling exponent. Consequently the “multi­
fractal” analysis approach, introduced by Frisch & Parisi (1985) and Halsey etal. 
(1986), has been used to describe RR time-series in terms of multiple local scaling 
indices, with several authors associating changes in RR multi-fractality with 
cardiac pathology (Ivanov etal. 1999,2001).
To date there has been:
• No determination o f the influence ofage and physical fitness on the 
sensitivity o f the scaling factor to different exercise work loads
• No quantification o f the temporal behaviour o f the scaling factor during 
the post-exercise period
• No investigation o f the fractal nature o f the QT interval in the ECG
Two common indices of entropy, namely approximate entropy (ApEn; Pincus 
1991) and sample entropy (SampEn; Richman & Moorman 2000), can be used to
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quantify signal complexity within short time segments (Fusheng etal. 1998).
ApEn and SampEn both quantify the probability that sequences of patterns in a 
data set that are initially closely related remain close on the next incremental 
comparison within a specified tolerance, with lower entropy values indicating a 
more predictable, hence less complex time series. ApEn differs from SampEn in 
that its calculation involves counting a self-match for each sequence of patterns, 
and this leads to bias in ApEn (Pincus & Goldberger 1994, Pincus 1995). 
Consequently ApEn has two drawbacks: (1) it is a function of the length of the 
data set being analysed, yielding values lower than expected for short data sets (it 
suggests greater similarity within the data than actually exists); (2) it lacks relative 
consistency across differing testing conditions (i.e. for different parameters of the 
entropy index). Conversely, SampEn does not count self-matches and therefore 
has reduced bias. SampEn is also largely independent of record length and 
displays better relative consistency than ApEn (Richman & Moorman 2000).
Both ApEn and SampEn have been used to examine non-linear aspects of 
physiological time series data, including the RR interval derived from the ECG. 
Although the physiological interpretation of non-linear indices such as entropy is 
not completely understood, a reduction in non-linear characteristics has been 
associated with both cardiac and autonomic neural pathology. Previous studies 
have investigated the influence of various factors on the entropy (complexity) of 
RR time-series data, including the effects of age (Pikkujamsa etal. 1999, Platisa & 
Gal 2006b), gender (Ryan etal. 1994, Platisa & Gal 2006a), posture (Javorka etal. 
2002, Vuksanovic & Gal 2005, Merati etal. 2006) and both cardiac and non­
cardiac pathology (Jokinen etal. 2001, Merati etal. 2006, Platisa & Gal 2006b). 
There is therefore some evidence to suggest the utility of quantifying the entropy 
of cardiac interval time-series data to characterise and discriminate between 
different physiological and pathological states.
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• To date there ha ve been very few  in vestigations o f the effects o f exercise 
on RR entropy, and these have involved either single low-intensity 
workloads (Tulppo et al. 2001) or have quantified entropy only during the 
pre- and post-exercise periods (Javorka et al. 2002)
• The influence o f exercise work load on RR time-series complexity is 
unknown, and estimation o f the sensitivity o f entropy to changes in work 
load would further the fu ll characterisation o f the mediators o f H RV
• There has been no in vestigation o f the entropy o f the QT interval o f the 
ECG
2.5.4.2.4 Linear frequency domain methods
It is generally accepted that frequency domain processing of HRV signals may be 
of more use than time domain methods as information is provided on both the 
magnitude of variability and its specific distribution as a function of frequency. 
The frequency dependent manner in which the branches of the ANS influence 
heart rate fundamentally suggests the utility of power spectral density (PSD) 
analysis. It has been used extensively in the investigation of HRV and its 
underlying rhythms, along with other haemodynamic parameters since the 1970s 
(Hyndman etal. 1971, Sayers etal. 1973).
The PSD approach provides information on what the underlying HRV rhythms 
are, the physiological processes which they represent and the relative 
contribution of each underlying rhythm to heart rate. It is based on the spectral 
estimation methods of autoregression (AR) (parametric) or fast Fourier 
transformation (FFT) (non-parametric) which uses the notion that any periodic 
signal may be expressed as a sum of an infinite set of sine and cosine functions 
with different characteristic periods of oscillation and different weighting 
coefficients (Freeman etal. 2006). The advantage of the FFT-based methods is
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their computational efficiency compared with AR methods, although the latter 
provides smoother and more easily interpretable spectral shapes (Task Force ESC 
& NASPE 1996).
Three major bandwidths of activity have generally been identified in the power 
spectrum of adult beat-to-beat heart rate data. The power of the signal over a 
frequency bandwidth is determined from integration of the PSD over that 
frequency band. The three major bandwidths are:
• Very low-frequency (VLF) < 0.04 Hz
• Low-frequency (LF) 0.04 - 0.15 Hz (long term variability)
• High-frequency (HF) 0.15 - 0.4 Hz (short term variability)
These have been described physiologically by Pagani etal. (1986) and Akselrod et 
al. (1981,1985). In addition, Yamamoto etal. (1991) identified HF components at 
frequencies above the Task Force’s recommended HF bandwddth limit. These 
parasympathetically mediated HF components are probably of respiratory origin, 
possibly reflecting tidal volume modulation of heart rate, and could be either 
neurally or mechanically mediated (Lewis 2005).
VLF activity, which may only adequately be assessed by longer term 
measurement with large streams of uninterrupted data (Malliani 1999), is 
associated with thermoregulation (Sayers 1973), vasomotor activity (Kamath & 
Fallen 1993) and the renin-angiotensin system (Akselrod etal. 1981) and results 
from sympathetic discharge. For example, VLF might reflect the direct effect of 
temperature on pacemaker activity at the SA node and indirect effects mediated 
by the ANS altering heart rate and HRV. Raising the core body temperature from 
36.0°C to 36.6°C can cause an increase in heart rate of the order of 40 beats/min in
46
males, whereas cooling the heart initiates bradycardia, a technique used in 
cardiac surgery (Stauss 2003) with the likely effect of a reduction of HRV with 
increasing heart rate and vice versa.
The origin of the variability exhibited in the LF band has two opposing 
viewpoints and has been the most contentious with regard to physiological 
interpretation (Malpas 2002): 1) that it reflects sympathetic and parasympathetic 
tone and 2) that it is generated by baroreceptor modulation of sympathetic and 
parasympathetic tone (section 2.6.3) and is therefore largely an index of 
baroreceptor gain (Malliani etal. 1991), although others (Houle & Billman 1999) 
have suggested that this is dependent on the experimental means used to augment 
the sympathetic activity. Both viewpoints accept that LF oscillation involve the 
action of the SNS on the vasculature. Workers believing LF oscillations reflect 
sympathetic tone have proposed a central oscillator model which details an 
apparent ability of the CNS to generate LF oscillations. Work supporting this 
central oscillator theory has not been widely endorsed. The dominant and 
accepted physiological theory is that involving the baroreflex feedback loop 
which results from baroreceptor action. However, Malpas (2002) stated that 
baroreflex activity alone cannot fully explain LF oscillations and suggested that 
other reflex pathways or CNS components involved with modulating sympathetic 
nervous activity may alter the LF component. Contentiously, Malpas (2002) 
concluded that the Task Force’s (Task Force ESC & NASPE 1996) statement that a 
measure of autonomic balance (section 2.5.4.25) is obtainable from the LF/HF 
ratio appears incorrect.
HF activity is associated with respiratory modulation of HRV via both respiratory 
frequency and tidal volume influences (Hirsch & Bishop 1981, Bemadi etal.
1989, Yamamoto etal. 1991). The closed loop coupling between heart rate and
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blood pressure has an input into HRV through respiratory sinus arrhythmia 
(RSA). RSA is an autonomic phenomenon, which may have a positive influence 
on gas exchange in the lung via efficient ventilation/perfusion matching, 
although the mechanisms responsible are not totally clear (Yasuma & Hayano
2004). RSA is pronounced in children and young adults, declines with age and 
can be absent in the elderly and those with disease (Hughson etal. 1995). Heart 
rate decreases during expiration (expirational bradycardia) and increases during 
inspiration (inspirational tachycardia) through influences on the flow of 
sympathetic and parasympathetic impulses to the SA node. Inspiration impedes 
vagus nerve activity leading to sympathetic dominance and this pattern is 
reversed on expiration (Jordan & Spyer 1987). The difference in RR interval 
duration between inspiration and expiration can be regarded as an indication of 
the magnitude of RSA (Eckberg 1983, Task Force ESC & NASPE 1996).
Reduced RSA has been demonstrated in pathophysiology including CHF (Saul et 
al. 1988), hypertension (Maver etal. 2004), weight gain (Arrone et al. 1995) and 
diabetes (Lindmark et al. 2003) although the causal relationship is unclear, with a 
similar situation existing in the RSA and hypertension relationship (Masi et al. 
2007). The consistent associations found between autonomic dysregulation, 
indicated by reduced RSA, and a variety of cardiovascular risk factors and disease 
processes make RSA an important target for further investigation. However 
despite it being a commonly used variable in physiological research, the methods 
for its quantification are not standardised (Denver etal. 2007).
Inter-individual variations in the distribution of HRV power in resting humans 
have been partly explained by such factors as age, gender and exercise training 
status. Power in each of the standard frequency bandwidths has been found to be 
negatively correlated with age in both males and females (Ryan etal. 1994,
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Jensen-Urstad etal. 1997). It has also been reported that the LF and total power 
components of HRV are greater in males (Jensen-Urstad etal. 1997, Ramaekers et 
al. 1998), but that the HF component is greater in females (Ryan etal. 1994).
In addition to the frequency bands detailed above, the Task Force (Task Force 
ESC & NASPE 1996) classified an ultra low frequency band (<0.00335Hz), the 
most prominent oscillation within this band of the PSD being the circadian 
rhythm, with the ANS contributing significantly to circadian HRV via the 
paraventricular nucleus of the hypothalamus (Stauss 2003).
To fully appreciate the temporal dynamics of the band limited frequency 
components of the PSD, combined time and frequency domain analysis and 
presentation is required. In its simplest form, this can be achieved by splitting the 
acquired physiological signal into multiple periods of short duration (for example 
of the order of one minute each). The PSD is then calculated for each section in 
order to construct a graphical representation of the temporal dynamics of the 
power distribution (Lewis 2005). Assessment of the regions in which this time- 
frequency representation shows high levels of power in each of the frequency 
bands provides information on the dominant mechanisms of heart rate control by 
the ANS. Analyses of this kind have indicated that there is a marked difference in 
the cardiac control methods apparent during periods of rest compared with 
during exercise. Figure 2.2 (a) shows an example of an RR and time-frequency 
plot and Figure 2.2 (b) shows the equivalent data as a PSD plot.
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Figure 2.2 (a) Reproduced with permission from Lewis (2005)
The upper figure shows the RR interval for a healthy 21-year-old subject during 
rest (0-24 minutes), progressive cycling exercise to 85% age-predicted maximal 
heart rate (24-48 minutes) and post exercise recovery (48-63 minutes). The lower 
figure is a time-frequency spectrogram plot for the same subject over the same 
period as above. Signal power is indicated by greyscale, high power to low power 
dark grey to light grey. The horizontal lines delineate the three frequency 
bandwidths recommended for HRV analysis (Task Force ESC & NASPE 1996). 
During rest there is high power in each bandwidth with the LF component 
dominating. During exercise, LF and HF powers are progressively reduced and 
VLF becomes dominant. During recovery, power is restored to all three 
bandwidths but HF power remains below the resting value. An alternative to this, 
displaying averaged power distributions calculated during specified periods of
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rest, high intensity exercise and recovery for the same subject is given in figure
2.2 (b).
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Figure 2.2 (b) reproduced with permission from Lewis (2005)
Figure 2.2 (b) is an alternative representation of the data presented in Figure 2.2 
(a) for selected periods of rest (upper plot, circles), moderate to high intensity 
exercise (lower plot, squares) and subsequent recovery (middle plot, diamonds). 
Each plot represents the averaged power spectrum calculated for the following 
ten minute periods: Rest (1-10 minutes), exercise (30-40 minutes), recovery (50- 
60 minutes). A substantial reduction in power across the full range of frequencies 
during exercise may be seen and power continues to diminish during the 
recovery period. The VLF, LF and HF bands are indicated by the vertical lines.
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2.5.4.2.5 The concept of sympathovagal balance
The complex interactions between the sympathetic and parasympathetic inputs to 
the SA node has led to the concept of “sympathovagal balance” reflecting the 
state which results from the dynamic interplay between the two ANS branches 
(Goldberger 1999). The dominant ANS branch at a particular time is largely 
determined by the physical and emotional states of an individual owing to the 
different physiological control processes evident at that time (Lewis 2005). 
Changes in LF band power are generally understood to reflect a combination of 
sympathetic and parasympathetic ANS outflow variations, whilst changes in the 
HF band power reflect vagal nerve modulation of cardiac output. The relative 
power of the LF and HF components of the power spectrum (i.e. the LF/HF 
power ratio) provides an accurate index of sympathovagal balance (Kitney 1984, 
Malliani etal. 1991, Ori etal. 1992).
Investigators in the field have opposing views regarding sympathovagal balance 
(Goldberger 1999). The concept of sympathovagal balance has been challenged by 
Eckberg (1997) as the reciprocity of the opposing branches of the ANS is not 
always present (for example, the case of the mammalian diving reflex whereby 
facial immersion in cold water initiates bradycardia and peripheral 
vasoconstriction) although it is largely felt that this is inapplicable to humans 
(Malliani 1999). Eckberg (1997) stated that calculations of sympathovagal balance 
may obscure rather than illuminate human physiology and pathophysiology.
A major deficiency of the LF/HF power ratio approach in the assessment of 
sympathovagal balance is that the method is linear and therefore does not 
account for the non-linearity of the ANS (Zhong etal. 2006). These workers 
introduced principal dynamic mode (PDM) analysis as a method of separating the
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dynamic characteristics of the two branches of the ANS and reported that use of 
the traditional PSD method is less accurate for diagnosing dysautonomia 
compared with the PDM method.
As previously stated, altered levels of autonomic balance from normal values are 
associated with pathological conditions as well as aerobic training. For example, 
enhanced sympathetic and reduced vagal activities have been associated with 
hypertension (Pagani etal. 1986). Stressful conditions such as orthostatic tilt, 
Valsalva manoeuvre, mental stress or moderate physical exercise have been 
shown to alter the sympathovagal balance in favour of elevated sympathetic 
activity (increased LF activity, decreased HF activity), together with a reduction 
in total ANS activity (reduced overall power in the HRV spectra (Malliani et al. 
1991)). However, several studies have, in fact, shown HF to gradually increase 
during exercise, whereas LF power decreases (Pichon etal. 2004). The HF and LF 
components provide measurement of the degree of autonomic modulation within 
these bands rather than absolute magnitude of autonomic tone (Task Force ESC & 
NAPSE 1996) which could account for the paradoxical reported increase in the 
HF component. Findings such as these have suggested that the interplay of 
multiple inputs to the heart need to be considered rather than autonomic balance 
in isolation. The physiological controversy surrounding sympathovagal balance is 
an indication of the extremely complex continuous modulation from numerous 
physiological processes acting at the SA node. Sympathovagal balance is a concept 
that currently has no definition and the most precise way to actually characterise 
it is unknown (Goldberger 1999).
The majority of frequency domain HRV investigations have focused on the 
detection of spectral peaks, in the belief that they reflect single regulatory 
cardiovascular control mechanisms. However, non-periodic variations appear on
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the PSD as powers spread over a broadband frequency with “noise-like 
variability” (Braun etal. 1998). Therefore both periodic and non-periodic 
behaviour should be analysed, a methodological bridge possibly being Poincare 
scatter plots (Japundzic-Zigon 2001). However, the circumstances under which 
non-linear HRV is applicable have not been fully elucidated (Stein & Reddy 
2005) although these authors acknowledged that a combination of traditional and 
non-linear HRV may be optimal for risk stratification. They further suggested 
that future Holter systems should have more sensitive beat detection and 
classification algorithms to allow routine calculation of non-linear HRV for risk 
stratification in the clinical setting.
2.5.4.3 Technical procedures for HRV assessment
Assessment of HRV is based on the analysis of consecutive sinus rhythm RR 
intervals derived from either short term (2 to 5 minutes) or long term ECG 
recording (24 to 48 hours) (Gang & Malik 2003). In clinical applications long term 
recording methodology has been predominant whereas short term recordings can 
provide a practical and flexible assessment of HRV during non-steady-state 
conditions such as those occuring during normal ambulatory activity and postural 
manoeuvre or during physical exercise. Practically all modem Holter ECG 
recording systems have dedicated modules for the calculation of long and short­
term HRV (Cemtti etal. 2006).
2.5.4.3.1 Influence and standardisation of postural manoeuvre
Postural change from supine to standing is used in clinical practice to elicit an 
autonomic shift from parasympathetic to sympathetic dominance in an attempt to 
examine pathophysiological influences on ANS function. For example, the head- 
up tilt test compares favourably with other diagnostic methods for the evaluation
of syncope (Mukherjee etal. 2006). The HRV response to changing posture is a 
more sensitive measure of ANS cardiac modulation than supine resting HRV in 
individuals with cardiac pathology as damage in this case results primarily from 
sympathetic impairment which can only be estimated with a stimulus (Camethon 
etal. 2002). Orthostatic stress by passive graded head-up tilt reduces stroke 
volume through pooling of 500-1000 ml of blood in the lower extremities (Jacob 
etal. 1998) and activates the baroreflex (section 2.6.3) to maintain systemic blood 
pressure and cardiac output (Shamsuzzaman etal. 1998). Absence of this reflex 
may cause orthostatic hypotension and syncope (Freeman 2008) particularly in 
the elderly and in individuals with cardiovascular disease and is a classic 
manifestation of sympathetic vasoconstrictor failure.
HRV analysis for different body positions has been compared in supine and left 
and right recumbent positions (Ryan etal. 2003), supine and sitting positions 
(Sipinkova etal. 1997), supine and standing positions (Chen etal. 1999, Siebert et 
al. 2004) and supine, standing and head-up and head-down tilt positions (Lida et 
al. 1999). In healthy individuals, autonomic balance does not change significantly 
between different recumbent positions but is clearly different between supine 
and vertical postures (Watanabe etal. 2007). Also, compared with the supine 
position, the right lateral decubitus position can increase vagal modulation in the 
healthy and also in those with CAD and acute myocardial infarction (MI) (Yang 
et al. 2008) and this position induces the greatest increase in HRV complexity 
compared with supine and left lateral decubitus position (Kim etal. 2005). This 
has clear relevance for the need of standardisation of experimental protocols to 
avoid the confounding influences of postural variations between subjects.
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25.4.3.2 Influence and standardisation of respiration
Several respiratory influences such as breathing frequency or tidal volume affect 
HRV indices (Badra etal. 2001, Brown etal. 1993, Sanderson etal. 1996) possibly 
confounding results unless controlled. Although HRV analysis conducted with 
spontaneous breathing could remain unaffected in qualitative terms, it is of 
interest to control all possible confounders (Tripathi 2004).
Spectral HRV analysis (section 25.4.2.4) assumes that HF oscillations result from 
RSA whereas LF oscillations are purely cardiovascular in origin (Malliani et al. 
1991). This implies that lung-volume oscillation frequencies are within the HF 
band (Pinna et al. 2006) a condition which is not always apparent. For example, 
in some trained individuals, the breathing frequency drops into the LF band 
during rest (Strano etal. 1998). Also, in individuals with a regular HF band 
breathing pattern, the breathing frequency displays variability between and 
within individuals (Hirsch & Bishop 1981). This variability then would likely 
translate as a variability of HF spectral parameters (Pinna etal. 2006).
Voluntary respiratory control at frequencies > 0.2 Hz has been advocated in an 
attempt to standardise short-term HRV analysis by avoiding spectral leakage of 
respiratory components into the LF band; this should result in attributing LF and 
HF spectral components to the correct physiological processes (Brown etal. 1993, 
Sanderson etal. 1996, Cooke etal. 1998, Strano etal. 1998). However, consensus 
on the use of controlled breathing protocols in the absence of definitive 
standardised guidelines has not been reached (Pinna etal. 2006).
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25.4.3.3 Standardisation of water ingestion
Water ingestion has several effects on cardiovascular autonomic regulation 
(Brown etal. 2005). Drinking 500 ml of water augments sympathetic 
vasoconstrictor tone measured through muscle sympathetic nerve activity and 
plasma norepinephrine levels (Scott etal. 2001). In the healthy young adult, this 
sympathetic activation causes little or no change in blood pressure but results in a 
pressor response of around 11 mmHg in the healthy elderly (Jordan et al. 2000).
In individuals with autonomic failure, drinking water can increase blood pressure 
by more than 30 mmHg for an hour or more (Jordan et al. 2000, Cariga & Mathias
2001). The exact mechanism of this pressor effect has caused controversy (Brown 
et al. 2005). Cariga & Mathias (2001) argued that it is not ANS reflex based owing 
to the time course involved, but Jordan etal. (2000) refuted this as autonomic 
blockade virtually eliminates the pressor effect. As well as sympathetic activation, 
water drinking apparently enhances parasympathetic tone in the healthy young, 
demonstrated by heart rate reduction and an increase in HRV (Routledge et al.
2002). These authors considered that an increase in parasympathetic tone buffers 
the pressor effect, a central mechanism absent in older subjects and those with 
autonomic failure.
Clinically, excess water ingestion may result in dangerous blood pressure 
elevation in individuals with supine hypertension or poor autonomic regulation 
(Jordan 2002). However, drinking water significantly improves orthostatic 
tolerance (Lu et al. 2003) and benefits individuals with orthostatic syncope 
(Shannon etal. 2002) within 15 minutes of drinking 500 ml of water (Schroeder 
etal. 2002). Dehydration however produces decreased orthostatic tolerance and 
resting tachycardia (Charkoudian etal. 2003). These authors also reported that 
mild exercise-induced dehydration causes an increase in resting heart rate and a 
decrease in baroreceptor sensitivity (section 2.6.3.1) which are potential
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mechanisms for post-exercise orthostatic intolerance and tachycardia in healthy 
individuals. This has clear implications for the need for standardisation of water 
ingestion prior to the commencement of ANS functional testing.
2.5.4.3.4 Standard clinical assessment of cardiovascular autonomic function
Autonomic dysfunction may result from primary neurological disease such as 
pure autonomic failure or multiple system atrophy secondary to a wide range of 
diseases (Ducla-Soares etal. 2007). It is commonly assessed using tests for 
abnormalities in cardiovascular reflexes, although ANS integrity can also be 
tested in other systems including the gastrointestinal, urogenital, sudomotor and 
neuroendocrine systems (Ewing & Clarke 1986). However, tests in systems other 
than the cardiovascular are more complex (Ryder & Hardisty 1990). 
Cardiovascular tests involve measurement of heart rate or RR interval during the 
Valsalva manoeuvre (Levin 1966), deep breathing (Wheeler & Watkins 1973), 
normal breathing (Murray etal. 1975), standing up (Ewing etal. 1978), tilting 
from supine to upright (Sundkvist et al. 1980) and variation over 24-hours (Ewing 
etal. 1985). ANS assessment has also been described using the blood pressure 
response to standing up (Clarke etal. 1979), tilting from supine to upright 
(Sundkvist etal. 1980) and sustained hand grip (Ewing etal. 1974). Ewing etal. 
(1981) proposed a battery of five autonomic tests, the “Ewing battery”. It consists 
of:
Mean maximum/minimum ratio during three Valsalva manoeuvres (a test 
of parasympathetic function)
Mean maximum-minimum heart rate difference during six deep breaths (a 
test of parasympathetic function)
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• The 30/15 ratio after standing (ratio of the 30th RR interval to the 15th, 
upon standing there is a reflex tachycardia, maximal around the 15th beat 
which diminishes thereafter) (a test of parasympathetic function)
• The systolic blood pressure fall after standing (a test of sympathetic 
function)
• The diastolic blood pressure rise during sustained handgrip (a test of 
sympathetic function)
The use of this battery has allowed classification of autonomic dysfunction 
according to severity, patients being characterised according to the number of 
abnormal test results (Ryder & Hardisty 1990).
Following the work of Ewing etal. (1981), O’Brien etal. (1986) described the 
“O’Brien battery”. This uses only one Valsalva manoeuvre and only one deep 
breath, reducing testing time and patient discomfort. Additionally, the O’Brien 
battery “normal” ranges are age-related, unlike the Ewing battery which was 
developed before the influence of aging on autonomic function was considered 
(Ryder & Hardisty 1990). Wieling (1987) stated however that the O’Brien battery 
provides much numerical information which is not supported by physiological 
interpretation. This view was supported by Ewing (1990) with the suggestion that 
the O’Brien battery contains physiological misconception. Whichever battery is 
used, the tests are commonly time consuming, require standardisation and patient 
compliance and are not always performable owing to an individual’s clinical 
status (Khandoker etal. 2009).
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2.6 Blood pressure and the cardiac cycle
Blood pressure is the pressure exerted by the circulating blood on the walls of 
blood vessels and is a consequence of cardiac contraction which forces the stroke 
volume (the ejection of blood from one ventricle in a single beat) into the aorta. 
This initial flow causes blood pressure which results from the inherent resistance 
of the vasculature. The pumping action of the heart together with total peripheral 
resistance of the blood vessels, maintains a continuous pressure difference 
between the arterial and venous sides of the vascular system, so allowing tissue 
perfusion. The relationship between mean blood pressure (BP), stroke volume 
(SV) and total peripheral resistance (TPR) is given by:
BP = SV x H R x  TPR
TPR is an indicator of the existing state of vasoconstriction and vasodilation, 
predominantly controlled by sympathetic tone. Arterioles present the main 
resistance to the flow of blood. Sympathetic nerves, which control the action of 
arterial wall muscle fibre, maintain resistance at a level sufficient for high arterial 
blood pressure by constricting the channel of the arteriole. Arterial pressure is 
also affected by the chemical composition of the blood. Decreased oxygen or 
increased carbon dioxide partial pressures cause a reflex elevation of blood 
pressure. Respiratory activity is therefore an important regulator of arterial 
pressure. At each stage of the cardiac cycle, there is a synchronous fluctuation in 
blood pressure.
Variation in blood pressure is dependent on several inter-finked regulating 
mechanisms. Generally, positive chronotropic influences result in increased blood 
pressure, whilst negative chronotropic influences result in decreased blood 
pressure owing to the relationship between heart rate (HR) and cardiac output 
(CO).
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CO = HR x SV
Blood pressure is regulated via the vasomotor centre of the medulla oblongata. 
Output from the vasomotor centre changes the heart rate to return blood pressure 
to acceptable levels. The renin-angiotensin-aldosterone system also provides 
hormonal control of blood pressure through renin production causing increased 
circulating levels of angiotensin II. This leads to vasoconstriction and increased 
blood pressure and also to increased sodium, hence water retention in the blood.
The blood pressure regulatory mechanisms described above involves three 
physiological sensors as detailed below.
2.6.1 Mechanoreceptors
Mechanoreceptors are located in the left ventricle, right atrium and large veins 
and respond to force changes in cardiovascular walls. They act as physiological 
transducers, converting a physical variable into an electrochemical signal which 
is portrayed via changes in electrolyte and hormone concentrations.
2.6.2 Chemoreceptors
Chemoreceptors are located centrally in the medulla oblongata and in the 
periphery and respond to changes in the concentration of blood gases. 
Chemoreceptors, found in the carotid bodies, sense decreases in the oxygen 
content of the blood. Those found in the aortic bodies sense increases of carbon 
dioxide and hydrogen ion concentrations in the blood. Stimulation of these 
chemoreceptors causes an increase in respiratory rate which stimulates the 
vasomotor centre such that heart rate, cardiac output, and blood pressure are 
modified.
2.6.3 Baroreceptors
Baroreceptors are a specific type of mechanoreceptor located in the auricles of the 
heart and venae cavae, although those with highest sensitivity are found in the 
carotid sinuses and aortic arch. The carotid sinus baroreceptors are innervated by 
the glossopharyngeal nerve (cranial nerve IX); the aortic arch baroreceptors are 
innervated by the vagus nerve (cranial nerve X). Baroreceptor activity (neural 
response to stimulation) travels along these nerves to the medulla oblongata. 
Baroreceptors detect the pressure of blood flowing through them and regulate 
blood flow by signalling the need for an increase or decrease in TPR and CO 
hence providing an important short term neural control system for maintaining 
cardiovascular stability (Sato etal. 2005). This occurs via a negative feedback 
mechanism whereby blood pressure increases are detected and responded to 
through the inhibition of sympathetic and activation of parasympathetic signals 
from the cardiac control centre. Rising blood pressure initiates vascular stretching 
and baroreceptors are activated. Heart rate is reduced, peripheral vasculature is 
dilated and blood pressure is therefore decreased towards normal levels. 
Conversely, a drop in blood pressure causes a decrease in the number of signals 
received at the baroreceptors and thus a balancing increase in blood pressure and 
cardiac output occurs. The baroreceptors are also responsible for rapid 
adjustments in blood pressure as seen when one moves from a sitting to a 
standing position (section 2.5.4.3.1). During dynamic exercise, there exists the 
paradox of the requirement of elevated blood pressure and the blood pressure 
lowering function of the baroreceptor.
2.6.3.1 Baroreflex sensitivity
Cardiovascular baroreflex sensitivity (BRS) is the arterial baroreflex-mediated 
change in the RR interval per unit change in systolic blood pressure (Sagawa
1983). Reduced sensitivity of baroreflex control of heart rate has been used
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widely as a marker for cardiovascular disease, being associated with an adverse 
prognosis. Intervention aimed at improving BRS including physical training may 
reduce the risk of onset of cardiac events (Parati 2005). Influences such as 
respiration and central neural mechanisms and the action of the renin- 
angiotensin system continually influence BRS (Lanfranchi & Somers 2002).
BRS has been shown to decrease with age and in the presence of hypertension, 
CAD, physical deconditioning and heart failure (Kardos etal. 2001). Diminished 
BRS has also been shown to commonly occur in conjunction with diabetes and 
provides a marker of poor prognosis following MI (Ryan et al. 2007). In 
hypertensive individuals, diminished BRS is associated with increased blood 
pressure variability (BPV) as the baroreflex is unable to induce the necessary 
cardiac and vascular adjustments in response to short term blood pressure 
fluctuations. Lenard et al. (2005) explored BRS in young healthy sedentary and 
endurance exercise trained subjects with and without a family history of 
hypertension. They found that reduced BRS characterises not only individuals 
with hypertension but also normotensive offspring of hypertensive individuals.
Dynamic exercise simultaneously increases arterial pressure and heart rate (Sala- 
Mercado et al. 2007) through a combination of sympathoexcitation and vagal 
withdrawal. The arterial baroreflex operating point is reset in relation to 
workload although the specific contribution of each branch of the ANS is unclear 
(Ogoh etal. 2005). These authors demonstrated that in the transition from rest to 
mild, moderate and heavy exercise workloads, the operating point of the 
baroreflex is progressively relocated to operate around the prevailing arterial 
pressure. This work verified previous observations (Bevegard & Shepherd 1966, 
Melcher & Donald 1981, Walgenbach & Donald 1983, Walgenbach & Shepherd
1984) that baroreceptor control of heart rate is maintained around an exercise
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induced increase in heart rate. However, until the early 1990s, it was generally 
accepted that baroreflex control of blood pressure was lost during exercise to 
enable the parallel increase in heart rate (Raven etal. 2006). Many studies 
confirming baroreflex resetting have indicated that central command activation 
(a “feed-forward” mechanism resulting from the brain assessing future 
sympathetic activity requirements (Williamson et al. 2006)) or the exercise 
pressor reflex (generated by activation of mechanical and chemical skeletal 
muscle receptors) or both, facilitate the resetting (Iellamo etal. 1997, Norton et 
al. 1999, Ogoh etal. 2002, Gallagher etal. 2006).
Baroreceptor resetting in exercise mimics that in hypertension (Joyner 2006) and 
exercise therapy in the hypertensive can restore baroreflex control of heart rate 
and blood pressure to more normal values (Timmers etal. 2004).
2.6.3.2 Quantifying baroreceptor sensitivity
There are three main indices of BRS (Lanfranchi & Somers 2002). The first gives 
the degree of change in heart rate or sympathetic signal for a given change in 
blood pressure, quantified by the response of the cardiovascular system to the 
application of an external mechanical or pharmacological stimulus. The second is 
an alternative in-vivo approach which evaluates spontaneous baroreflex 
modulation of heart rate by identifying sequences of successive beats from the 
ECG which show progressive increases in systolic pressure being followed by a 
progressive lengthening of RR interval (or vice versa). The gradient of the 
regression line between systolic pressure and RR interval gives the magnitude of 
baroreflex gain. The third method is provided by cross-spectral analysis of systolic 
pressure and RR interval or of sympathetic nerve signal to muscle. This method 
relies on the fact that the low frequency band of the power spectrum (section
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2.5.4.2.4) is modulated by the baroreflex and that RR interval and systolic 
pressure fluctuate at the same frequency.
The immense complexity of neural control mechanisms at times stops the 
baroreflex from overcoming non-baroreflex influences on blood pressure, hence 
occasionally systolic changes are not coupled with the reflex change in RR 
interval (Di Rienzo etal. 2001). These authors suggested a new approach to the 
quantification of baroreceptor function: the baroreflex effective index which 
quantifies the number of times the baroreflex has clearly driven the SA node, 
rather than BRS, which quantifies the power of the reflex when SA node drive 
has taken place. They reported that beat-to-beat RR interval changes are only 
induced by the baroreflex in response to 21% of systolic blood pressure changes 
owing to central inhibitory influences or to interference at SA node level by non- 
baroreflex mechanisms.
2.7 Applications of HRV analysis during physical activity
2.7.1 Introduction
Cardiovascular alterations to exercise constitute well coordinated responses 
throughout the body, with virtually every organ system doing more work than 
when at rest, whilst at times receiving impaired blood flow (Sheriff etal. 2006). 
Exercise therapy is now widely utilised owing to its effectiveness in the 
rehabilitation of individuals with cardiac disease and also lifestyle-related 
conditions such as diabetes mellitus and obesity (Ino-Oka etal. 2009). That aside, 
the risk of sudden death is dramatically increased during and immediately after 
exercise compared with sedentary periods (Mittleman & Siscovick 1996, Albert et 
al. 2000). Although heart rate alone may be a powerful tool in the assessment of 
autonomic tone (Lahiri etal. 2008), it provides no direct detailed information
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regarding either the sympathetic or parasympathetic inputs. The profile of heart 
rate change during exercise and in the post-exercise recovery period however is 
recognised as having more prognostic significance than during rest (Jouven et al. 
2005).
A lower resting heart rate is achieved largely through parasympathetic input from 
vagal tone in healthy individuals. The major physiological means of enhancing 
basal vagal tone and lowering resting heart rate is habitual dynamic exercise 
(Katona etal. 1982, Smith etal. 1989, Sugawara etal. 2001) resulting in increased 
cardiac electrical stability and protection against ventricular fibrillation (Hull et 
al. 1994). Conversely, impairment of vagal tone and elevated resting heart rate 
occurs with physical deconditioning (Wichi etal. 2009).
2.7.2 Cardiopulmonary exercise testing
Cardiopulmonary exercise testing (CPET) has become the most widely used 
method for initial evaluation of suspected coronary disease and its severity 
(Kligfield & Lauer 2006), being used diagnostically but more so prognostically. It 
provides assessment of the integrative exercise responses involving the 
pulmonary, cardiovascular and skeletal muscle systems which are not adequately 
reflected through the measurement of individual organ system function. Exercise 
capacity is a powerful predictor of mortality, being a superior prognostic marker 
compared with smoking history, hypertension or prior infarction (Maeder et al.
2005). An individual’s exercise capacity however depends not only on age, gender 
and level of fitness, but also on the mode of exercise employed and the exercise 
protocol applied (Myers 1996). In North America, treadmill use is more popular, 
whereas in Europe, bicycle ergometer testing is more commonly used. Studies 
comparing the two modalities have generally revealed a higher peak oxygen
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uptake (V02max), higher maximal heart rate and better sensitivity in detecting 
coronary ischemia using the treadmill compared with the bicycle (Maeder et al 
2005). However, bicycle ergometry testing is often the preferred method owing 
to its reduced upper body motion which simplifies ECG and blood pressure 
recording (Myers 1996).
CPET use in patient management has increased with the understanding that 
resting pulmonary and cardiac function testing does not reliably predict exercise 
performance or functional capacity and that overall health status correlates better 
with exercise tolerance than with resting measurements (Albouaini etal. 2007). 
The clinical variables elicited during exercise testing are markers of general 
cardiovascular fitness and ANS function (an individual is considered to have a 
positive diagnosis if signs or symptoms of ischemia are displayed such as ST 
segment depression (Miller 2008)) these include (adapted from Miller 2008):
• Exercise duration
• Exercise hypotension (a fall in systolic blood pressure occurring at 
maximal workload)
• Exercise hypertension (an increase in blood pressure occurring at maximal 
workload)
• Chronotropic incompetence (failure to use 80% of heart rate reserve (De 
Sutter et al. 2006)
• Heart rate variability including the HF and LF components
Notably, the utility of CPET to evaluate ANS function and its modulation of the 
cardiovascular system has recently become recognised owing to the increasing 
evidence of its prognostic value (Freeman etal. 2006). Data regarding ANS
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balance can be obtained through the evaluation of several discrete aspects of the 
cardiopulmonary exercise test including: the pre-test period, the heart rate 
response to dynamic exercise and heart rate recovery from the exercise test.
2.7.3 Heart rate increase at the onset of exercise
Generally it takes around one second to induce a 25% heart rate increase and in 
the following seconds, the acceleration increases further until it reaches a steady 
level within one-three minutes (Coote & Bothams 2001). Nobrega etal. (1990) 
investigated the heart rate response during the first 4 seconds of exercise onset 
and found that a relative tachycardia within this period was exclusively a result of 
vagal withdrawal independent of sympathetic activation, hence an exaggerated 
initial heart rate response to exercise could signal autonomic (specifically 
parasympathetic) dysfunction (Chaitman 2007). Leeper etal. (2007) demonstrated 
for the general population and for a subset of those subjects with documented 
CAD that a greater rise in heart rate early in treadmill exercise is associated with 
increased survival. Interestingly, Falcone et al. (2005) reported the converse in a 
similar population using a semi-supine bicycle ergometer protocol, as faster vagal 
withdrawal in response to dynamic exercise heightens the deleterious effect of 
sympathetic activation unopposed by vagal activity. Although the two studies 
arrived at different conclusions, both have value as the major difference between 
them was body position (Chaitman 2007). The increase in heart rate with exercise 
in the supine position may be more rapid than in the upright position as stroke 
volume contributes less to cardiac output compared with the upright position in 
which the increase is the result of augmented stroke volume and heart rate. The 
two studies had fundamental design differences in that the patient population 
considered by Leeper et al. (2007) were “considerably sicker” than those 
considered by Falcone etal. (2005), specifically in terms of autonomic 
dysfunction, smoking history and p-adrenergic blocker use. Chaitman (2007)
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suggested however that in the clinical setting, rapid acceleration of heart rate in 
the early phases of exercise should not be used to predict cardiovascular outcomes 
until there is a clearer understanding of the autonomic mechanisms governing 
heart rate response during these periods in individuals both in the upright and 
supine positions and in medicated populations.
2.7.4 Heart rate during progressive exercise
During exercise, cardio-acceleration results from parasympathetic inhibition at 
low exercise intensities and from both parasympathetic inhibition and 
sympathetic activation at moderate intensities (Shepard 1987). The evaluation of 
maximal heart rate during CPET has been conducted in a variety of subjects, with 
and without cardiovascular disease. Vagal withdrawal with the onset of exercise 
can result in an initial increase in heart rate of 30 to 50 beats per minute, but 
further increases are considered to result from sympathetic activation. Clinically, 
the general “rule of thumb” is that the higher the heart rate reached during 
testing, the better the prognosis (Freeman etal. 2006).
Many factors affect maximal heart rate during dynamic exercise, including age, 
although a consistently poor correlation has been found in this relationship 
(Freeman etal. 2006). Stepwise multiple regression analysis performed by 
Londeree & Moeschberger (1984) on more than 23000 subjects from the literature 
revealed that age alone accounted for 75% of the variability in maximal heart rate 
and other factors including mode of exercise, level of aerobic fitness and country 
of origin added only an additional 5%. The authors found that heart rates at 
maximum work rate were lower when using bicycle ergometry as the exercise 
method compared with treadmill use and lower still with swimming. They also
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confirmed that trained individuals generally have lower maximal heart rates than 
untrained subjects.
Jouven et al. (2005) tested the hypothesis that among apparently healthy 
individuals, SCD is likely to be associated with abnormal heart rate profiles 
during exercise and subsequent recovery. They used a bicycle ergometer protocol 
and found that the prognostic value of the absolute increase in heart rate was 
greater than that of either the resting heart rate or heart rate recovery, suggesting 
that altered neural control of cardiac function contributes to SCD. The authors 
suggested that autonomic imbalance may precede the onset of arrhythmia, aiding 
in the early identification of at-risk individuals.
2.7.5 Heart rate recovery
In general, initial heart rate recovery post-exercise is finked to inhibition of 
sympathetic activity and parasympathetic reactivation (Arai etal. 1989, Imai etal. 
1994, Pierpont etal. 2000) although the specific timing of these events has not 
been fully examined (Suzuki etal. 2008). Slower changes in the stimuli to 
chemoreceptors and baroreceptors accompanying clearance of metabolites, along 
with delayed elimination of excess body heat and catecholamines are thought to 
be other contributory factors, although parasympathetic activation is considered 
the main mechanism of cardio-deceleration post exercise (Javorka etal. 2002). 
Kannankeril et al. (2004) analysed heart rate in healthy individuals during 
maximal exercise and subsequent recovery under normal physiological conditions 
as well as during selective parasympathetic blockade with atropine. They 
demonstrated that even at maximal exercise, the parasympathetic system has a 
small but significant effect on heart rate, with rapid reactivation upon cessation of 
exercise within the first minute post-exercise and a steady increase until 4
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minutes into recovery at which time parasympathetic input to heart rate remains 
constant. Sundaram et al. (2004) considered how sympathetic withdrawal 
contributes to heart rate recovery following sub-maximal exercise. Subjects were 
analysed during normal physiological conditions along with selective p~ 
adrenergic blockade with propranolol, selective parasympathetic blockade with 
atropine, or double blockade with both agents. These workers reported that early 
heart rate recovery following exercise is complex but predominantly a result of 
parasympathetic reactivation with sympathetic and non-autonomic components 
playing lesser roles.
Heart rate recovery post-exercise is becoming an increasingly important 
prognostic index (Cole etal. 1999, Shetler etal. 2001, Watanabe etal. 2001). Cole 
et al. (2000) showed that a delayed decrease in heart rate during the first minute 
post-exercise of less than 12 beats per minute following graded exercise is a 
powerful predictor of overall mortality regardless of achieved workload or 
changes in heart rate during exercise. The majority of studies (and all those 
discussed above) revealing an association between heart rate recovery in the first 
minute post exercise and clinical outcome have used treadmill exercise. The two 
studies assessing the prognostic value of heart rate recovery in the first minute 
after bicycle ergometer testing have provided conflicting conclusions. Notably, 
slower heart rate recovery in the first minute provides a strong predictor of SCD 
among apparently healthy men (Jouven etal. 2005), although Gaibazzi etal.
(2004) failed to find a significant correlation between heart rate recovery and 
SCD. Further investigation into the physiological basis and prognostic 
significance of autonomic function during recovery may delineate the 
relationship between autonomic dysfunction, all-cause mortality and SCD (Lahiri 
etal. 2008).
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2.7.6 Heart rate variability and exercise
The Task Force guidelines (Task Force ESC & NAPSE 1996) did not assess the 
impact of physical exercise on the physiological variables that directly affect 
HRV. However a number of studies have investigated the influence on HRV of 
exercise and subsequent recovery in the time and frequency domains and have 
also involved the use of pharmacological blockade, measurement of plasma 
norepinephrine concentration and muscle sympathetic activity (Sone et al. 2004). 
Improved physical training status has also been associated with increased HF 
power and, paradoxically, with either an increased or decreased LF power (Furlan 
etal. 1993, Janssen etal. 1993, Aubert etal. 2001, Verlinde etal. 2001). In 
addition, the application of non-linear dynamical analysis methods, such as 
quantification of sample entropy, can provide information about cardiovascular 
system control in exercise which is undetectable by conventional linear HRV 
(Javorka etal. 2002).
Equivocal findings have been reported from investigations comparing the 
distribution of HRV power during rest with that during dynamic exercise. 
Bemardi etal. (1990) and Rimoldi etal. (1992) reported an increase in LF power 
and a decrease in HF power during low intensity exercise, both studies therefore 
implying an increase in the LF/HF ratio during low intensity exercise, a trend 
similarly described by Tulppo etal. (2001) and Pichon etal. (2004). Casadei etal. 
(1995) and Perini etal. (1990) however described reductions in LF power at 
higher exercise intensities, whilst at yet higher exercise intensities, Arai etal. 
(1989) and Bernardi etal. (1989) documented increased HF power. Variations in 
both the mode and the relative intensity of exercise employed in these studies 
have made it difficult to reliably compare their results and to re-iterate, the LF 
arid HF components indicate rates of sympathetic and parasympathetic 
modulation rather than reflecting the magnitude of their tone. Additionally there
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exists the potential confounder of non-normalisation. Measurement of VLF, LF 
and HF power components is usually made in absolute values of power (ms2), but 
LF and HF may be measured in normabsed units (Pagani etal. 1986, MaUiani et 
al. 1991) which represent the relative value of each power component in 
proportion to the total power minus the VLF component (Task Force ESC & 
NASPE 1996).
There is no universally accepted pattern of change of HRV during exercise. This 
is largely owing to between-study differences in subject characteristics such as 
age and physical fitness, data analysis methods and data accuracy resulting from 
the use of different experimental apparatus. However, the general consensus is 
that values for the LF, HF and total power components of HRV at high work rates 
are diminished, compared with during rest and low work rates (Yamamoto etal. 
1991, Polanczyk etal. 1998, Hautala etal. 2003, Cottin etal. 2004). Some authors 
have also reported gradual reductions in LF and HF powers during progressive 
maximal exercise, these trends appearing to be exponential in nature (Rimoldi et 
al. 1992, Tulppo etal. 1996, Perini etal. 2000, Lewis & Kingsley 2003) and 
interpreted as representations of progressive and substantial withdrawal of ANS 
control.
2.7.7 Influence of respiratory sinus arrhythmia on HRV during dynamic exercise
Modulation of SA node activity via respiratory frequency and respiratory tidal 
volume is the main mechanism influencing the HF component of HRV. However, 
accurate data regarding RSA action during progressive exercise are scarce owing 
to the lack of stationarity and the difficulty in controlling breathing patterns 
encountered during exercise (Blain etal. 2005). The central frequency of RSA in 
HRV analysis has been shown to correlate strongly with respiratory frequency
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(Bemardi etal. 1989) and increases linearly with metabolic demand (Perini etal. 
1998). Unsurprisingly, several authors have identified HRV components at 
frequencies exceeding the Task Force's recommended HF bandwidth (0.15 to 0.4 
Hz) during exercise (Cottin etal. 2004, Nakamura etal. 1993, Yamamoto etal. 
1991, Warren etal. 1997). Consequently these authors chose to reclassify the HF 
bandwidth used in their studies, using one of several alternative bandwidths 
(0.15-0.8 Hz, 0.1-1.0 Hz, 0.15-1.0 Hz or 0.15-1.5 Hz). Moreover, Blain etal.
(2005) found that RSA occurred throughout exercise, and was greatest during the 
highest work rates. These authors also observed that the amplitude of RSA did 
not differ when ventilation was kept constant for differing respiratory frequency 
and tidal volume combinations, and suggested that this implied a mechanical 
process for RSA. These results provide a clear rationale for extending the HF 
bandwidth during exercise to include the underlying respiratory frequency: 
failing to do this would exclude at least part of the influence of RSA on the HF 
component of HRV. Nevertheless, and in the absence of specific guidelines, most 
studies continue to report HRV parameters (including the commonly compared 
LF/HF ratio) using the Task Force’s restricted HF bandwidth.
2.7.8 QT interval during and after exercise
The physiology of autonomic effects on QT interval dynamics following exercise 
is not well understood owing to the changing autonomic profile that occurs 
during exercise (Sundaram etal. 2008). However, it is generally accepted that the 
QT interval shortens with progressive exercise (Sarma etal. 1988, Roukema etal. 
1998, Rajappan etal. 2003) this being observed throughout a wide range of heart 
rate and involving heart rate dependent and independent QT modulation (Porta 
etal. 1998, Almeida etal. 2006). However, rate correction imprecision, 
particularly at high exercise intensities has precluded a fundamental 
understanding of the autonomic effects of exercise and recovery on the QT
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interval (Sundaram etal. 2008). It is notable that QT interval evaluation during 
exercise is subject to several methodological problems: noise and baseline drift 
make the determination of the end of the T wave difficult and fusion of the end 
of the T wave with the subsequent P wave further obscures the end of cardiac 
repolarisation (Kligfield & Lauer 2006). Limitations aside, several studies have 
suggested that lengthening of the rate-corrected QT interval with exercise 
identifies myocardial ischemia (Elgoff etal. 1987, Arab etal. 2000, Watanabe et 
al. 2000) particularly in individuals with exercise related ventricular arrhythmias 
(Cuomo etal. 1989).
To date, there has been:
1. No comparison o f QT and its variability between different leads o f the 
ECG system
2. No simultaneous analysis o f QT and RR variability during exercise
3. No assessment o f the relationship between these parameters and 
ventricular function
4. No previous study which has quantified the influence o f ECG electrode 
placement on QT-RR hysteresis
5. No investigation o f the entropy o f the QT interval during different 
physiological conditions (and different exercise workloads)
6. No examination o f the relationships between sample entropy and 
traditional HRVparameters and no comparison o f the ability o f these 
parameters to distinguish between physiological states
75
2.8 Current research trends and priorities
Whilst the initial focus of HRV application was the prediction of mortality in 
post-MI patients, or those with valvular or congestive heart disease, the major 
clinical focus of HRV research now is the prediction of the onset of fatal 
ventricular arrhythmias (Kleiger etal. 2005). Recent advances in HRV analysis 
have come about through the use of more sophisticated signal processing of beat- 
to-beat cardiovascular variability. A variety of data analysis algorithms and tools, 
such as wavelet analysis and methods of non-linear analysis, together with 
improved processing power, have substantially improved both ECG signal 
acquisition and its temporal and morphological analysis in recent years. Emphasis 
now needs to be given to bridging the two areas of HRV signal processing and 
physiological modelling (Cerutti et al. 2006) in order to simplify aspects of multi­
system dynamics to provide new avenues for innovative interpretations and 
explorations. A major continuing challenge is also to demonstrate the utility and 
clinical implications of specific measures of HRV in diagnosis and monitoring so 
that such measures become part of routine patient care. For example, HRV may 
be clinically useful in the functional assessment of cardiac autonomic regulation 
in critical care where HRV can aid diagnosis and prognosis and inform treatment 
strategy (Lewis 2005). HRV, used as a clinical tool, is likely to become 
increasingly common in future as a result of the more widespread 
implementation of HRV analysis facilities into clinical monitoring and 
informatics systems.
Although there is a significant body of evidence demonstrating an association 
between endurance exercise training and HRV (Al-Ani etal. 1996, Pichot etal. 
2000, Iellamo et al. 2002, Iwaski et al. 2003, Tulppo et al. 2003, Hautala et al.
2004, Kiviniemi et al. 2006) the use of HRV measurement as a tool for adjusting 
endurance training programmes has not been widely assessed. Kiviniemi et al.
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(2007) however, through HF power assessment, suggested that improved 
cardiorespiratory fitness can be achieved by using daily HRV measurement for 
exercise prescription when compared with a standardised training regime. The 
challenge remains to individually define the training stimulus that produces 
optimum metabolic and structural changes in the cardiovascular and 
neuromuscular systems without compromising recovery (Hautala etal. 2009).
The recent understanding that HRV may in fact be representative of complex 
phenomena which reflects the non-linear fluctuations of cardiac-autonomic 
outflow in a fractal or entropic or chaotic manner requires further investigation. 
Wu et al. (2009) suggested that definitive testing of these divergent 
characterisations is the key to unravelling the physiological mechanisms of HRV, 
critical for its effective use as a non-invasive marker for cardiac risk assessment 
and stratification.
Several challenges remain in the development of a more complete understanding 
of the mechanisms of cardiovascular control during physical activity, and the 
influences thereon of physical training. In this regard it has become apparent that 
a comprehensive understanding of ANS changes during exercise and recovery 
requires a multimodal approach. Only in recent years has this been achievable 
through the introduction of more advanced signal processing and numerical 
analysis techniques and the introduction of advanced haemodynamic 
measurement systems such as the TFM. To reiterate section 2.3.3.2, the TFM 
allows non-invasive continuous measurement of blood pressure via the vascular 
unloading technique and beat-to-beat stroke volume measurement with ICG 
(Fortin etal. 1998). These beat-to-beat data also enable real-time calculation of 
HRV, BPV, BRS, systemic vascular resistance and measures of cardiac ventricular 
performance such as ejection fraction. Measurement of these parameters
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synchronously with indices HRV during rest, quantified exercise and subsequent 
recovery, is likely to be the best strategy in the quest to understand the intricacies 
of physiological control. Such information will be of value in assessing the 
influences of acute exercise and of physical training on cardiovascular regulation. 
Furthermore it would provide a comparative model to help elucidate 
pathophysiological changes in a variety of cardiac and systemic disorders, thereby 
integrating our understanding of autonomically-mediated physiological control 
mechanisms, and the most appropriate quantitative methods for their assessment. 
This will be an important translational step towards establishing cardiovascular 
autonomic function testing as a clinically useful tool.
I t is reasonable to postulate that progress towards this goal w ill be expedited 
through quantification of:
• The QT-RR (hysteresis) relationship during exercise
• The influence o f ECG electrode placement on RR and QT, their 
variabilities and the QT-RR hysteresis relationship
• An analysis o f the ability ofsample entropy to discriminate between 
different physiological states (and different exercise workloads)
• The relationships between sample entropy and traditional HR V  
parameters
• A  determination o f the influence o f age and physical fitness on the 
sensitivity o f the DFA scaling factor to different exercise work loads
• A  quantification o f the temporal behaviour o f the DFA scaling factor 
during the post-exercise period
• An investigation o f the fractal nature o f the QT interval in the ECG
• The relationship between indices o f HR V and QTV and clinical measures 
o f cardiac function (in particular ventricular function)
• The effects o f gender and individual exercise work capacity on the above
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Chapter 3 Investigating the relationship between QT and RR time-series 
during rest and exercise
3.1 Rationale
Multi-lead ambulatory ECG recording offers recognised advantages for 
ventricular QT interval analysis, especially during physical exercise. However, 
data are usually reported for a single lead and do not quantify between-lead 
variability, leading to possible misinterpretation. There may then be significant 
between-lead and between-gender QT interval differences when reporting results 
from a multi-lead ambulatory ECG under conditions of physical stress. Therefore, 
the magnitude of the lag in QT interval adaptation to recovering heart rate 
following exercise (which has been described as QT-RR hysteresis (Ahnve & 
Vallin 1982)) may also be dependent on accurate ECG electrode placement. No 
previous studies have quantified the influence of ECG electrode placement on 
hysteresis following physical exercise.
3.2 Aims and objectives
The aims of this chapter were:
1. To assess the between-lead agreement for QT and RR intervals obtained 
from a commercial three-lead ambulatory ECG system
2. To characterise QT-RR hysteresis using this ECG system during physical 
exercise within a range of low to high intensities and during subsequent 
recovery
The objectives of the studies were:
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1. To quantify between-lead agreement for QT and RR intervals during 
conditions of rest, physical exercise and subsequent recovery using a 
Bland-Altman analysis
2. To determine the influence of gender on between-lead agreement for 
these parameters
3. To quantify the magnitude and temporal variation of QT-RR hysteresis 
using standardised electrode locations
4. To quantify between-lead differences in QT-RR hysteresis
5. To quantify the influence of gender on QT-RR hysteresis
3.3 Methodology
All physiological testing and measurements were performed in the Exercise 
Physiology Laboratory at the Sport and Exercise Science Research Centre, 
Swansea University and the investigation was approved by the departmental 
ethics committee. Subject health screening was undertaken using the American 
Heart Association/American College of Sports Medicine pre-participation 
screening questionnaire (Balady etal. 1998). All subjects were apparently healthy 
non-smokers and were physically active to a similar level. Subjects were free of 
cardiovascular and chronic respiratory problems (including asthma), had no 
history of sleep apnoea, central or peripheral nervous system disorder, and were 
not taking any medication at the time of investigation. All subjects were informed 
in writing about the demands of the study, and subsequently gave their written 
informed consent for participation prior to commencing the study. Subjects were 
not permitted to consume tea, coffee, alcohol or a heavy meal within two hours 
prior to physiological assessment, and no physical exercise was permitted within 
the 24 hour period prior to assessment.
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The preliminary and main study populations used for the work of this chapter are 
both subsets of a main subject group which underwent an identical testing 
protocol. The subjects were investigated continuously during a progressive 
exercise test on an electromagnetically braked cycle ergometer (Lode Excalibur 
Sport; Lode, Netherlands). The bicycle test was chosen in order to allow simple 
quantification of exercise workload, to diminish movement artifact through 
improved upper body stability compared with treadmill use and to maximise 
subject comfort and safety in fine with the American Thoracic Society Statement 
on Cardiopulmonary Exercise Testing (ATS 2003). Following the 
recommendations of this statement, a sub-maximal incremental protocol was 
employed. The work rate began at 60 W for 5 min in order to achieve 
standardised baseline conditions and thereafter increased in 30 W increments 
every 3 minutes until the subjects reached 85% of their age-predicted (220-age 
(years)) maximal heart rate. This endpoint was chosen in an attempt to keep 
subjects below the anaerobic threshold.
Subjects were instructed to pedal at a constant cadence of 60 rpm, although a 
further advantage of using an electromagnetically braked ergometer was that 
fluctuations in cadence were automatically adjusted for workload by the 
ergometer, thereby providing power output control, this having particular 
importance when subjects became fatigued. RR interval (Reynolds Holter 
recorder; Del Mar Reynolds Medical Ltd., UK), breath-by-breath respiratory 
frequency (ft), minute ventilation (the volume of gas inhaled (or exhaled) in one 
minute) (VE) and oxygen consumption (Vo2) (Oxycon Pro; Jaeger, Germany) 
were recorded simultaneously. Prior to testing, subjects underwent baseline 
spirometric assessment of the form:
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• Forced expiratory volume in one second (FEVi), the largest volume of gas 
forcibly exhaled in one second
• Forced vital capacity (FVC), the largest amount of gas forcibly exhaled 
following maximal inspiration
• Maximum voluntary ventilation (M W ), the maximum amount of gas 
which could be exhaled and inhaled in one minute
During testing the Category Ratio (CR)-IO scale adapted from Borg (1982) was 
used at regular intervals in order to assess subjects’ perceived exertion. Prior 
to and immediately post exercise, pulse oximetry was conducted (Nonin 8500 
digital handheld pulse oximeter; Nonin Inc., USA) in order to screen for 
possible hypoventilation. Following the cessation of exercise subjects stood for 
10 minutes recovery. The following is a step-by-step description of the 
experimental process undertaken for the assessment of each subject:
• Calibration of the Oxycon Pro gas analysis system
• Mass and height of the subject measured
• Lode ergometer set correctly (saddle height and handlebar reach)
• 85% of age predicted heart rate calculated
• Baseline spirometry characterisation undertaken
• Oxycon Pro and Lode ergometer control systems programmed for a 
continuous ramped protocol with recovery period
• Reynolds Holter recorder attached to the subject and recording started
• Subject settled comfortably on the Lode ergometer to sit for 15 minutes of 
rest investigation prior to exercise
• Pulse oximetry reading taken
• Oxycon Pro gas analysis started
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• Oxycon Pro and Reynolds systems synchronised by the manual insertion 
of “markers” at the beginning of exercise
• Following 5 minutes of exercise “markers” inserted to the Oxycon Pro and 
Reynolds systems to label the transition to the higher work rate
• The previous step repeated at every 3 minute stage of the protocol until 
the subject reached 85% of age predicted maximum heart rate
• The subject shown the CR-10 perception scale at each exercise work rate
• At 85% of age predicted maximum heart rate the subject is removed from 
the Lode ergometer and the Oxycon Pro system is manually “forwarded” 
to signify the recovery period
• The subject stands for 10 minutes post exercise recovery
A subject undergoing testing is illustrated in Figure 3.1.
Figure 3.1 A subject undergoing testing
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3.3.1 Preliminary study subject characteristics
Nine males (age 23.6 ± 4.7 years, mass 85.7 ± 8.5 kg (mean ± SD)) and eight 
females (age 21.9 ± 4.8 years, mass 64.0 ± 4.2 kg) volunteered to take part in the 
investigation. Individual maximal oxygen uptake ( V02rnax) values confirmed the 
similarity of aerobic fitness within both groups: males (46.7 ± 5.2 ml-kg ^m in1) 
and females (40.1 ± 8.8 ml-kg ^m in1). Work capacity (WRmax), estimated from the 
relationship between work rate and heart rate and extrapolating to maximum 
heart rate (HRmax), were: 289 ± 46 W (males) and 195 ± 45 W (females) (mean ± 
SD).
3.3.2 Main study subject characteristics
Six males (age 23.5 ± 4.3 years, mass 87.5 ± 8.8 kg (mean ± SD)) and six females 
(age 22.2 ± 5.3 years, mass 64.8 ± 4.7 kg) volunteered to take part in the 
investigation. Individual maximal oxygen uptake (V02max) values confirmed the 
similarity of aerobic fitness within both groups: 46.4 ± 6.3 ml-kg ^m in1 (males) 
and 39.4 ± 7.9 ml-kg^-min1 (females). WRmax, estimated from the relationship 
between work rate and heart rate and extrapolating to HRmax, were: 295 ± 52 W  
(males) and 202 ± 43 W  (females) (mean ± SD).
3.4 Physiological measurement
3.4.1 Apparatus
A Reynolds Lifecard CF digital Holter recorder (Del Mar Reynolds Medical Ltd., 
UK) was used to record a three-lead ECG throughout exercise and for 10 minute 
periods pre- and post-exercise. The ECG leads were positioned in the modified 
V5, CC5, modified V5R electrode configuration (Figure 3.2).
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Figure 3.2 A subject with electrodes 1-3 positioned in the modified V5, CC5, 
modified V5R configuration
This system provided ECG data with a sample accuracy of 2.5 pV (magnitude of 
least significant bit; 12-bit resolution) and 128 Hz sampling frequency. 
Subsequently, each lead was separately analysed using a Reynolds Pathfinder 
digital analyser with Reynolds Research Tools software (Del Mar Reynolds 
Medical Ltd., UK). All ECG recordings used for subsequent analysis in these 
studies were free of any form of morphologically abnormal beat, and this was 
verified by both the Holter system and by human observation prior to subsequent 
analysis. When either the RR or QT intervals were considered to be anomalous, 
both the RR and QT data points were removed from the data set. This occurred 
infrequently (and mainly during exercise), resulting in fewer than 1% of the data 
being removed.
All QT analysis in this chapter was based on the QTa interval (Qwave onset to T 
wave apex). Preliminary observations prior to beginning the study showed that 
the apex of the T wave (Ta) was more reliably measurable by the Holter system’s 
detection algorithm compared with the end point of the T wave (Te). This was 
evident as exercise progressed to higher intensities, where the elevated heart rates 
made it particularly problematic to detect Te, but Ta could still be reliably 
detected. (Subsequent studies assessing the reliability of Ta as an estimate of the 
ventricular depolarisation-repolarisation phase are presented in chapter 5). Only 
sinus rhythm beats were considered in these analyses.
3.5 Data processing
3.5.1 Preliminary study
Mean values within consecutive one-minute windows were calculated for both 
QT and RR data sets for all three ECG leads. Subsets of the averaged QT and RR 
data sets were defined that represented these data within specified intervals 
during exercise and during the pre- and post-exercise phases:
1. Consecutive one-minute intervals during the pre-exercise resting phase, 
which lasted for 10-minutes
2. The final one-minute period (in order to represent physiologically steady- 
state conditions) of each exercise stage
3. Consecutive one-minute intervals during the post-exercise resting phase, 
which lasted for 10-minutes
Single pre-exercise values for RR and QT were then calculated for each of the 
three leads, using the mean of the ten one-minute averages during this period in
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order to obtain representative values for pre-exercise rest. These were considered 
appropriate values as there was no substantial physiological variation during this 
time. The method described by Bland & Altman (1999) was used to quantify the 
between-lead bias and associated limits of agreement (LOA) for the RR and QT 
data recorded for each pair of ECG leads. Mean values of between-lead difference 
(bias) and the corresponding LOA (bias ± 2 X SD of between-lead differences) 
were calculated for the whole pre-exercise interval, for the final one-minute 
interval of each exercise stage, and for consecutive one-minute intervals during 
recovery. Composite paired-lead values that represented the mean bias and 
associated LOA for the whole experimental period were also calculated.
The Lilliefors test for goodness of fit to a Normal distribution confirmed that the 
data samples were Normally distributed and therefore the suitability of the 
selected parametric statistical tests. Student’s two-sample t-tests for unequal 
variance (heteroscedastic data) were used to assess between-lead and between- 
gender differences in the data at each stage of the experimental protocol. All data 
quoted in the text represent mean ± SD. Error bars in the figures represent the 
SEM (standard error in the mean) for the plotted parameters.
3.5.2 Main study
The non-uniformly sampled QT and RR data sets were linearly interpolated with 
a sampling frequency of 2 Hz to provide data that were uniformly sampled in the 
time-domain (sampling interval 0.5 seconds, this made it computationally easier 
to accurately measure time intervals in the analysis). Mean values were then 
calculated for consecutive non-overlapping one-minute windows as described in 
section 3.5.1, for both QT and RR data sets, separately for all three ECG leads.
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The one-minute mean RR data were next re-sampled to provide a reference RR 
data set with sampling intervals of 10 ms (to improve RR resolution and thus the 
accuracy of the subsequent algorithm used in this analysis). This procedure was 
performed separately for the rest/exercise and the post-exercise recovery periods 
to assist in computational efficiency. The corresponding QT data were then 
linearly interpolated as a function of the uniformly sampled RR data. This 
allowed the determination of RR and QT within consecutive one-minute post­
exercise time intervals, as well as the QT values at the same matched RR values 
during the rest/exercise periods. This enabled the calculation of QT-RR 
hysteresis, defined as the difference in magnitude of QT for the same value of RR 
during the rest/exercise and post-exercise recovery periods. A positive value of 
hysteresis was defined as a shortened post-exercise QT relative to that during the 
exercise or pre-exercise periods (i.e. a positive hysteresis value indicated a lagging 
QT recovery towards pre-exercise values).
The Lilliefors test for goodness of fit to a Normal distribution confirmed that the 
data samples were Normally distributed and therefore confirmed the suitability of 
the selected parametric statistical tests. One way analysis of variance (ANOVA) 
was used to compare the magnitudes of hysteresis calculated at each stage of the 
post-exercise recovery period. Multiple pairwise comparisons were performed for 
these data using Tukey’s honestly significant difference criterion, and differences 
were considered significant for p<0.05. Student’s two-sample t-tests for unequal 
variance (heteroscedastic data) were used to assess between-lead and between- 
gender differences in the data at each stage. All data quoted in the text represent 
mean ± SD.
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3.6 Results
3.6.1 Preliminary study
Owing to the difficulty of measuring QT interval during the elevated heart rates 
associated with moderate- to high-intensity exercise, QT data were available only 
for exercise intensities up to 68 ± 8% of WRmax in males and up to 75 ± 10% of 
WRmax in females (equivalent to mean heart rates of 152 ± 9 bpm in males and 157 
± 4 bpm in females).
3.6.1.1 Between-lead agreement for RR and QT data
There were no significant differences in the R R  values obtained from the three 
leads at any stage of the protocol for either males or females. In contrast, there 
were significant (p<0.05) differences in the QT interval values obtained from the 
different leads during exercise and recovery periods in both males and females 
(Figures 3.3 (a) & 3.3 (b) respectively).
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Figure 3.3 (a) Group mean values of QT interval for each ECG lead (male group) 
(lead 1, lead 2, lead 3 = ECG leads 1, 2 & 3; § = significant difference between lead 
1 and lead 2; f = significant difference between lead 1 and lead 3; * = significant 
difference between lead 2 and lead 3) (p = pre-exercise stages, e = exercise stages, 
r = recovery stages)
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Figure 3.3 (b) Group mean values of QT interval for each ECG lead (female 
group) (lead 1, lead 2, lead 3 = ECG leads 1, 2 & 3; § = significant difference 
between lead 1 and lead 2; f = significant difference between lead 1 and lead 3; * = 
significant difference between lead 2 and lead 3) (p = pre-exercise stages, e = 
exercise stages, r = recovery stages)
Figures 3.3 (c) & 3.3 (d) present example Bland-Altman plots (between-lead 
differences plotted against mean values calculated for those leads) for beat-to-beat 
RR and QT intervals respectively from a typical male subject. The plots show the 
mean between-lead bias for these ECG parameters together with the associated
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limits of agreement (LOA), plotted separately for the rest, exercise and recovery 
periods. Bias and LOA are indicated separately for each defined one-minute stage 
during exercise and recovery. The plots show that the range of LOA for QT is 
much larger than for RR, particularly during pre-exercise rest. Figure 3.3 (d) (iii) 
also shows a non-linear relationship between bias and mean QT, with an 
inflection point in this example for QT values of around 260 ms. There is no such 
trend in RR for the equivalent lead pair (Figure 3.3 (c) (iii)). Similar results were 
obtained for the other paired-lead analyses in each subject.
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Figure 3.3 (c) Bland-Altman analysis of between-lead agreement for RR data (lead 
1-lead 3, for a typical male subject) (Horizontal bars show ranges of measured 
intervals: Solid = mean bias; dashed = upper and lower limits of agreement.
Values are indicated separately for each defined one-minute stage during exercise 
(six stages, el-e6 [plot (ii)]) and recovery (ten stages, rl-rlO) [plot (iii)]). Plot (i) 
illustrates pre-exercise rest and plot (iv) illustrates the complete testing period
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Figure 3.3 (d) Bland-Altman analysis of between-lead agreement for QT data 
(lead 1-lead 3, for a typical male subject) (Horizontal bars show ranges of 
measured intervals: Solid = mean bias; dashed = upper and lower limits of 
agreement. Values are indicated separately for each defined one-minute stage 
during exercise (six stages, el-e6 [plot (ii)]) and recovery (ten stages, rl-rlO) [plot 
(iii)]). Plot (i) illustrates pre-exercise rest and plot (iv) illustrates the complete 
testing period
3.6.1.2 Group mean values of bias and LOA for RR and QT data
Bland-Altman analysis was also used to calculate the group mean values of bias 
and the associated LOA for RR and QT, using each lead-pair. These data are 
shown in Figures 3.4 (a) and 3.4 (b), respectively (male group only). There were 
no significant between-stage differences in mean bias or LOA for either RR or QT
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for any lead-pair. The LOA for RR tended to be largest during pre-exercise and 
during late recovery and smallest during exercise and early recovery. There was 
no discernible trend for QT LOA during the experimental protocol. There were 
occasional significant differences in mean bias of QT for males and females.
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Figure 3.4 (a) Group mean values of between-lead bias and associated limits of 
agreement (LOA low, LOA high) determined from Bland-Altman analysis of RR 
interval for each protocol stage (male group) (Top: leads 1&2; Middle: leads 1&3; 
Bottom: leads 2&3. A = significant difference between male and female groups)
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Figure 3.4 (b) Group mean values of between-lead bias and associated limits of 
agreement (LOA low, LOA high) determined from Bland-Altman analysis of QT 
interval for each protocol stage (Male Group) (Top: leads 1&2; Middle: leads 1&3; 
Bottom: leads 2&3. A = significant difference between male and female groups)
Tables 3.1 (a) & 3.1 (b) present mean values of the bias and LOA for RR and QT 
intervals, respectively, taken over the whole recording period for each of the lead 
pairs. The ranges of LOA for RR were similar for each lead pair, and were slightly 
larger in females (p<0.05). The results were similar with regard to LOA for QT, 
with larger values for females in two of the lead pairs (p<0.01). The mean bias was 
significantly larger for QT compared with RR in two or more lead pairs for both 
males and females (pel O'6). There were also isolated between-gender differences 
in mean bias of RR and QT (p<0.05). The results shown in Tables 3.1 (a) and 3.1 
(b) were also quantified relative to the mean parameter values (% of the mean 
absolute RR or QT value during the whole recording period): paired-lead bias for 
RR was 0.1% (males) and 0.3% (females); range of paired-lead LOA for RR was 
5.0% (males) and 6.7% (females); paired-lead bias for QT was 8.3% (males) and 
6.9% (females); range of paired-lead LOA for QT was 13.1% (males) and 12.8% 
(females).
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Table 3.1 (a) Mean bias and associated limits of agreement (± SEM) of the RR 
interval for paired leads, calculated for the entire recording period
Lead
Pair
Mean Bias (ms) Lower Mean 
LOA (ms)
Upper Mean 
LOA (ms)
Range Mean LOA 
(ms)
Male Group
1,2 -0.2 ± 0.2 t -10.0 ± 0.7 9.6 ± 0.5 19.6 ± 1 .01A u 3)(2,3)
1,3 0.2 ± 0 .3,A -13.5 ± 0.9 13.9 ±1.0 27.4 ± 1.8 t w
2,3 0.1 ± 0 .3 1 4 -14.8 ±1.0 15.0 ±1.1 29.9 ± 2.0 w
Female Group
1,2 0.1 ± 0.5 t -P.3) -14.0 ±1.3 14.3 ±1.8 28.3 ± 2.9 A
1,3 -1.3 ± 0.6 4 -18.9 ± 2.2 16.2 ± 2.2 35.0 ± 4.2
2,3 -1.5 ± 0.5 t 4'<w> -19.9 ± 2.2 17.0 ±1.7 36.9 ± 3.7
(A = significant between-gender difference (p<0.05);,(x,y) = significant difference
between lead-pair x,y;f = significant difference between values for QT and RR
(p<10-6))
Table 3.1 (b) Mean bias and associated limits of agreement (± SEM) of the QT 
interval for paired leads, calculated for the entire recording period
Lead
Pair
Mean Bias (ms) Lower Mean 
LOA (ms)
Upper Mean 
LOA (ms)
Range Mean 
LOA (ms)
Male Group
1,2 9.9 ± 1.4 t AU3)(2,3) -5.1 ± 1.4 24.9 ±1.4 30.0 ± 0.8 tus)
1,3 -9.9 ± 1 .4 tAU2)(2,3) -26.2 ±1.6 6.5 ±1.4 32.8 ± 1 .0 +,(li2)
2,3 -19.6 ±1.8 tU2)(i,3) -35.5 ± 1.9 -3.7 ±1.7 31.7 ±0.8
Female Group
1,2 17.5 ±1.0 t A *(1>3)(2,3) 1.3 ±1.3 33.8 ±1.4 32.5 ± 1.7
1,3 0.0 ±1.9 a’(12)(23) -16.3 ±1.9 16.3 ± 2.2 32.7 ±1.6
2,3 -17.5 ± 1.3 t*a.2)(U) 34.1 ± 1.2 -0.9 ±1.8 33.2 ±1.7
(A = significant between-gender difference (p<0.01); *ky> = significant difference
between lead-pair x,y;f = significant difference between values for QT and RR
(p<10-6))
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3.6.2 Main study: analysis of QT-RR hysteresis
Figure 3.5 (a)-(c) shows the magnitude of the QT interval as a function of the 
corresponding RR interval for a male subject, determined from each of the three 
ECG leads throughout the exercise and recovery periods. These plots demonstrate 
the magnitude of QTa-RR hysteresis and the typical shapes of the QTa-RR “loops” 
that were observed for individual subjects. It is notable that the shapes of these 
loops often varied substantially between the different ECG leads recorded for the 
same subject.
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Figure 3.5 QT interval as a function of the corresponding RR interval for a single 
typical male subject: (a) ECG lead 1, (b) ECG lead 2, (c) ECG lead 3
The magnitude of the QTa-RR hysteresis calculated for each consecutive one- 
minute interval of the post-exercise recovery period is shown separately for each 
subject in Figure 3.5 (d)-(f) (males) and Figure 3.5 (g)-(i) (females). The 
magnitudes and temporal trends in hysteresis were similar for the majority of 
male individuals, with females demonstrating a greater inter-individual 
variability in hysteresis.
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Figure 3.5 (d-f) QT-RR hysteresis as a function of recovery time (minutes post­
exercise); male group. Symbols represent different individuals (n=6): (d) ECG lead 
1, (e) ECG lead 2, (f) ECG lead 3
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Figure 3.5 (g-i) Q T -R R  hysteresis as a function of recovery time (minutes post­
exercise); female group. Symbols represent different individuals (n=6): (g) ECG 
lead 1, (h) ECG lead 2, (i) ECG lead 2
Mean hysteresis values for the subject groups are presented in Figures 3.5 (j) and 
3.5 (k) for males and females respectively, demonstrating the existence of some 
between-lead and between-gender differences in both magnitudes and temporal 
trends of Q T a-R R  hysteresis.
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Figure 3.5 (j) Mean hysteresis as a function of recovery time (minutes post­
exercise); male group. (§ = significant difference between ECG lead 1 and ECG 
lead 2; f = significant difference between ECG lead 1 and ECG lead 3; A1 = 
significant difference in ECG lead 1 compared with Female group; A3 = 
significant difference in ECG lead 3 compared with Female group. * = significant 
difference in ECG lead 1 compared with value at 1 and 3 minutes; ** = significant 
difference in ECG lead 1 compared with value at 2 minutes)
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Figure 3.5 (k) Mean hysteresis as a function of recovery time (minutes post­
exercise); female group, (y = significant difference between ECG lead 1 and ECG 
lead 2; f  = significant difference between ECG lead 1 and ECG lead 3; Al = 
significant difference in ECG lead 1 compared with male group; A3 = significant 
difference in ECG lead 3 compared with male group)
3.6.2.1 Temporal variation of hysteresis
The magnitude of hysteresis for the male group (Figure 3.5 (j)) was greatest 
during either the second minute (leads 1 and 3) or the third minute (lead 2) post­
exercise, with the following maximal values: 17.5 ± 7.5 ms (lead 1), 10.9 ± 11.7 ms 
(lead 2), 25.5 ± 16.8 ms (lead 3). After this time, the magnitude of hysteresis 
showed a trend towards smaller and more temporally stable values towards the 
end of the recovery period for all leads. The situation was similar for females in 
leads 1 and 2, but hysteresis calculated from lead 3 displayed some anomalous 
characteristics (Figure 3.5 (k)). The magnitude of hysteresis for the female group
was greatest during either the second minute (lead 1), the third minute (lead 2) or 
the fifth minute (lead 3) post-exercise, with the following maximal values: 19.1 ±
10.3 ms (lead 1), 19.6 ± 12.1 ms (lead 2), 28.4 ± 3.0 ms (lead 3). Again, the 
magnitude of hysteresis showed a trend towards smaller and more temporally 
stable values towards the end of the recovery period for all leads. It is notable that 
the hysteresis values in males were negative between the fourth and tenth 
minutes of recovery in lead 1 only, and during the first and second minutes of 
recovery in lead 2 for some subjects. Hysteresis values in females were negative in 
some subjects during the first minutes of recovery in leads 1 and 2, and during the 
eighth minute of recovery in lead 2 only.
For the male group (Figure 3.5 (j)) there were some significant differences 
between the hysteresis values calculated using lead 1 at different times during the 
post-exercise period. Hysteresis values at 1 and 3 minutes post-exercise were 
significantly different from each of the four hysteresis values between 6 and 9 
minutes post-exercise. Hysteresis at two minutes post-exercise was significantly 
different from each of the hysteresis values for the period between 4 and 10 
minutes post-exercise. There were no differences amongst any of the seven 
hysteresis values for the period between 4 and 10 minutes post-exercise, or 
amongst the hysteresis values for the first three minutes post-exercise. There 
were no differences between the hysteresis values at any stage for either lead 2 or 
lead 3, although there were trends towards reduced values after the second 
minute. For the female group (Figure 3.5 (k)) the only significant difference in 
hysteresis between stages was between the values calculated for lead 3 at 1 and 5 
minutes post-exercise. There were no differences between the hysteresis values at 
any stage for either lead 1 or lead 2.
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3.6.2.2 Between-lead differences in hysteresis
In males there were significant differences between the magnitudes of hysteresis 
calculated using leads 1 and 2 during the fifth, sixth, eighth and ninth minutes 
post-exercise. There were also significant differences between the magnitudes of 
hysteresis calculated using leads 1 and 3 for the fourth and seventh minutes of 
recovery. In females the only significant between-lead difference was associated 
with leads 1 and 3 during the fifth minute of recovery.
3.6.2.3 Between-gender differences in hysteresis
There were significant differences between the magnitudes of hysteresis 
calculated for males and females using lead 1 for the period between 6 and 10 
minutes post-exercise. The magnitudes of hysteresis calculated using lead 3 were 
significantly different for males and females only during the fifth minute post­
exercise. There were no gender differences in the magnitude of hysteresis 
calculated using lead 2.
3.7 Discussion
3.7.1 Between-lead agreement for QT and RR data
The preliminary analysis of between-lead agreement reported indicated that the 
range of paired-lead LOA for RR was low, with maximal values (% of mean) of 
5.0% for the male group and 6.7% for the female group. However whereas the 
paired-lead bias for RR was also low (0.1% and 0.3% of mean respectively), the 
paired-lead bias (8.3% and 6.9% of mean) and LOA (13.1% and 12.8% of mean) 
for QT were substantially larger. It is notable that even these relatively small 
between-lead differences in RR (mainly attributable to the exercise and recovery 
periods) were observed, suggesting differences in the sensitivity of the leads to
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the measured fiducial point during these conditions. This might be the result of a 
more pronounced influence of the signal quality in individual leads on the 
accuracy of the detection algorithm during these periods. The observed between- 
lead differences in QT might have implications for the clinical interpretation of 
ambulatory studies examining either the absolute magnitude or variability of the 
QT interval.
The electrocardiographic RR and QT intervals cannot be quantified with 
equivalent accuracy or precision owing to the nature of the ECG characteristics 
that are used in their measurement. The RR interval can be measured with a high 
degree of accuracy and repeatability owing to the ease of locating the R wave 
peak as a fiducial point. However it is more difficult to measure the QT interval, 
in large part owing to the ambiguity in locating either the peak or the end-point 
of the T wave. Importantly, the accuracy and precision of RR and QT 
measurement are not comparable and are likely on physiological grounds to be 
related to lead position. A logical and necessary first step prior to further 
consideration of QT and RR parameters in this thesis was therefore to determine 
whether QT and RR durations are independent functions of lead placement.
Kingsley et al. (2005) demonstrated good agreement between single-lead RR 
interval data from the Reynolds ambulatory ECG system and a Polar 810s heart 
rate monitor. Similarly, Gamelin et al. (2006) and Vanderlei et al. (2008) 
demonstrated good agreement between a Polar 810s heart rate monitor and 
twelve lead ECG systems. Whilst these studies can be interpreted as providing 
“implied validity” of the RR data there has been no similar assessment for QT 
data. Furthermore there has been no evaluation of the between-lead agreement 
for either RR or QT interval data recorded from this or any similar ambulatory 
ECG system. Specifically, between-lead differences in RR and QT data need to be
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quantified throughout the physiological range of heart rates in order to determine 
whether they are affected by chronotropic factors. Such differences would need 
to be considered for example in the interpretation of: studies reporting data from 
only a single ECG lead, studies presenting data recorded under different 
physiological conditions, such as rest and exercise and data from different studies 
and different investigators.
It is particularly notable that between-lead variability of the QT interval, 
measured as the difference between maximum and minimum QT duration in a 
particular set of ECG leads, has generally been proposed as an index of myocardial 
repolarisation dispersion (Day etal. 1990, Barr etal. 1994, Macfarlane etal. 1998). 
However it has been suggested that, rather than reflecting the presence of 
pathology, QT dispersion might instead simply reflect the projection of cardiac 
electrical activity on to the different ECG lead axes (Cowan etal. 1988,
Macfarlane 1998, Macfarlane etal. 1998). Quantification of the between-lead 
agreement for QT data is therefore important in distinguishing between 
“physiological” (e.g. QT interval changes during exercise or cardiac arrhythmia) 
and “methodological” or “technical” variation in QT intervals measured using 
multiple ECG leads. The preliminary study of this chapter has therefore provided 
useful information in this regard by quantifying the methodological (between- 
lead) variation in QT interval during the distinct physiological conditions of rest, 
physical exercise and post-exercise recovery.
This new information is also likely to be very important in the clinical 
interpretation of QT interval duration, especially if this involves examination of 
QT under different physiological conditions and/or heart rates. For example, 
there is impairment of QT shortening during exercise in patients with congenital 
LQTS (Schwartz etal. 1975, Chiang & Roden 2000). More recent studies have
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indicated that gene mutations affecting myocardial repolarisation currents cause 
different patterns of adaptation of QT interval to heart rate during exercise and 
other autonomic stimuli (Paavonen etal. 2001). Analysis of the dynamic 
behaviour of the QT interval during these conditions might therefore facilitate 
clinical diagnosis of LQTS in subjects with borderline QT prolongation 
(Dillenburg etal. 2002, Toivonen 2002) and might be used to screen for 
individuals with a genetically determined susceptibility to repolarisation 
abnormalities. The results of the studies presented here suggest that any such 
analysis of the QT-RR relationship must take adequate account of the lead 
locations used in its determination. The between-lead agreement, and the 
influence of heart rate thereon, should be quantified for the particular ECG 
system used to record these data.
3.7.2 QT-RR hysteresis
3.7.2.1 Magnitude of QTa-RR hysteresis
The magnitudes of the QTa-RR hysteresis calculated using each of the three ECG 
leads were comparable with the results of previous investigations (Sundqvist & 
Sylven 1989, Krahn etal. 1997). There was also reasonably good between-subject 
agreement with regard to the magnitudes and temporal trends of hysteresis, 
particularly for the male subjects. Several characteristics of the observed data are 
also worthy of note, and these are discussed below.
3.7.2.2 Influence of ECG lead and gender on QTa-RR hysteresis
It is possible that differences in hysteresis calculated using specific ECG leads are 
related to the relative orientations of the instantaneous atrial and ventricular 
depolarisation-repolarisation vectors. Projections of these myocardial electrical
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vectors onto the thoracic surface are likely to result in position-dependent 
alterations in the temporal features of the surface ECG. It is possible that 
between-gender differences in hysteresis are associated with anatomical 
differences and their consequent influence on the temporal characteristics of the 
surface ECG.
3.7.2.3 Time of maximal hysteresis
As previously described (section 2.3.2.2), the lag in the adaptation of QT interval 
to changes in RR interval has two components: an immediate rapid component 
with a short time constant acting over 1-2 cardiac cycles and a delayed 
component with a time constant of the order of 1-3 minutes (Toivonen 2002). 
Furthermore, the lengthening of the QT interval in response to decreasing heart 
rate has previously been shown to begin after two minutes of recovery (Benatar & 
Decraene 2001) with post-exercise hysteresis values being significantly greater in 
females than males (Chauhan etal. 2002). The results of the present studies are in 
good agreement with the studies mentioned above, as maximal hysteresis values 
were observed during either the second or third minute post-exercise (males and 
females), depending on the ECG lead used to calculate this parameter and female 
hysteresis values were larger during the fifth minute (lead 3) post-exercise.
3.7.2.4 Possible influence of the autonomic nervous system on hysteresis
The phenomenon of hysteresis demonstrates that the relationship between the 
durations of QT and RR intervals throughout the physiological range of heart rate 
is not straightforward, as the QT-RR relationship is altered during the period of 
recovering heart rate following physiological stress. Previous studies have offered 
some insight into the possible mechanisms of this anomalous QT-RR relationship 
and its implications of differential regulation of cardiac depolarisation and
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repolarisation. For example, there is a direct autonomic influence on the 
ventricular myocardium, and this might affect ventricular depolarisation- 
repolarisation independently of heart rate (Browne etal. 1982, Belardinelli & 
Isenberg 1983, Charpentier & Rosen 1994). It is therefore possible that QT-RR 
hysteresis might be associated with independent ANS modulation of the atrial 
and ventricular myocardia. Exercise-induced QT shortening has also been related 
to the level of catecholamine activity which is increased following sympathetic 
stimulation and this effect is independent of heart rate (Ahnve & Vallin 1982, 
Arrowood etal. 1993). It is notable that plasma norepinephrine level rises during 
exercise and also during the early recovery period, with a half-life of 2.8 minutes 
(Hagberg etal. 1979, Dimsdale etal. 1984). This suggests a temporal pattern of 
catecholamine influence that is consistent with maximal hysteresis values 
between the second and third minutes of post-exercise recovery, as observed in 
the present work. Plasma catecholamine level might therefore be a substantial 
factor in the mechanism of QT-RR hysteresis following exercise.
3.8 Limitations
For both the preliminary and main studies, the apex of the T wave rather than 
the end of the T wave was chosen to examine the period of ventricular 
depolarisation-repolarisation (QT interval), owing mainly to the improved 
reliability with which this parameter was measured by the Holter system’s 
detection algorithm. However, QTa represents only a part of the complete 
depolarisation-repolarisation period, although previous studies have indicated 
that this period contains the majority of the inter- and intra-individual variability 
of the QT interval (Merri etal. 1989, Bidoggia etal. 2000). In agreement with 
Chauhan etal. (2002), it was observed that the T wave apex is a more reliable 
fiducial point for the measurement of QT when the heart rate is very high. It has 
also previously been noted that the shape of the T wave becomes more
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symmetrical when heart rate is elevated during exercise and recovery (Langley et 
al. 2002). However, the relative influence of this symmetry change on the 
location of the end point and apex of the T wave requires further investigation. 
The view was therefore taken that the QTa interval provides the most reliable 
determination of the ventricular depolarisation-repolarisation phase during high 
intensity physical exercise and subsequent recovery.
3.9 Conclusion
The results of the preliminary study showed that the magnitude of paired-lead 
bias and the associated LOA of the bias are substantially greater for QT compared 
with RR, and this is true in both males and females. The difference in paired-lead 
bias for RR and QT is understandably related to differences in the orientation of 
the cardiac vector during these two phases of the cardiac cycle. The difference in 
LOA for RR and QT is likely related to the differential accuracy and precision 
with which these two parameters can be measured from the ECG. Although these 
findings are specific to the Reynolds Lifecard Holter system, the methodology 
employed here could similarly be used in other similar systems. This work 
suggests that the between-lead bias and associated LOA for electrocardiographic 
RR and QT data should be quantified in future investigations using multi-lead 
ambulatory ECG. Interpretation of the results of such studies should take 
adequate account of the between-lead variation in these parameters, and should 
specify each subject’s physiological state.
The relationship between QT and RR intervals for the three different electrode 
lead configurations of an ambulatory ECG system following dynamic physical 
exercise was characterised and compared. The calculated magnitudes of QTa-RR 
hysteresis were significantly affected by the locations of the paired ECG
112
electrodes used to record the surface ECG. These results emphasise the need for 
standardisation of ECG electrode placement in future investigations of QTa-RR 
hysteresis. There is also evidence of differences in hysteresis between genders, 
and so a standard set of ECG electrode locations should be established separately 
for males and females. Further investigation of the physiological mechanisms 
responsible for QTa-RR hysteresis will then be required. Standardised ECG 
recording methodologies should help to elucidate the hypothesised association 
between QTa-RR hysteresis and differential autonomic control of atrial and 
ventricular myocardia.
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Chapter 4 Complexity of electrocardiographic RR and QT time-series data 
during rest and exercise
4.1 Rationale
Variability analysis does not utilise the information available from time- 
dependent changes in data series. Correlation analysis however does, providing a 
measure of the complexity, hence predictability of data. More complex data has 
less predictability and could be associated with healthier physiology. Complexity 
estimation methods include detrended fluctuation analysis (DFA) and entropy. 
The influence of exercise work load on RR time-series complexity is unknown, 
and estimation of the sensitivity of entropy to changes in workload could further 
aid the full characterisation of the mediators of HRV. Also, physical exercise 
causes marked changes in the duration of the QT interval (Sarma etal. 1987, 
Sundqvist etal. 1989), observed throughout a wide range of heart rates and 
apparently involving both heart rate-dependent and heart rate-independent QT 
modulation (Porta etal. 1998, Almeida etal. 2006). It could therefore be of 
potential clinical significance to also examine the complexity characteristics of 
the QT interval during conditions of rest and exercise. Entropy and DFA may be 
of use in this, as although they are commonly used investigative methods, they 
have not been extensively assessed during exercise and recovery.
4.2 Aims and objectives
The aims of this chapter were:
1. To investigate the sample entropy (SampEn) of RR and QT interval data 
during different physiological conditions (rest, dynamic physical exercise 
and post-exercise recovery)
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2. To investigate the fractal (scaling) properties of RR and QT interval data 
during these physiological conditions
The objectives were:
1. To estimate the optimal choice of the parameters “r” and “M” for 
calculating SampEn of RR and QT time-series data (SampEn-RR and 
SampEn-QT) during different physiological conditions (rest, dynamic 
physical exercise and post-exercise recovery)
2. To quantify SampEn-RR and SampEn-QT during each of these conditions
3. To assess the influence of the parameters (r,M) on SampEn-RR and 
SampEn-QT for a selection of “best-choice” combinations of r and M
4. To assess the ability of SampEn-RR and SampEn-QT to discriminate 
between different physiological states (and different exercise work loads)
5. To examine the relationships between traditional HRV parameters and 
each of SampEn-RR and DFA a, and to compare the ability of each of 
these parameters to distinguish between different physiological states
6. To quantify the fractal scaling exponents for RR and QT data using the 
DFA method during each of these physiological conditions
7. To examine the relationships between the scaling exponents and 
traditional HRV parameters
4.3 Methodology
4.3.1 Subject characteristics
Twelve males (age 20.8 ± 0.4 years, mass 78.6 ± 7.7 kg [mean ± SD]) volunteered 
to take part in the investigation. Subject health screening was undertaken using 
the American Heart Association/American College of Sports Medicine pre-
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participation screening questionnaire (Balady etal. 1998). Further subject 
selection criteria were as described in section 3.3.
4.3.2 Exercise testing protocol
All measurements were carried out between 9.00AM and 10.00AM in the 
Exercise Physiology Laboratory at the Sport and Exercise Science Research 
Centre, Swansea University and the investigation was approved by the 
departmental ethics committee. Subjects were initially at rest and were asked to 
breathe in accordance with a metronome set to a rate of 15 breaths per minute 
(0.25 Hz) for six minutes. At the end of this period they were instructed to 
breathe spontaneously for a further six minutes at rest. Subjects then immediately 
performed a progressive exercise test on an electromagnetically braked cycle 
ergometer (Lode Excalibur Sport; Lode, Netherlands). The exercise protocol was 
similar to that described in section 3.3 with the addition that exercise continued 
until volitional fatigue. Breath-by-breath oxygen uptake (V02) data were 
recorded throughout using an Oxycon Pro respiratory gas analysis system (Jaeger, 
Germany).
4.3.3 Physiological measurement
A Reynolds Lifecard CF digital Holter recorder (Del Mar Reynolds Medical Ltd., 
UK) was used to record a three-lead ECG continuously throughout the pre­
exercise, exercise and post-exercise periods. The ECG leads were positioned in the 
modified V5, CC5, modified V5R electrode configuration as shown in Figure 3.1. 
This system provided ECG data with a sample accuracy of 2.5 pV (magnitude of 
least significant bit; 12-bit resolution) and 128 Hz sampling frequency. The 
previously quantified between-lead differences in RR and QT data using this ECG 
system (preliminary study, chapter 3) led to the consideration that there would
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be no benefit from quantifying SampEn or the fractal scaling exponents in each 
lead. All analyses in this investigation therefore were performed using data from a 
single ECG lead (lead 1 for each subject). The ECG recordings were analysed 
using a Reynolds Pathfinder digital analyser (Del Mar Reynolds Medical Ltd.,
UK). All ECG data used for subsequent analysis in this study were free of any 
form of morphologically abnormal beat, and this was verified by both the Holter 
system and by human observation. Beat-to-beat cardiac interval (RR) and QT 
interval data were automatically measured for each sinus beat and exported for 
further analysis using the Reynolds Research Tools software (Del Mar Reynolds 
Medical Ltd., UK). The QT and RR data also underwent human visual 
examination in order to verify the accuracy of the data prior to subsequent 
analysis. When either the RR or QT intervals were considered to be anomalous 
both the RR and QT data points were removed from the data set. This occurred 
infrequently (and mainly during exercise), resulting overall in fewer than 1% of 
the data being removed. All QT analyses in this chapter were based on the QTe 
interval (Qwave onset to T wave end) as the detection performance for Ta and Te 
of the Holter system used were considered broadly equivalent. Fingertip capillary 
blood samples were analysed for whole blood lactate and glucose concentration 
using a YSI 2300 Lactate and Glucose Analyser (YSI Inc., USA).
4.3.4 Data analysis
Subsets of the QT and RR data sets were defined that represented these data 
within specified intervals during exercise and during the pre- and post-exercise 
phases:
1. Consecutive one-minute intervals during the six minute period of 
metronomic breathing
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2. Consecutive one-minute intervals during the six minute period of 
spontaneous breathing
3. The final one-minute period of each exercise stage (in order to represent 
physiologically steady-state conditions)
4. Consecutive one-minute intervals during the post-exercise resting phase, 
which lasted for 15-minutes
Prior to further data processing the QT and RR data were linearly detrended 
within consecutive one-minute segments (corresponding to the subsets defined 
above) in order to remove any time-dependent trends in the data.
4.3.4.1 SampEn analysis
To reiterate section 2.5.4.2.3, SampEn is defined as the negative natural logarithm 
of the conditional probability that two sequences of data values that are similar 
for “M” points will remain similar at the next point in the data set, within a 
tolerance “r” that is expressed as a fraction of the standard deviation of the data. 
This is represented mathematically as SampEn(r,M) = -ln(A/B), where A and B 
are the total number of forward matches of length m+1 and m, respectively 
(Richman & Moorman 2002). As noted by Lake etal. (2002) no guidelines exist 
for the optimal selection of the parameters r and M. Therefore in order to 
evaluate the theoretically optimal values of r and M for entropy analysis, an 
approach similar to that of Lake et al. (2002) was used in this analysis to find r,M 
such that SampEn was maximal and the associated standard error (SE-SampEn) 
was minimal. SampEn and its standard error were calculated using a 20 x 15 
matrix of combinations of r=0.05, 0.10,...,1.00 and M=l,2,...,15. The resulting 
SampEn and associated SE-SampEn matrices were then normalised (by dividing 
each value within the matrix by the maximum value for that matrix). The 
product of the matrices [(normalised SampEn) x (1-normalised SE-SampEn)] was
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then calculated separately for the RR and QT data sets, and individually for the 
pre-exercise, exercise and post-exercise states. Four r,M combinations were 
selected as optimal choices on the basis of this estimation procedure. SampEn was 
then calculated for the defined one-minute periods of the detrended RR and QT 
time series using each r,M parameter pair: r=0.1,M=2; r=0.15,M=2; r=0.2,M=2; 
r=0.25,M=2.
HRV parameters were quantified in the time domain (RMSSDNN: square root of 
the mean of the sum of the squares of differences between adjacent RR intervals, 
and SDNN: standard deviation of all RR intervals) and the frequency domain 
(Total power: 0.017 to 0.4 Hz, low frequency (LF: 0.04-0.15 Hz), high frequency 
(HF0.4: 0.15-0.4 Hz), LF/HF0.4, normalised LF (LFn) and normalised HF0.4 (HFo.4n)) 
according to the Task Force guidelines on HRV (Task Force ESC & NASPE 1996). 
The extended high frequency component (HF1.0: 0.15 to 1.0 Hz) was also 
calculated along with the corresponding LF/HF1.0 ratio, since it has previously 
been shown that the Task Force’s recommended HF0.4 bandwidth does not 
adequately account for the influence of RSA during moderate-to-high exercise 
work loads (Lewis eta l. 2007). Frequency domain data analysis procedures were 
as described in this previous work (Lewis e t  al. 2007): RR interval data were re­
sampled using a sampling frequency of 2 Hz and then linearly de-trended and 
Hanning windowed in consecutive one-minute segments; the power spectral 
density of each segment was then calculated using the Welch periodogram 
method, using short-term Fourier transformation and a 50% overlap between 
adjacent segments. In addition, the QTVI according to the equation described by 
Berger eta l. (1997) was calculated.
Each of the SampEn and HRV parameters was averaged to provide a single 
representative value for discrete physiological states during pre-exercise
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(metronomic breathing and spontaneous breathing states) and during post­
exercise (0-5, 5-10 and 10-15 minute post-exercise recovery periods). (Exercise 
values for each parameter were already defined for representative one-minute 
stages.)
4.3.4.2 Detrended fluctuation analysis
The DFA a  exponents were calculated separately for RR and QT time series data 
using the method suggested by Little etal. (2006). The data were first integrated 
over a specified number of data points (window length n) and fitted with the 
local linear trend, which was then subtracted from the locally integrated data set. 
This was repeated for all consecutive windows of length n within the original 
data set. The average root-mean-squared (RMS) fluctuation of the data was then 
calculated over the entire length of the data set. This procedure was repeated for 
multiple window lengths, to give the RMS fluctuation as a function of n (F(n)). A 
log-log plot of F(n) against n yielded the scaling exponent (a) via the gradient of 
the plot. In accordance with previous work (Peng etal. 1995, Hautala etal. 2003, 
Penttila et al. 2003) two a  parameters were quantified: short-term ai was 
determined using n between 4 and 11 samples, and long-term ou was calculated 
for all greater values of n, up to the maximum permitted by the data sample. The 
DFA a  parameters were then individually averaged to provide a single 
representative value for discrete physiological states during pre-exercise 
(metronomic breathing and spontaneous breathing states) and during post­
exercise (0-5, 5-10 and 10-15 minute post-exercise recovery periods). (Exercise 
values for the scaling exponents were already defined for representative one- 
minute stages.) The relative between-state discriminating ability of the HRV 
parameters described in section 4.3.4.1 was compared with that of the DFA a  
exponents.
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4.3.5 Statistical analysis
The Lilliefors test for goodness of fit to a Normal distribution was used to assess 
whether individual parameters in the data were Normally distributed, and 
thereby informed the selection of appropriate parametric or non-parametric 
methods of statistical analysis.
4.3.5.1 Statistical analysis-SampEn
SampEn values for the four r,M combinations were compared for each 
physiological state using separate mixed between-within repeated measures 
ANOVA for the RR and QT data. Bartlett’s test was consulted to confirm the 
assumption of sphericity for the data in the different physiological states. A 
significant P value for the two-way interaction effect (physiological state x r,M 
combination) was deemed to represent differences in the patterns of SampEn 
responses to physiological state. Where simple effect analysis identified a 
significant difference between the SampEn values (either for different r,M in a 
given physiological state, or for a single r,M between different physiological 
states) multiple pairwise comparisons with Bonferonni confidence interval 
adjustment were used to identify differences between individual SampEn values.
Differences between SampEn-RR and SampEn-QT for individual physiological 
states were assessed using paired t-tests. Correlations between individual HRV 
parameters and SampEn-RR were assessed using Spearman’s rank order 
correlation coefficient (rho) since the assumptions of Normality (Lilliefors test) 
and homoscedasticity (Levene’s test) were violated for the HRV parameters. 
Friedman’s non-parametric one-way repeated measures ANOVA was used to 
compare mean HRV parameter values between physiological states, separately for
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each parameter. To enable direct comparison, this procedure was repeated for the 
SampEn-RR values calculated for each of the four r,M parameter pairs.
4.3.5.2 Statistical analysis-fractal characteristics
The DFA a  values were compared for each physiological state using separate one­
way repeated measures ANOVAs for the RR and QT data. Bartlett’s test was 
consulted to confirm the assumption of sphericity for the data in the different 
physiological states. Paired t-tests were used to examine differences between a  
for RR and a  for QT, and to examine differences between the short-term (ai) and 
long-term (0 2 ) values for both RR and QT data, in each physiological state.
Correlations between individual HRV indices and DFA a  values were assessed 
using Spearman’s rank order correlation coefficient (rho) since the assumptions of 
Normality (Lilliefors test) and homoscedasticity (Levene’s test) were violated for 
the HRV parameters. In addition to the ANOVA procedures noted above, 
Friedman’s non-parametric one-way repeated measures ANOVA was used to 
compare the mean DFA a  exponent values between different physiological states, 
separately for both RR and QT data. This was instructive as it was the statistical 
procedure as employed in the SampEn analysis (section 4.3.5.1), and thereby 
enabled direct comparison of the between-state discriminating ability of the DFA 
a  values and HRV parameters.
All data quoted in the text represent mean ± SD. Error bars in the figures 
represent the SEM (standard error in the mean) for the plotted parameters. 
Statistical differences were considered significant at the level P<0.05.
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4.4 Results
Individual maximal oxygen uptake (V02max) values obtained during the study 
confirmed the homogeneity of aerobic fitness within the subject group (49.6 ± 4.8 
ml-kg^min1). Owing to the difficulty of reliably measuring QT interval during 
the elevated heart rates associated with exercise, QT data were available only for 
exercise intensities up to 70.1 ± 6.3 % V02max (equivalent to a heart rate of 151 ±9 
bpm). Table 4.1 provides a characterisation of group mean responses to the 
different physiological states used in the experimental protocol with regard to 
heart rate, relative work load, blood lactate and blood glucose.
Table 4.1 Physiological responses to different physiological states in the study 
(group mean ± SEM)
State MB SB e l e2 e3 e4 e5 r5 rlO rl5
Heart rate
(bpm)
80 ± 4 81 ±4 103 ±4 116 ± 4 132 ±4 144 ±5 151 ±9 136 ±4 122 ±6 117 ±7
Relative 
work rate
(% V 0 2
max)
20.3 ± 3.4 18.6 ± 3.1 37.7 ± 1.0 44.0 ±1.4 54.1 ± 1.3 62.3 ± 1.5 70.1 ± 1.8 55.5 ± 2.8 46.8 ± 2.3 45.6 ± 2.9
Lactate
(mmolL1)
0.9 ± 0.0 1.2 ±0.1 1.2 ±0.1 1.6 ±0.1 2.8 ±0.2 5.0 ± 0.5 8.8 ±0.5 -
Glucose
(mmol-L1)
- 4.7 ± 0.2 4.7 ± 0.2 4.6 ± 0.2 4.5 ± 0.2 4.5 ± 0.2 4.4 ± 0.3 5.2 ± 0.4 - -
MB = metronomic breathing stage; SB = spontaneous breathing stage; el-e5 = 
exercise stages 1-5; r5,rl0,rl5 = recovery stages (r5 = 0-5 minutes, rlO = 5-10 
minutes, rl5  = 10-15 minutes post-exercise)
4.4.1 SampEn results
Figure 4.1 shows a truncated version of the distributions of the product 
[(normalised SampEn) x (1-normalised SE-SampEn)] for differing r,M paired 
parameters during the resting, exercise and recovery conditions, separately for 
the RR and QT data sets. The plots show distinct regions in which this array
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product yielded the highest values, and thereby suggests combinations of r and M 
that are optimal for SampEn calculation. Group mean values for SampEn-RR are 
presented in Figure 4.2 (a) as functions of heart rate and physiological state.
Group mean values for SampEn-QT are presented in Figure 4.2 (b) as functions of 
heart rate and physiological state.
Figure 4.1 Distributions of the array product [(normalised SampEn) X (1- 
normalised SE-SampEn)] as a function of r and M for RR (a-c) and QT (d-f) data 
sets during pre-exercise (a & d), exercise (b & e) and recovery (c & f). Colour 
scale: Red represents larger values of the array product, blue represents smaller 
values as indicated in (a)
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Figure 4.2 (a) SampEn-RR as a function of heart rate and physiological state. (MB 
= metronomic breathing stage; SB = spontaneous breathing stage; el-e5 = exercise 
stages 1-5; r5,rl0,rl5 = recovery stages (r5 = 0-5 minutes, rlO = 5-10 minutes, rl5 
= 10-15 minutes post-exercise)
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Figure 4.2 (b) SampEn-QT as a function of heart rate and physiological state. (MB 
= metronomic breathing stage; SB = spontaneous breathing stage; el-e5 = exercise 
stages 1-5; r5,rl0,rl5 = recovery stages (r5 = 0-5 minutes, rlO = 5-10 minutes, rl5 
= 10-15 minutes post-exercise)
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For the group mean values for SampEn-RR, there was a statistically significant 
main effect for physiological state, with a large effect size (F9,345=9.75; p<0.0001; 
partial eta squared=0.203). Post-hoc comparisons using the Bonferroni test 
indicated that mean SampEn-RR during the first and second stages of exercise 
was significantly greater than that during metronomic breathing and spontaneous 
breathing, and significantly greater than that during minutes 6 to 15 of recovery. 
SampEn-RR during the third stage of exercise was also greater than that during 
minutes 11 to 15 of recovery. There were no other differences between 
physiological states. There was a statistically significant main effect for r,M paired 
parameters, with a large effect size (F3,345=83.3; p<0.0001; partial eta 
squared=0.420). Post-hoc comparisons using the Bonferroni test indicated that 
SampEn-RR was significantly different for every comparison of r,M pair. The 
interaction effect (physiological state x r,M pair) was not statistically significant 
(F27.345=0.24; p=1.0; partial eta squared=0.019), indicating that the trend of SampEn 
across physiological states was not influenced by the choice of r,M (i.e. different 
r,M for this subset of optimal combinations resulted in a consistent magnitude 
difference (bias) only).
For the group mean values for SampEn-QT, there was a statistically significant 
main effect for physiological state, with a moderately large effect size (F9,36o=3.94; 
p=0.0001; partial eta squared=0.090). Post-hoc comparisons using the Bonferroni 
test indicated that mean SampEn(QTe) during the first stage of exercise was 
significantly less than that during both metronomic and spontaneous breathing 
and significantly less than that during minutes 6 to 15 of recovery. There were no 
other differences between physiological states. There was also a statistically 
significant main effect for r,M paired parameters, with a large effect size 
(F3,36o= 180.4; p<0.0001; partial eta squared=0.600). Post-hoc comparisons using the 
Bonferroni test indicated that SampEn-QTe was significantly different for every
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comparison of r,M pair. The interaction effect (physiological state X r,M pair) was 
not statistically significant (F27,36o=0.30; p=0.9998; partial eta squared=0.022).
SampEn-RR was significantly less than SampEn-QT for all equivalent 
physiological states except during the first two stages of exercise (p=0.0001 to 
0.039), when SampEn-RR was substantially elevated. SampEn-RR demonstrated a 
low-to-moderate negative correlation with LFn (r=-0.24 to -0.32, p<0.021), 
LF/HFo.4 (r=-0.22 to -0.27, p<0.039) and LF/HFi.o (r=-0.22 to -0.30, p<0.039) for 
each of the four r,M pairs. SampEn-RR with r=0.1 and M=2 was additionally 
negatively correlated with HFi.oand HFo.4n (r=-0.22, p<0.041 for both). There were 
no other statistically significant correlations between SampEn-RR and HRV 
parameters. Table 4.2 shows the HRV and SampEn parameters ranked according 
to their ability to discriminate between physiological states, based on the results 
of Friedman’s one-way repeated measures ANOVA. Only SDNN and QTVI were 
sensitive to differences between exercise states.
Table 4.2 Sample entropy and indices of heart rate variability for RR time-series 
data, in rank order according to between-state discriminating ability
Rank Parameter Chi-sq P>Chi-sq Partial eta squared
1 SDNN* 70.65 3.64 x 1012 0.736
2 RMSSDNN 66.13 2.88 x 10 11 0.689
3 HFO.4 52.63 1.27 x 108 0.548
4 Total 46.86 1.63 x 10-7 0.488
5 H F i.o 41.80 1.48 x 106 0.435
6 QTVI* 41.24 1.88 x 106 0.430
7 L F /H F i.o 32.63 7.18 x 10-5 0.340
8 L F /H F 0.4 28.20 4.38 x 10 4 0.294
9 LFn 28.14 4.48 x 10-4 0.293
10 HFo.4n 27.05 6.93 x 10-4 0.282
11 SampEn-RR (r=0.25,M=2) 23.72 2.60 x 103 0.247
12 L F 21.37 6.20 x 103 0.223
13 SampEn-RR (r=0.2,M=2) 21.35 6.30 x 103 0.222
14 SampEn-RR (r=0.15,M=2) 14.62 6.71 x 102 0.152
15 SampEn-RR (r=0.1,M=2) 14.33 7.37 x 102 0.149
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Chi-sq = Chi-squared statistic from Friedman’s one-way repeated measures 
ANOVA; *Parameter distinguished between different exercise work loads
4.4.2 Fractal characteristics results
4.4.2.1 Results for the short-term DFA cxi exponent
Group mean values for the short-term on exponents for RR and QT data are 
presented in Figure 4.3 (a) as functions of heart rate and physiological state.
Recovery (minute]
170 110 130 150 170
Heart rate (bpm)
• •• * ••  RR *  QT
Figure 4.3 (a) DFA on as a function of heart rate and physiological state. (MB = 
metronomic breathing stage; SB = spontaneous breathing stage; el-e5 = exercise 
stages 1-5; r5,rl0,rl5 = recovery stages (r5 = 0-5 minutes, rlO = 5-10 minutes, rl5 
= 10-15 minutes post-exercise)
There was a statistically significant main effect of physiological state on both 
these parameters, the effect size being moderately large (on (RR): F9,94= 3.11, p = 
0.003, partial eta squared = 0.230; on (QT): F9,88= 2.53, p = 0.013, partial eta 
squared = 0.205). However, post-hoc tests revealed that the only differences in on 
(RR) were between states e5 and SB. No between-stage differences were
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identified for ai (QT). ou (RR) was significantly greater than oti (QT) for each 
individual physiological state (p<0.00001 during rest; 0.000 l<p<0.032 during 
exercise; 0.001<p<0.016 during recovery).
For the purposes of comparison with the parameters in section 4.4.1, Friedman’s 
one-way repeated measures ANOVA was carried out to compare ai for the 
different physiological states. Friedman’s ANOVA confirmed that the DFA a  
parameters were moderate discriminators of differing physiological states (ai 
(RR): Chi-sq = 32.94, P>Chi-sq = 1.4 x 10~4, partial eta squared = 0.305; on (QT): 
Chi-sq = 17.68, P>Chi-sq = 0.039, partial eta squared = 0.164). on (RR) was a better 
state discriminator than ou (QT), with ai (RR) values during the final two stages of 
exercise being significantly lower compared with those at rest. However, ou (RR) 
was a relatively poor discriminator of physiological state when compared with 
the majority of other tested parameters. (Chi-sq = Chi-squared statistic from 
Friedman’s one-way repeated measures ANOVA.)
It was observed that oti (RR) demonstrated significant low-to-moderate 
correlations with the following HRV parameters: RMSSDNN (r=0.22, p=0.030), 
SDNN (r=0.46, p = 5 X 10 6), LF (r=0.28, p=0.005), LFn (r=0.41, p = 3 x 10*), 
LF/HF0.4 (r=0.27; p=0.009), LF/HFi.o (r=0.36; p = 4 X 104), QTVI (r=-0.31, p=0.005) 
and SampEn(RR) (-0.49, p = 5 x 10'6). There were no other statistically significant 
correlations between ou (RR) and HRV parameters. As expected, there were no 
statistically significant correlations between ou (QT) and any of the HRV 
parameters.
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4.4.2.2 Results for the long-term DFA 0C2 exponent
Group mean values for the long-term ou exponents for RR and QT data are 
presented in Figure 4.3 (b).
1.2 
1.1
^  0 9
Q.
<
<
Q  0 8
07  
OS 
0 5
70 90 110 130 150 170 110 130 150 170
Heart rate (bpm)
A* • RR *  QT
Figure 4.3 (b) DFA ou as a function of heart rate and physiological state. (MB = 
metronomic breathing stage; SB = spontaneous breathing stage; el-e5 = exercise 
stages 1-5; r5,rl0,rl5 = recovery stages (r5 = 0-5 minutes, rlO = 5-10 minutes, rl5 
= 10-15 minutes post-exercise)
There was no statistically significant main effect of physiological state on either of 
these parameters, the effect size being small in each case (ou (RR): F9,96= 0.61, p = 
0.78, partial eta squared = 0.06; ou (QT): F9,94= 1.13, p = 0.35, partial eta squared = 
0.10). Therefore there were no differences in ou between physiological states for 
either RR or QT time series data, ou (RR) was again significantly greater than ou 
(QT) for each individual physiological state (p<0.00001 during rest; 0.00l<p<0.034 
during exercise; 0.0001<p<0.002 during recovery).
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Friedman’s ANOVA confirmed that the 0 2  parameters were relatively poor 
discriminators of differing physiological states ( 0 2  (RR): Chi-sq = 8.40, P>Chi-sq = 
0.4944, partial eta squared = 0.078; 012 (QT): Chi-sq = 17.16, P>Chi-sq = 0.0462, 
partial eta squared = 0.159). Thus, although 0 2  (QT) was better than 0 2  (RR) in 
this regard, both were poorer discriminators of physiological state than the 
majority of other tested HRV parameters.
It was observed that 0 2  (RR) demonstrated significant low-to-moderate negative 
correlations with the following HRV parameters: RMSSDNN (r=-0.29, p=0.003), 
SDNN (r=-0.23, p=0.018), Total Power (r=-0.22, p=0.028), HFi.oand HFo.4(r=-0.25, 
p<0.012 for both). There were no other statistically significant correlations 
between 012 (RR) and HRV parameters (including SampEn and QTVI). As 
expected, there were no statistically significant correlations between 0 2  (QT) and 
any of the HRV parameters.
4.5 Discussion
4.5.1 Selection of optimal values of r and M for SampEn calculation
The distributions of the array product [(normalised SampEn) x (1-normalised SE- 
SampEn)] suggested that there were some differences in the optimal r,M 
combinations for different physiological states, and between the RR and QT data 
sets. As noted by Pincus & Goldberger (1994), the utility of entropy (ApEn) is as a 
relative measure of data complexity, using a fixed r,M pair. The selection of a 
single r,M pair from the preliminary analysis that could be used consistently for 
both RR and QT data sets and for each of the different physiological states was 
therefore sought. The results of this procedure indicated that optimal values were 
within the range r=0.1-0.2 and M=2-4. The choice of the four r,M pairs for 
subsequent analysis was based on these results. However, M=2 for each of the
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four cases was used, in order to conform to the guideline that a reasonable 
estimate of entropy (ApEn) requires at least 10M data points (Pincus & Goldberger 
1994). There were between 80 and 150 data points in each analysed one-minute 
period, and so the most appropriate choice of M was 2. One value of r outside the 
indicated optimal range (r=0.25) was also used in order to examine the effect of 
reduced tolerance.
4.5.2 Influence of physiological state on the magnitude of SampEn
The magnitudes of both SampEn-RR and SampEn-QT were strongly dependent 
on the selection of r and M parameters. As stated previously, SampEn-RR and 
SampEn-QT responded similarly to different physiological conditions for each of 
the four r,M pairs, demonstrating their consistency in response to differing 
physiological conditions. SampEn-RR showed a general trend towards increased 
values during the initial stages of exercise, declining as exercise intensity 
increased, and then initially increasing prior to a continuing further decline 
during recovery. SampEn-RR was significantly greater during light-to-moderate 
exercise work loads compared with during pre-exercise and the final 10 minutes 
of recovery. SampEn-QT showed a general trend towards decreased values during 
the initial stage of exercise, maintained a fairly uniform magnitude as exercise 
intensity increased (apart from when r=0.1 and M=2), and then either increased 
or maintained a uniform magnitude during recovery. SampEn-QT was 
significantly reduced during the lowest exercise work load compared with during 
pre-exercise and the final ten minutes of recovery. Neither SampEn-RR nor 
SampEn-QT distinguished between any of the other physiological states, 
including respiratory mode (spontaneous or metronomic breathing).
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There have been several investigations of the relative influence of spontaneous 
and controlled (metronomic) breathing on traditional indices of HRV. Pagani et 
al. (1986) observed that controlled respiration produces a marked increase in HF 
power, whilst later studies showed that the influence of metronomic breathing on 
HRV is rate-dependent (Patwardhan et al. 1995, Sanderson etal. 1996). Strano et 
al. (1998) further suggested that standardising the respiratory rate in athletes to 
15 breaths per minute (0.25 Hz) facilitates optimal estimation of the respiratory- 
related (HF) component of HRV. The assessment of SampEn during standardised 
breathing conditions was therefore sought, hence the inclusion of spontaneous 
and metronomic breathing in the testing protocol. A slightly elevated SampEn- 
RR and a slightly reduced SampEn-QT during metronomic breathing at 0.25 Hz 
compared with spontaneous breathing was observed, but the difference was not 
statistically significant. There was therefore some indication that SampEn 
parameters are sensitive to respiratory mode (possibly via altered parasympathetic 
influence or mechanical effects, or both) although this requires further 
investigation.
No previous study has quantified SampEn for QT time-series data. SampEn-RR 
was significantly lower than SampEn-QT for equivalent r,M pairs during all 
physiological conditions except during the initial stages of exercise, when 
SampEn-RR was generally at its highest values. This observation, interpreted as 
evidence of greater complexity in the modulation of QT interval compared with 
the RR interval, might be explained with regard to differential ANS modulation 
of the atrial and ventricular myocardium. The ANS has a direct parasympathetic 
influence on the ventricular myocardium, and this might affect cardiac 
repolarisation independently of chronotropic (heart rate) modulation of the SA 
node, especially at elevated heart rates (Ahnve & Vallin 1982, Shimizu etal. 1994, 
Magnano etal. 2002). Moreover, QT shortening during exercise has a substantial
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component that is not controlled by heart rate (Rickards & Norman 1981, Milne 
etal. 1988). This therefore leads to the tentative suggestion that SampEn-QT 
reflects, to a degree, the combined influence of ANS modulation of both the atrial 
and ventricular myocardium. Moreover, during moderate-to-high exercise work 
loads, SampEn-QT might dominantly represent the complexity of ANS 
modulation of ventricular repolarisation.
Few previous studies have attempted to characterise the influence of exercise on 
measures of RR interval complexity. In agreement with the present work, Tulppo 
etal. (2001) observed that ApEn increased during low-intensity steady state 
exercise (a walking test) compared with baseline. Javorka et al. (2002) quantified 
SampEn in the standing and supine positions following sub-maximal exercise (a 
step test at an intensity equivalent to 70% of maximal work rate). SampEn in the 
supine position was significantly lower during post-exercise recovery compared 
with pre-exercise (and re-attained the pre-exercise value within 30 minutes), and 
was greater than during pre-exercise standing. However, these authors did not 
assess SampEn during exercise itself. In the present study, subjects were in the 
seated position during pre- and post-exercise, and post-exercise SampEn tended 
to initially increase and then decrease as recovery proceeded.
4.5.3 Relationship between SampEn-RR, heart rate and linear indices of HRV
Tulppo etal. (2001) noted that ApEn (and the change in ApEn from baseline 
during low-intensity steady state exercise) was either uncorrelated or was only 
weakly correlated with heart rate or spectral measures of HRV. However, Platisa 
& Gal (2006b) reported significant (p<0.01) correlations between SampEn and the 
natural logarithm of each of the parameters Total Power (r=0.62), LF (r=0.56), HF 
(r=0.83), and LF/HF (r=-0.78). Platisa & Gal (2006b) reported a generally linear
134
relationship between SampEn and RR and noted that at the highest heart rates 
the trend of reduced SampEn with increasing heart rate (observed in young 
subjects) was reversed in elderly subjects (SampEn increased with increasing HR). 
In comparison, significant low-to-moderate negative correlations between 
SampEn(RR) and LFn for each of the four r,M pairs were observed in this work. 
Similar to Platisa & Gal (2006b), reductions in SampEn were observed when heart 
rate was substantially elevated in our healthy young subjects. When linear and 
non-linear cardiac indices were ranked according to their ability to discriminate 
between different physiological states, the time-domain HRV parameters (SDNN 
and RMSSDNN) performed best and SampEn-RR performed worst. Notably, 
lower values of tolerance (r) were associated with poorer discriminating ability.
4.5.4 Magnitude of a  scaling exponents for RR data
Peng etal. (1995) noted values of ou = 1.201 ± 0.178 and ou = 0.998 ± 0.124 for RR 
data in healthy young adults. Pikkujamsa etal. (1999) noted similar values of ai = 
1.15 ± 0.16 and ou = 1.00 ± 0.08. These values are consistent with the resting 
values observed in the present study: on = 1.37 ± 0.08 (spontaneous breathing) and
1.43 ± 0.06 (metronomic breathing); ot2 = 0.93 ± 0.03 (spontaneous breathing) and
0.92 ± 0.04 (metronomic breathing). The post-exercise recovery values were 
similar to those at rest, ranging between 1.09 ± 0.12 and 1.35 ± 0.11 (ou) and 
between 1.00 ± 0.05 and 1.03 ± 0.04 (0C2).
Hautala etal. (2003) noted that, compared with rest, ou increased from 1.13 ± 0.18 
to 1.36 ± 0.11 during uniform low-intensity exercise and decreased from 1.19 ±
0.26 to 0.58 ± 0.26 during uniform high-intensity exercise. During a progressive 
maximal exercise test these authors observed that ou increased initially (from 1.07 
± 0.24 at rest to 1.50 ± 0.25 at ~40% V02irax) and then decreased linearly until the
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end of exercise (to a value of 0.38 ± 0.10). This bidirectional change was 
interpreted with regard to the influence of an initial withdrawal of 
parasympathetic (vagal) modulation during the initial stages of exercise, since the 
effect was not observed when the exercise test was repeated following vagal 
blockade with atropine (during which ai reduced linearly). The authors also 
noted that atropine administration during rest caused ai to increase significantly 
(from 0.91 ± 0.23 to 1.37 ±0.31), confirming a similar effect observed by Penttila 
etal. (2003). In the present work, resting values for ai of between 1.37 ± 0.08 and
1.43 ± 0.06 were observed, which were comparable to the values noted by 
Hautala et al. (2003) following parasympathetic blockade at rest. A linear 
reduction in ai as a function of increasing exercise work load (to a minimum 
value of 0.99 ± 0.09 at ~70% V02) was also observed, with no bidirectional change 
(Figure 4.3 (a)). This difference in results may be interpreted as the consequence 
of a greater initial reduction in cardiac parasympathetic modulation at the onset 
of exercise for our subjects. The subjects in the present study were physically 
active and reasonably well trained, and they were considerably younger than 
those examined by Hautala etal. (2003). A rapid and substantial reduction in 
parasympathetic activity at the onset of even low-to-moderate intensity exercise 
for such subjects has been previously noted (Lewis etal. 2007).
4.5.5 Magnitude of a  scaling exponents for QT data
The ai values for QT were significantly lower than for RR during all 
physiological states: 0.66 ± 0.02 (rest, spontaneous breathing) and 0.72 ± 0.02 
(rest, metronomic breathing); 0.63 ± 0.09 to 0.71 ± 0.05 (range, exercise); 0.69 ±
0.03 to 0.82 ± 0.02 (range, post-exercise recovery). The 0C2 values for QT were also 
significantly lower than for RR during all physiological states: 0.68 ± 0.03 (rest, 
spontaneous breathing) and 0.72 ± 0.03 (rest, metronomic breathing); 0.66 ± 0.09 
to 0.80 ± 0.05 (range, exercise); 0.69 ± 0.04 to 0.82 ± 0.06 (range, post-exercise
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recovery). The ou and 0C2 values for QT were significantly different only during 
parts of the rest and recovery periods.
4.5.6 Influence of physiological state on a  exponents
In section 4.4.1, when linear and non-linear cardiac indices were ranked 
according to their ability to discriminate between different physiological states 
(Table 4.2), the linear time-domain HRV parameters (SDNN and RMSSDNN) 
performed best and the non-linear parameter SampEn-RR performed worst. 
Moreover, only the linear indices SDNN and QTVI were sensitive to differences 
between exercise states. For the detrended fluctuation analysis, the ou parameter 
for RR data displayed a moderate ability to discriminate between physiological 
states. However, it was a poor discriminator of physiological state when 
compared with the majority of the other quantified parameters, at least for the 
short time periods considered here. Conversely neither ou (for RR) nor either ou 
or 0(2 (for QT) were able to differentiate between the physiological states in the 
study protocol in any statistically meaningful way. It is also worthy of note that 
Penttila et al. (2003) suggested that breathing rate can significantly affect the a  
scaling exponent and these authors suggested that the respiratory rate should be 
controlled at 15 breaths per minute (0.25 Hz) to standardise protocols. However, 
no significant differences in a  value between metronomic breathing and 
spontaneous breathing states were observed in the present study.
4.5.7 Relationship between a  exponents and other indices of heart rate variability
It was observed that the ou and ou scaling exponents for RR demonstrated 
differences in their correlations with the other calculated HRV characteristics, 
although both exponents correlated with RMSSD and SDNN. Makikallio et al. 
(1999) previously suggested that ou was not correlated with any single measures
137
of HRV, although it was related to the LF/HF ratio. Jokinen etal. (2001) observed 
significant correlations between ai and SDNN, VLF, HF and ApEn and between 
0 2  and each of LF, HF and ApEn. Francis et al. (2002) also later concluded that 
the ai and ou indices are frequency-weighted versions of the spectral ratios 
LF/(HF + LF) and VLF/(LF + VLF), respectively. Hautala etal. (2003) observed a 
strong resting correlation between ai and LF and a strong inverse correlation 
between ai and HFn, noting that the correlations were weaker during exercise 
and following parasympathetic blockade. The results of the present study are only 
partly consistent with these previous findings, possibly owing to differences in 
the measurement periods used for HRV parameter determination in the different 
studies.
4.6 Limitations
The electrocardiographic RR and QT intervals cannot be quantified with 
equivalent accuracy or precision owing to the nature of the ECG characteristics 
that are used in their measurement (chapter 3). Here, the detection performance 
for Ta and Te of the Holter system used were considered broadly equivalent. The 
Ta-Te interval contains an independent variability component (Davey 1999). 
These findings suggest that QTe provides the most reliable and accurate 
assessment of QT interval dynamics. Nevertheless, it is possible that the 
measurement accuracy and precision of the QT time-series data might have 
influenced the calculation of SampEn-QT, and further investigation is needed to 
assess this. It is also recognised that it is possible that the SampEn-QT results 
detailed in this chapter are specific to the Holter measurement system used, and 
that it might be useful to quantify this parameter for other systems.
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The QT interval is also known to vary in part as a function of heart rate, however, 
it was decided not to adjust QT interval for heart rate in this study. The 
limitations of universal formulae for adjusting the QT interval in this way are 
well recognised (Aytemir etal. 1999, Desai etal. 2003). Moreover, the results 
detailed in chapter 3 indicated that physical exercise appears to perturb the QT- 
RR relationship via a substantially altered ANS influence and so a single QT 
adjustment could not reliably be applied across the different physiological states. 
Investigation of any potential influence on SampEn-QT of heart rate adjustment 
of the QT interval might perhaps be the topic of further investigation.
A uniform time interval of one minute for the analysis of SampEn and fractal 
charecteristic a  during each of the physiological states was used, rather than a 
uniform number of time-series data points. It could be argued that this might 
have influenced the results since the uniform time interval contained increasing 
numbers of data points as heart rate increased. However, Merati et al. (2006) 
noted that the use of either a fixed number of beats or a fixed time period for 
entropy calculation provides largely equivalent results and suggested that these 
methods are “interchangeable”. Hautala et al. (2003) observed that there were was 
no difference between ai values calculated for either a three-minute period of RR 
data during exercise or a 200 beat subset of data chosen from that period. 
Recently, Delignieres etal. (2006) showed that DFA provides acceptable estimates 
of the scaling exponent using data sets consisting of 128 or more points. It is 
considered therefore that the methodology used in this chapter was appropriate 
given the physiological restraints, and moreover was a logical choice for enabling 
the direct comparison of SampEn and a  and indices of HRV (also calculated for 
fixed one minute periods).
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4.7 Conclusion
The sample entropy of RR time-series data is sensitive to differing physiological 
conditions when an appropriate choice of parameters is used for its calculation. 
The results of the study presented in this chapter suggest that values of r=0.1-0.15 
and M=2 represent an optimal choice for the consistent estimation of SampEn for 
RR and QT data. However the ability of SampEn to discriminate between resting 
and exercise conditions is poorer than that of the common linear measures of 
HRV, and it was unable to differentiate between the work loads used in this 
study.
SampEn of RR data is negatively correlated with normalised LF and LF/HF 
parameters in cardiac control, confirming that the complexity of cardiac interval 
time-series is associated with ANS functional status. Pincus & Goldberger (1994) 
suggested that the reduction in entropy (ApEn) during pathology represents 
system decoupling from external inputs, or a reduction in the influence of these 
inputs. Changes in SampEn for RR or QT data in terms of the altered ANS control 
of either the atrial or ventricular myocardium (or both) during discrete 
physiological states are similarly interpreted here. Further investigations might 
usefully examine the utility of a combined analysis of SampEn for RR and QT 
data during specific types of pathology.
The DFA scaling exponent values for RR were in general agreement with those 
observed previously during rest and exercise. Post-exercise recovery values of the 
scaling exponents have not previously been documented; it was observed that 
recovery values reverted to pre-exercise values within the observation period. 
During rest and post-exercise recovery stages, the RR data displayed strong 
scaling characteristics tending towards those of brown noise (a=2). However, as
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exercise work loads increased the RR data tended to demonstrate a 1/f scaling 
behaviour (a=l).
Scaling exponent values for QT data had not previously been reported. It was 
observed that a  values for QT were significantly lower than those for RR during 
all physiological states. Moreover, the a  values for QT approached 0.5 during the 
heaviest exercise work loads, suggesting that the QT data had the characteristics 
of uncorrelated white noise during these periods.
Short-term (ai) and long-term (012) values for RR differed significantly during rest 
and during the initial stages of exercise, but were otherwise comparable, whilst ai 
and 0 C2 values for QT differed only for parts of the rest and recovery stages. 
However, 0 0  for RR was found to be the better discriminator between different 
physiological states. These differences suggest that it is preferable to report both 
ou and 0(2 exponents for RR and QT data. Nevertheless it should be borne in mind 
that the ability of a  to discriminate between resting and exercise conditions is 
poorer than that of the majority of common linear and non-linear measures of 
HRV. The 0 0  exponent for RR was found to be negatively correlated with various 
linear and non-linear indices of HRV, confirming that the fractal characteristic of 
cardiac interval time-series data is associated with ANS functional status.
These results suggest that RR and QT have dissimilar fractal structures, possibly 
reflecting differences in the mechanisms of temporal modulation of these two 
aspects of cardiac electrical activity. Further investigations might usefully 
compare the fractal characteristics of both RR and QT data in cases of cardiac or 
neural pathology.
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Chapter 5 Investigation of QT interval variability and its association with 
ventricular function in healthy adults during rest and exercise
5.1 Rationale
Perturbation of the resting QT-RR relationship during physical exercise is 
possibly caused by the onset of differential parasympathetic modulation of the 
atrial and ventricular myocardium. One method of investigating this non- 
invasively could be through the quantification of the QTVI which reflects the 
ratio of variabilities of QT and RR time-series and might be related to the heart 
rate-dependent and heart rate-independent influences on the QT interval. 
Simultaneous characterisation of the influence of physical exercise on cardiac 
ventricular function and cardiac electrical variability has not been previously 
conducted, hence little is known about the relationship between ventricular 
function and either heart rate (RR) or repolarisation (QT) variability. The 
relationship between QTVI and ventricular function could be of clinical interest 
and it is postulated that QTVI might have use as a non-invasive surrogate marker 
of ventricular function.
5.2 Aims and objectives
The aims of this chapter were:
1. To quantify electrocardiographic QT interval and RR interval variability 
during rest and dynamic physical exercise
2. To quantify indices of cardiac ventricular function, as assessed indirectly 
by ICG and non-invasively by ECG measurement, through the 
determination of RR and QT intervals and their variabilities in the time- 
domain and their relative variabilities via the QTVI
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The objectives were:
1. To interpret QT and RR variabilities in terms of relative autonomic 
modulation of the atrial and ventricular myocardium
2. To characterise the relationships between QT, QTc and RR intervals and to 
consider their associations with differential autonomic regulation
3. To quantify the above in terms of the data collected from the different 
leads of a clinical Holter ECG system
4. To examine whether the above are influenced by gender
5. To characterise measures of cardiac ventricular function during rest, 
progressive (maximal) physical exercise and post-exercise recovery
6. To examine and compare the relationships between ventricular function 
indices and standard measures of RR and QT interval variability 
(including QTVI) using multiple regression analysis
7. To examine whether the relationship between these parameters is altered 
following high-intensity physical exercise
5.3 Introduction
5.3.1 Study 1: Analysis of QT interval and its variability
There have been relatively few studies of the influence of dynamic physical 
exercise on the QT interval or of the QT-RR relationship during these conditions. 
Several authors have reported a linear relationship between uncorrected QT and 
both heart rate and RR interval during light exercise (Kligfield etal. 1996,
Mayuga 2001, Chauhan 2002). However, Mayuga etal. (2001) compared several 
heart rate correction models for a range of heart rates during exercise, concluding 
that a natural logarithmic model was the best description of the QT-RR 
relationship. The dynamic QT-RR relationship is further complicated by the fact 
that the magnitude of QT shortening in response to increased heart rate depends 
on the mechanism causing the increase. Increased heart rate during atrial pacing
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causes a smaller reduction in QT interval compared with that during exercise at 
similar heart rates (Rickards & Norman 1981, Milne etal. 1982). In addition, QT 
interval shortening has been observed during exercise at uniformly-paced heart 
rates in patients with heart block (Rickards & Norman 1981). Porta etal. (1998) 
used spectral analysis to model the relationship between the RR and ventricular 
repolarisation (RTa) intervals. These authors observed that RTa was heart rate- 
dependent within the standard low frequency and high frequency bandwidths, 
but there was a substantial heart rate-independent contribution to this parameter 
at very low frequencies. Almeida et al. (2006) used a similar approach and found 
that the heart rate-independent contribution to QT variability was greater than 
40% in the majority of healthy subjects in their study. These studies 
demonstrated that QT interval shortening during exercise has a substantial 
component that is not controlled by heart rate. It has since been shown that the 
ANS has a direct influence on the ventricular myocardium, and this might affect 
cardiac repolarisation independently of chronotropic modulation via the SA node 
(Shimizu etal. 1994, Magnano etal. 2002).
To date there have been no reports of the quantification of heart rate-dependent 
and heart rate-independent influences on the atrial and ventricular myocardium 
during physical exercise. To reiterate section 2.3.2.3, QTVI quantifies the relative 
magnitude of temporal variability in QT and RR intervals and can be interpreted 
with regard to the relative autonomic modulation of these two parameters. QTVI 
might therefore be a useful index for delineating the relative autonomic 
influences on the atrial and ventricular myocardium.
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5.3.2 Study 2: Relationship between ventricular function, RR variability and QT 
variability
Several previous studies have indicated an association between changes in QTVI 
and altered ANS activity. For example, QTVI is decreased after postural tilt in 
healthy subjects (Piccirillo etal. 2001) and is increased in patients with chronic 
renal failure (Johansson etal. 2004). Moreover, increased QTVI is a risk factor for 
sudden cardiac death (Atiga etal. 1998,2000), indicates a greater susceptibility for 
malignant ventricular arrhythmias (Berger etal. 1997, Atiga etal. 1998,2000) and 
is associated with an independent risk for ventricular tachycardia or ventricular 
fibrillation (Haigney etal. 2004). Recently, Piccirillo etal. (2007) found that an 
elevated QTVI was a strong predictor of SCD in chronic heart failure patients 
who were asymptomatic and had only a slightly depressed ejection fraction.
However, despite its increasing use in clinical research, QTVI during physical 
exercise, a physiological condition during which there are marked changes in 
both ANS activity and cardiac functional performance, has not been extensively 
assessed. To date, there has been no investigation of the relationship between QT 
or RR variability parameters or QTVI and traditional indices of cardiac functional 
performance. In particular it would be of great clinical interest to establish which 
aspects of cardiac performance have the greatest association with QTVI.
Moreover there appears to have been no previous study in which the range of 
cardiac ventricular performance indices have been characterised and compared 
during conditions of rest, exercise and subsequent recovery.
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5.4 Methodology
Although this chapter is presented as two studies, each study population is a 
subset of a main group which underwent an identical testing protocol. All 
recordings were performed in the Exercise Physiology Laboratory at the Sport 
and Exercise Science Research Centre, Swansea University and the investigation 
was approved by the departmental ethics committee. Subject health screening 
was undertaken using the American Heart Association/American College of 
Sports Medicine pre-participation screening questionnaire (Balady etal. 1998). 
Further subject selection criteria were as described in section 3.3.
5.4.1 Study 1
5.4.1.1 Subjects
Nine males (age 23.6 ± 4.7 years, mass 85.7 ± 8.5 kg [mean ± SD]) and eight 
females (age 21.9 ± 4.8 years, mass 64.0 ± 4.2 kg) volunteered to take part in the 
investigation. Individual maximal oxygen uptake (V02max) values confirmed the 
similarity of aerobic fitness within both groups: males (46.7 ± 5.2 ml-kg ^m in1) 
and females (40.1 ± 8.8 ml-kg^min1). All subjects performed a progressive sub- 
maximal exercise test on an electromagnetically braked cycle ergometer (Lode 
Excalibur Sport; Lode, Netherlands). The testing protocol used is described in 
section 3.3. Maximal work rates (WRmax, used to calculate sub-maximal 
workloads) were estimated from the relationship between work rate and heart 
rate, extrapolated to the age-predicted maximal heart rate (220-age (years)): 289 ± 
46 W  (males) and 195 ± 45 W  (females).
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5.4.1.2 Physiological measurement
A Reynolds Lifecard CF digital Holter recorder (Del Mar Reynolds Medical Ltd., 
UK) was used to record a three-lead ECG throughout exercise and for 10 minute 
periods pre- and post-exercise. The ECG electrodes were positioned in the 
modified V5, CC5, modified V5R electrode configuration as shown in Figure 3.1. 
This system provided ECG data with 12-bit accuracy. Subsequently, each lead was 
separately analysed using a Reynolds Pathfinder digital analyser (Del Mar 
Reynolds Medical Ltd., UK). Beat-to-beat cardiac cycle interval of normal sinus 
origin (RR), QTa (Qwave onset to T wave apex) and QTe (Qwave onset to T wave 
end) interval data were measured for each sinus beat and exported for further 
analysis using the Reynolds Research Tools software (Del Mar Reynolds Medical 
Ltd., UK).
5.4.1.3 Data analysis
The QT and RR data sets were linearly interpolated with a sampling frequency of 
2Hz; this facilitated easier separation of the data into specific time segments and 
ensured a uniform number of points within each analysis period. Mean values 
were calculated for consecutive one-minute windows for both QT and RR data 
sets for all three ECG leads. Subsets of the averaged QT and RR data sets were 
then defined that represented these parameters within specified intervals during 
exercise and during the pre- and post-exercise phases:
1. Consecutive one-minute periods during the pre-exercise resting phase 
(denoted p i to p i0)
2. The final one-minute period of each exercise stage, in order to represent 
physiologically steady-state conditions (denoted el to e6 in males and el 
to e3 in females)
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3. Consecutive one-minute periods during the post-exercise recovery phase 
(denoted rl to rlO)
The QT data were adjusted using the Bazett correction formula (section 2.3.2.1), 
in an attempt to provide heart rate-independent QT values. All group mean QTc 
data presented here were calculated using the QTa interval only since it was more 
reliably detected by the analysis software. Linear regression analysis using the 
method of least squares was used to quantify the relationship between QTc and 
work rate during exercise.
QTVI was calculated for the periods defined above according to the equation 
described by Berger etal. (1997) (section 2.3.2.3). QT variance (QTv) normalised 
for mean QT (QTm) (QTVN) was also quantified according to the definition by 
Haigney etal. (2004):
QTVN = QTv /(QTm)2
Prior to calculating QTv and RRv the QT and RR data were linearly detrended 
within consecutive one-minute segments in order to remove the potential 
influence on variability of time-dependent trends in the data. Two sets of data 
were calculated for each of the above indices (QTaVI and QTeVI, QTYVN and 
QTYVN), in order to compare the relative influence thereon of using either QTa or 
QTe intervals.
The Lilliefors test for goodness of fit to a Normal distribution confirmed that all 
parameters were Normally distributed at each stage of the measurement protocol.
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One way analysis of variance (ANOVA) was used to compare the mean pre- 
exercise values of QT, QTc, QTaVI, QTeVI, QTaVN and QTeVN with their 
respective mean values during each stage of exercise and recovery. ANOVA was 
also used to perform between-stage comparison of parameters during each stage 
of exercise and recovery. Multiple pairwise comparisons were performed for 
these data using Tukey’s honestly significant difference criterion, and differences 
were considered significant for p<0.05. Student’s two-sample t-tests for unequal 
variance (heteroscedastic data) were used to assess between-lead and between- 
gender differences for all parameters at each stage of the protocol. Student’s two- 
sample t-tests for paired samples were used to assess differences between the 
indices QTaVI and QTeVI and the indices QTaVN and QTeVN at each stage of the 
protocol. All data quoted in the text represent mean ± SD.
5.4.2 Study 2
5.4.2.1 Subjects
Eight males (age 20.7 ± 0.4 years, mass 78.4 ± 7.7 kg [mean ± SD]) volunteered to 
take part in the investigation. Individual maximal oxygen uptake (V 0 2max) values 
confirmed the homogeneity of aerobic fitness within the group (50.7 ± 4.9 ml kg-1 
min-1 [mean ± SD]). Subjects were initially at rest and were asked to breathe in 
accordance with a metronome set to a rate of 15 breaths per minute (0.25 Hz) for 
a period of six minutes. At the end of this period they were instructed to breathe 
spontaneously for a further six minutes at rest. Subjects then immediately 
performed a progressive exercise test on an electromagnetically braked cycle 
ergometer (Lode Excalibur Sport; Lode, Netherlands). The exercise protocol 
employed was similar to that described in section 3.3, with the difference that the 
work rate was increased until volitional fatigue. Breath-by-breath oxygen uptake 
( VO 2) data were recorded throughout using an Oxycon Pro respiratory gas
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analysis system (Jaeger, Germany) to enable estimation of subjects’ aerobic 
capacity.
5.4.2.2 Physiological measurement
A Reynolds Lifecard CF digital Holter recorder (Del Mar Reynolds Medical Ltd., 
UK) was used to record a three-lead ECG continuously throughout the pre­
exercise, exercise and post-exercise periods. The ECG leads were positioned in the 
modified V5, CC5, modified V5R electrode configuration (Figure 3.1). This 
system provided ECG data with a sample accuracy of 2.5 pV (magnitude of least 
significant bit; 12-bit resolution) and 128 Hz sampling frequency. All analyses in 
these studies were performed using data from a single ECG lead (lead 1 for each 
subject) as the between-lead differences in RR and QT data using this ECG 
system had been previously quantified (preliminary study, chapter 3). The ECG 
recordings were analysed using a Reynolds Pathfinder digital analyser (Del Mar 
Reynolds Medical Ltd., UK). All ECG data used for subsequent analysis in this 
study were free of any form of morphologically abnormal beat, and this was 
verified by both the Holter system and by human observation. Beat-to-beat 
cardiac interval (RR) and QT interval data were automatically measured for each 
sinus beat and exported for further analysis using the Reynolds Research Tools 
software (Del Mar Reynolds Medical Ltd., UK). The QT and RR data also 
underwent human visual examination in order to verify the accuracy of the data 
prior to subsequent analysis. When either the RR or QT intervals were 
considered to be anomalous, both the RR and QT data points were removed from 
the data set. This occurred infrequently (and mainly during exercise), resulting 
overall in fewer than 1% of the data being removed. All QT analysis in this 
investigation was based on the QTe interval (Qwave onset to T wave end), 
resulting from the previous observation that the detection performance for Ta and 
Te of the Holter system used were considered broadly equivalent.
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The Task Force Haemodynamic Monitor (CNSystems Medizintechnik GmbH, 
Austria) was used to record beat-to-beat cardiac ventricular performance 
parameters (via ICG) and beat-to-beat blood pressure (via photoplethysmography, 
employing the vascular unloading technique at the finger) (Figures 5.1-5.6).
Figure 5.1 (a) Task Force Monitor oscillometric blood pressure cuff
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Figure 5.1 (b) Task Force Monitor photoplethysmographic blood pressure cuff
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Figure 5.1 (d) Task Force Monitor ICG neck electrode
Figure 5.1 (e) Task Force Monitor ICG abdominal electrodes (electrodes 4-5) and 
ECG electrodes (electrodes 6-9)
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Figure 5.1 (f) Task Force Monitor
Using these methods the following parameters were determined (all defined in 
section 2.3.3.2): stroke volume index (SVI), cardiac output index (Cl), left 
ventricular ejection time (LVET), end diastolic volume index (EDVI), ejection 
fraction (EF), index of contractility and acceleration index (IC and ACI, both of 
which are measures of the inotropic state of the myocardium), total peripheral 
resistance (TPRI), left ventricular work index (LVWI), systolic and diastolic blood 
pressure (BP) and pulse pressure (PP). The term ‘index’ in several of these 
measures indicates that the original parameter values were normalised by 
dividing the individual values by the subject’s body surface area (mean ± SEM 
body surface area = 1.97 ± 0.03 m2).
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5.4.2.3 Data analysis
Subsets of the QT and RR data sets were defined that represented these data 
within specified intervals during exercise and during the pre- and post-exercise 
phases:
1. Consecutive one-minute intervals during the six minute period of 
metronomic breathing
2. Consecutive one-minute intervals during the six minute period of 
spontaneous breathing
3. The final one-minute period of each exercise stages (in order to represent 
physiologically steady-state conditions)
4. Consecutive one-minute intervals during the post-exercise resting phase, 
which lasted for 15-minutes
Prior to further data processing the QT and RR data were linearly detrended 
within consecutive one-minute segments (corresponding to the subsets defined 
above) in order to remove any time-dependent trends in the data.
Variability of the RR interval was quantified in the time domain (RMSSDNN: 
square root of the mean of the sum of the squares of differences between adjacent 
RR intervals, and SDNN: standard deviation of all RR intervals) according to the 
Task Force guidelines on HRV (Task Force ESC & NASPE 1996). (In these 
definitions “NN” indicates that the RR intervals are measured from normal beats 
of sinus origin). RMSSDNN and SDNN represent the high-frequency variability 
and the total variability of the RR interval data respectively (Task Force ESC & 
NASPE 1996). Equivalent time domain parameters were calculated to describe
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the variability of the QT interval (RMSSDQT and SDQT). QTVI was calculated 
according to the equation described by Berger etal. (1997) (section 2.3.2.3).
Each of the measured parameters was separately averaged to provide single 
representative values for the discrete physiological states during pre-exercise 
(metronomic breathing and spontaneous breathing states) and during post­
exercise (0-5, 5-10 and 10-15 minute post-exercise recovery periods). (Exercise 
values for each parameter were already defined for representative one-minute 
stages.) All data quoted in the text represent mean ± SD. Error bars in the figures 
represent the SEM (standard error in the mean) for the plotted parameters.
5.4.2.4 Statistical analysis
The Stepwise method of multiple linear regression was used to establish whether 
a significant predictor model could be obtained for the following dependent 
variables: RR, QTe, RMSSDNN, SDNN, RMSSDQT, SDQT and QTVI. This was 
done separately for pre- and post-exercise data (not using exercise data). Each of 
the independent (predictor) variables was first visually checked for the presence 
of outliers and to assess linearity using scatterplots. Each of the predictor variables 
obeyed these assumptions and so each was standardised (giving its z score) prior 
to subsequent regression analysis. Parameter inclusion was carefully considered 
with regard to underlying physiology; any parameter that was a direct linear 
product of other (included) fundamental parameters was excluded from 
subsequent analysis to avoid singularity. Multicollinearity was minimised by the 
judicious selection of predictor variables, examination of the predictor variable 
correlation matrix (Table 5.1), and by manually examining the influence of 
variable inclusion on the resulting R2 values (proportion of explained dependent 
parameter variance for the models). These procedures resulted in the selection of
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the following subset of predictor variables: SVI, LVET, EDVI, IC, ACI, TPRI, 
LVWI, PP. Standardised (Beta) coefficients were used to report the contribution 
of each predictor variable to the multiple regression models. Adjusted R2 (adjR2) 
values were reported as this was considered to be the most appropriate measure of 
R2 for small samples. A value of p<0.05 for a predictor variable indicated its 
statistically significant unique contribution to the model. The standard 
assumptions of multiple regression (Normality, linearity and homoscedasticity) 
were verified via scatterplots of the residuals (differences between the observed 
values of the dependent variable and those predicted by the regression model) 
and using Normal probability plots, separately for pre- and post-exercise states.
5.5 Results
5.5.1 Study 1
5.5.1.1 Characterisation of RR, QT and QTc as a function of exercise work rate
The QT interval was measurable for exercise intensities up to 68±8% of WRma* in 
males and 75±10% of WRmaxin females, equivalent to mean heart rates of 152±9 
bpm (males) and 157±4 bpm (females). There were significant differences in RR 
values between males and females during both the pre-exercise and exercise 
stages, and also during the initial stages of recovery. Gender differences in QT 
occurred infrequently during recovery only. Significant between-lead differences 
in QTa (Figure 5.2 (a) & (b)) and QTe were observed during both exercise and 
recovery periods in males and females. Bazett-corrected QTc values displayed 
significant between-lead differences at various stages throughout the pre­
exercise, exercise and recovery periods (Figure 5.2 (c) & (d)).
157
310
290
j= 270 
roI—O
250
230
210
p1 p2 p3 p4 p5 p6 p7 p8 p9 p10 e1 e2 e3 e4 e5 e6 r1 r2 r3 r4 r5 r6 r7 r8 r9 r10
Stage
A -■Leadl • • ■  ■ ■ Lead2 • • a  • - Lead3
Figure 5.2 (a) Values of QTa obtained from the three E C G  leads (male group) (§ = 
significant difference between leads 1 and 2; f  = significant difference between 
leads 1 and 3; * = significant difference between leads 2 and 3)
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Figure 5.2 (b) Values of QTa obtained from the three E C G  leads (female group) (§ 
= significant difference between leads 1 and 2; * = significant difference between 
leads 2 and 3)
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Figure 5.2 (c) Bazett-corrected QTa (Q T c) values for the three E C G  leads (male 
group) (§ = significant difference between leads 1 and 2; f = significant difference 
between leads 1 and 3; * = significant difference between leads 2 and 3)
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Figure 5.2 (d) Bazett-corrected QTa (Q T c) values for the three E C G  leads (female 
group) (§ = significant difference between leads 1 and 2; f = significant difference 
between leads 1 and 3; * = significant difference between leads 2 and 3)
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Figures 5.2(a)-(d) show that Bazett-correction reversed the trend of QT reduction 
as a function of exercise work rate. This over-correction of QT resulted in an 
almost linear increase in QTc as a function of work rate. Table 5.1 presents the 
results of linear regression analysis of group mean QTc as a function of work rate 
for each of the three ECG leads.
Table 5.1 Parameters of the linear regression fit of QTc (heart rate-corrected QTa 
interval) against work rate during exercise
Lead Gradient
(ms-W-1)
Intercept
(ms)
R2
Female
1 0.442 357 0.937
2 0.435 337 0.998
3 0.550 360 0.986
Male
1 0.673 282 0.996
2 0.464 291 0.965
3 0.644 312 0.960
5.5.1.2 QT variability indices (QTVI and QTVN)
Figure 5.3 illustrates the effect of linearly detrending the RR, QTa and QTe time- 
series data within consecutive one-minute segments, performed prior to 
calculating the QT variability indices.
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Figure 5.3 (a) R R , QTa and Q Te data from a single subject (E C G  lead 1). Vertical 
bars: solid (interval) = exercise period; dashed (interval) = period during which 
Q T  could not be measured (high intensity exercise)
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Figure 5.3 (b) R R , QTa and Q Te data from a single subject (E C G  lead 1) following 
detrending within consecutive one minute blocks. Vertical bars: as above
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The QT variability indices are presented in Figures 5.4 (a) & (b) and 5.4 (c) & (d) 
for males and females, respectively. Figures 5.4 (a) and 5.4 (c) show the variability 
ratios (QTaVI) calculated using the QTa interval, whilst Figures 5.4 (b) and 5.4 (d) 
show the variability ratios (QTeVI) calculated using the QTe interval.
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Figure 5.4 (a) Q T  variability index (Q T aV I) calculated from the three ECG leads 
(male group) (A = significant difference between male and female groups in at 
least one lead)
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Figure 5.4 (b) Q T  variability index (Q T eV I) calculated from the three E C G  leads 
(male group) (A = significant difference between male and female groups in at 
least one lead; * = significant difference between two or more leads; y = significant 
difference compared with Q T aV I in at least one lead)
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Figure 5.4 (c) Q T  variability index (Q T aV I) calculated from the three E C G  leads 
(female group) (A = significant difference between male and female groups in at 
least one lead; * = significant difference between two or more leads)
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Figure 5.4 (d) Q T  variability index (Q T eV I) calculated from the three E C G  leads 
(female group) (A = significant difference between male and female groups in at 
least one lead; * = significant difference between two or more leads; y = significant 
difference compared with Q T aV I in at least one lead)
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There were no appreciable between-lead differences for either QTaVI or QTeVI in 
males, but there were between-lead difference in these indices for females during 
rest. Both QTaVI and QTeVI were significantly smaller (more negative) in males 
compared with females in at least one lead during the majority of pre-exercise, 
but there were no appreciable gender-related differences during the exercise and 
recovery periods. There were significant differences between QTaVI and QTeVI 
in at least one lead during all phases of the experimental protocol for males and 
females.
There was an initial rapid increase in both QTaVI and QTeVI (of approximately 
one order of magnitude) within the first minute of exercise in both males and 
females. This was generally followed by progressively smaller (and non­
significant) increases in these parameters for each increment in work rate. 
Compared with the mean pre-exercise value, QTaVI was significantly increased 
throughout exercise and during the first nine minutes of recovery in males 
(p<0.001) and females (p<0.01). Similarly QTeVI was significantly increased 
throughout exercise and during the first nine minutes of recovery in males and 
females (both p<0.001). QTVI values greater than zero indicate a greater 
variability of QT compared with RR. In males both QTaVI and QTeVI were 
greater than zero from the third minute of exercise until the end of the exercise 
period. In females both QTaVI and QTeVI were greater than zero throughout 
exercise and during the initial stages of recovery.
When expressed as a simple non-logarithmic ratio, It was observed that both 
QTaVI and QTeVI displayed a strong linear relationship with exercise work rate 
up to moderately high intensities in males and females (QTaVI: R2 = 0.94 for 
males, 0.95 for females; QTeVI: R2 = 0.95 for males and females). This linearity 
extended up to work rates of 52±8% of WRmax in males (equivalent to a mean HR
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of 141±11 bpm) and 48±11% of WRmax in females (equivalent to a mean HR of 
156±3 bpm).
Normalised QT variance (QTVN) indices are presented in Figures 5.5 (a) & (b) 
and 5.5 (c) & (d) for males and females respectively. Figures 5.5 (a) and 5.5 (c) 
show QTVN normalised using the QTa interval (QTYVN), whilst Figures 5.5 (b) 
and 5.5 (d) show QTVN normalised using the QTe interval (QTeVN).
166
♦  ■•Leadl L ead 2- • ♦ • - Lead3
Figure 5.5 (a) Q T  variance normalised by mean QTa, calculated from the three 
ECG leads (male group) (A = significant difference between male and female 
groups in at least one lead)
10
1"<o
Z
>0>}—a
p1 p2 p3 p4 p5 p6 p7 p8 p9 p10 e1 e2 e3 e4 e5 e6 r1 r2 r3 r4 r5 r€ r7 r8 r9 r10
Stage
♦  Leadl - - ■  • • Lead2 - A • • Lead3
Figure 5.5 (b) Q T  variance normalised by mean Q T e, calculated from the three 
ECG leads (male group) (A = significant difference between male and female 
groups in at least one lead; * = significant difference between two or more leads; y 
= significant difference compared with Q T a V N  in at least one lead)
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Figure 5.5 (c) Q T  variance normalised by mean QTa, calculated from the three 
ECG leads (female group) (A = significant difference between male and female 
groups in at least one lead; * = significant difference between two or more leads)
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Figure 5.5 (d) Q T  variance normalised by mean Q T e, calculated from the three 
ECG leads (female group) (A = significant difference between male and female 
groups in at least one lead; * = significant difference between two or more leads; y 
= significant difference compared with Q T a V N  in at least one lead)
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In comparison with pre-exercise there was a general trend towards elevated 
values for both Q T a V N  and Q T eV N  during exercise and recovery in males and 
females. There were no significant between-stage differences in either index for 
males or females. There were sporadic between-lead and between-gender 
differences in Q T aV N  and Q T eV N  for males and females. Notably there were 
significant differences between Q T aV N  and Q T eV N  throughout the experimental 
protocol for males, but only isolated differences for females.
5.5.2 Study 2
Figure 5.6 (a) presents the characterisation plots of cardiac ventricular function 
indices during pre-exercise, exercise and post-exercise recovery.
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Figure 5.6 (a) Cardiac ventricular performance indices (MB = Metronomic 
Breathing; SB = Spontaneous Breathing; Exl-Ex5 = Exercise Stages; R5, R10, R15 
= Recovery periods (0-5, 5-10 and 10-15 minutes post-exercise, respectively)
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The blood pressure response and associated functional indices are shown in 
Figure 5.6 (b).
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Figure 5.6 (b) Blood pressure response and related performance indices
The plots in Figures 5.6 (a) & 5.6 (b) show substantial differences in parameter 
values during exercise compared with pre- and post-exercise periods, with 
parameters exhibiting gradual returns to pre-exercise values within the 
observation period. The magnitude and trends in the response of each variable 
were consistent for all subjects. For the same periods, Figure 5.6 (c) presents the 
absolute values of RR and QT together with indices of their variability and a 
measure of their relative variability (QTVI).
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Figure 5.6 (c) RR and QT variability indices, together with QTVI
RR variability parameters (RMSSDNN and SDNN) demonstrated the expected 
exponential-type decline with increasing exercise work rates (Lewis et al. 2007). 
Conversely, QT variability (RMSSDQT and SDQT) increased at the onset of 
exercise with a gradual reduction prior to a second increase at the higher exercise 
work rates. It was not possible to determine QT variability during the highest 
exercise work rates owing to acknowledged difficulties in accurate QT 
determination at very high heart rates. Therefore values of QT or RR variability 
(or QTVI) during exercise stage “Ex8” have not been reported. QTVI 
demonstrated the rapid and substantial increase in magnitude that was apparent 
in study 1 (section 5.5.1.2). Reflecting to a degree the observation for QT 
variability, QTVI was further substantially increased during the highest exercise 
work rates. QTVI was substantially elevated in comparison with pre-exercise 
values throughout the post-exercise period.
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Multiple linear regression analysis using the stepwise method resulted in 
significant models for the dependent variables. These models are reported in 
Tables 5.2-5.10, which also quantify the strength of the model (ANOVA F 
statistic and p value, together with the adjR2 value), separately for the pre- and 
post-exercise states. For comparison between pre- and post-exercise states, each 
table lists those predictor variables (cardiac performance parameters) that made a 
significant unique contribution to either the pre- or post-exercise model. 
Significant predictor variables are highlighted in bold type and have associated p 
values less than 0.05. Where a predictor variable is fisted but did not make a 
significant unique contribution to the model, the specified Beta coefficient is that 
which would have resulted from adding that term to the model.
Table 5.2 Pearson correlation coefficient matrix for the selected predictor 
variables
Predictor
variable SVI LVET EDVI IC ACI TPRI LVWI PP
SVI 1.00 0.65 0.97 0.88 0.34 -0.30 0.61 0.66
LVET 1.00 0.49 0.48 -0.18 0.36 0.33 0.34
EDVI 1.00 0.88 0.44 -0.46 0.59 0.68
IC 1.00 0.45 -0.40 0.66 0.63
ACI 1.00 -0.51 0.20 0.16
TPRI 1.00 -0.01 -0.20
LVWI 1.00 0.73
PP 1.00
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Table 5.3 Multiple linear regression model for RR
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.912; F5,9o = 200.5; p< 104 adjR2 = 0.839; F5,ii4 = 125.9; p<104
Dependent 
variable =
Predictor
variable
Beta P Predictor
variable
Beta P
RR SVI 0.65 0.0003 SVI 1.51 0.0000
EDVI 0.61 0.0011 EDVI -0.50 0.0000
IC -0.18 0.0176 IC -0.82 0.0000
TPRI 0.93 0.0000 TPRI -0.20 0.0004
LVWI 0.56 0.0000 LVWI -0.16 0.0173
Table 5.4 Multiple linear regression model for QT
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.856; F 6,89 = 96.4; p<104 adjR2 = 0.570; F3.116 = 32.9; p<104
Dependent 
variable =
Predictor
variable
Beta P Predictor
variable
Beta P
QT SVI 1.32 0.0000 SVI 0.29 0.1838
EDVI 0.45 0.0636 EDVI 0.68 0.0000
IC -0.20 0.0416 IC -0.28 0.0680
ACI 0.21 0.0000 ACI -0.45 0.0001
TPRI 0.65 0.0000 TPRI -0.25 0.0005
LVWI -0.59 0.0000 LVWI -0.04 0.6889
PP -0.20 0.0025 PP -0.05 0.7067
Table 5.5 Multiple linear regression model for RMSSDNN
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.654; F2,93 = 92.0; p<104 adjR2 = 0.099; Fi.ns = 1—* cn jo ►d 11 0 0 0 0 *—
»
Dependent Predictor Beta P Predictor Beta P
variable = variable variable
RMSSDNN SVI 0.14 0.2662 SVI 0.34 0.0002
LVET 0.69 0.0000 LVET -0.07 0.5060
TPRI 0.25 0.0002 TPRI 0.14 0.1491
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Table 5.6 Multiple linear regression model for SDNN
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.602; Fi,94 = 147.3; p<10 4 adjR2 = 0.297; F2>ii7 = 18.2; p<10-4
Dependent Predictor Beta P Predictor Beta P
variable = variable variable
SDNN SVI 0.07 0.3838 SVI 0.71 0.0000
LVET 0.78 0.0000 LVET -0.16 0.2844
IC 0.09 0.2139 IC -0.28 0.0218
Table 5.7 Multiple linear regression model for RMSSDQT
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.253; F2>94 = 17.8; p<104 adjR2 = 0.183; F3,ii6 = 10.3; p<10 4
Dependent Predictor Beta P Predictor Beta P
variable = variable variable
RMSSDQT SVI -0.98 0.0000 SVI 0.24 0.3435
EDVI -0.32 0.3686 EDVI 0.39 0.0044
IC 0.62 0.0010 IC -1.02 0.0000
ACI 0.14 0.1735 ACI 0.51 0.0005
Table 5.8 Multiple linear regression model for SDQT
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.248; F2,93 = 17.3; p<10 4 adjR2 = 0.220; F3,ii6 = 12.6; p<10 4
Dependent Predictor Beta P Predictor Beta P
variable = variable variable
SDQT SVI 0.98 0.0000 SVI -0.24 0.3725
EDVI -0.45 0.2116 EDVI 0.40 0.0017
IC 0.64 0.0008 IC -1.21 0.0000
ACI 0.12 0.2132 ACI 0.68 0.0000
Table 5.9 Multiple linear regression model for QTVI
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.411; F2.93= 35.0; p<10 4 adjR2 = 0.270; F2)ii7 = 23.6; pel O'4
Dependent 
variable =
Predictor Beta p 
variable
Predictor Beta 
variable
P
QTVI SVI -0.68 0.0000 
ACI 0.38 0.0000
SVI -0.43 
ACI 0.51
0.0000
0.0000
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Table 5.10 Multiple linear regression model for EF
Stage Pre-Exercise Post-Exercise
Model adjR2 = 0.975; F2.93 
pel 0'4
= 1885.2; adjR2 = 0.967; F2,ii7
p<104
= 1741.3;
Dependent 
variable =
Predictor Beta 
variable
P Predictor Beta 
variable
P
EF SVI 3.88 
EDVI -3.65
0.0000
0.0000
SVI 2.33 
EDVI -1.91
0.0000
0.0000
The regression models for both RR and QT included significant unique 
contributions from a large number of the predictor variables, and consequently 
accounted for a large proportion of the variance in these parameters (91% and 
86% during pre-exercise and 84% and 57% during post-exercise for RR and QT, 
respectively). However, whereas the predictor variables included in the model for 
RR were consistent for pre- and post-exercise, fewer predictor variables 
contributed to the post-exercise QT model compared with those during pre- 
exercise.
The ability of the regression model to describe the variability of RR (RMSSDNN 
and SDNN) was substantially reduced post-exercise (accounting for 65% and 10% 
of variability in RMSSDNN and 60% and 30% of variability in SDNN, pre- and 
post-exercise respectively). Moreover, the predictor variables making a unique 
contribution to the model were different (and mutually exclusive) for the pre- 
and post-exercise models for both RMSSDNN and SDNN.
The predictive abilities of the regression models for RMSSDQT and SDQT were 
low-to-moderate but were very similar to each other, and also did not differ 
greatly for pre- and post-exercise states (25% and 25% during pre-exercise and 
18% and 22% during post-exercise for RMSSDQT and SDQT, respectively). The
predictor variables included in the models for RMSSDQT and SDQT were 
identical when compared for either the pre- or post-exercise states. There was 
partial consistency between the predictor variables included in the pre- and post­
exercise models for RMSSDQT and SDQT, with IC providing a significant unique 
contribution in both.
The predictive abilities of the regression models for QTVI were moderately good 
(41% and 27% for pre- and post-exercise, respectively) and there was good 
consistency between the predictor variables included in the pre- and post­
exercise models, with SVI and ACI providing significant unique contributions in 
both.
In order to test and validate the chosen methods of multiple regression modelling, 
an additional multiple regression analysis with ejection fraction (EF) as the 
dependent variable was also performed. All possible predictor variables were as 
previously stated. The predictive abilities of the regression models for EF were 
very high (98% and 97% for pre- and post-exercise, respectively) and there was 
good consistency between the predictor variables included in the pre- and post­
exercise models, with SVI and EDVI providing significant unique contributions 
in both. The magnitude of the Beta coefficients for SVI and EDVI were large, 
indicating a strong contribution to the model, and were appropriately signed in 
accordance with the theoretical relationship between these parameters:
(EF = SVI / EDV I )
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5.6 Discussion
5.6.1 Study 1
5.6.1.1 RR and QT characterisation during exercise and recovery
Moderate-to-high intensity exercise predictably caused significant changes in 
heart rate, RR, QT and QTc intervals compared with pre-exercise resting values in 
both males and females. Heart rate did not recover to pre-exercise values within 
the observed ten minute recovery period, consistent with the known persistence 
of autonomic disturbance following exercise. The prolonged (lagging) reduction 
in QT observed during the first two minutes of recovery is attributable to QT-RR 
hysteresis (main study, chapter 3). The QTc interval returned to the mean pre­
exercise value within the first minute of recovery for males and females, whilst 
QT remained significantly altered for a further three to eight minutes. There 
were significant gender differences in QT duration only during the recovery 
period. However, QTc was significantly different between males and females in at 
least one lead during every stage of the protocol, and this provides some evidence 
that there are gender differences in the relationship between QT and heart rate.
5.6.1.2 Use of the Bazett correction formula
The results of study 1 confirm that the Bazett correction formula adequately 
accounts for the relationship between QT and RR during the pre- and post­
exercise periods (heart rate ranges for males and females during pre-exercise were 
70-79 and 78-85 bpm, respectively, and during post-exercise were 100-139 and 
102-153 bpm, respectively). However, during exercise this relationship was valid 
only for work rates up to 90 W  (31 ±5 %WRmax) in males and up to 60 W  (32±8 
%WRmax) in females. The Bazett formula substantially over-corrected for the 
influence of heart rate on QT during all but the lowest exercise intensities. In fact 
the highly non-linear reduction in QT with increasing exercise intensity was
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reversed following Bazett correction, yielding QTc values that increased 
substantially with progressive exercise. Ahnve & Vallin (1982) observed a similar 
“trend reversal” when QT was adjusted using the Bazett correction formula 
during atrial pacing at various rates. This substantial over-correction was 
explained by the suggestion that the normal QT-RR relationship (assumed to be 
adequately described by the Bazett formula) depends on the parallel influence of 
autonomic tone on heart rate and ventricular repolarisation, and that the 
“artificial” increase in heart rate during atrial pacing abolishes this relationship. 
The results of this study suggest that physical exercise might represent a similar 
perturbation of the QT-RR relationship via the substantially altered ANS 
influence that occurs during exercise conditions.
Ahnve & Vallin (1982) also noted that the magnitude of QT shortening is not 
influenced by the sympathetic nervous system since propanolol (beta 
adrenoceptor antagonist) did not change QT at constant-paced heart rates. 
However, cholinergic blockade using atropine caused a reduction in QT, and the 
authors suggested that this was evidence of a direct cholinergic influence on 
depolarisation-repolarisation of the ventricular myocardium. More recently, 
Magnano et al. (2002) showed that parasympathetic modulation of the ventricular 
myocardium has a major influence on the dynamic adaptation of QT to changing 
heart rate. These authors examined QT duration and the QT-heart rate slope 
during heart rate elevation following the administration of atropine, 
isoproterenol (beta adrenoceptor agonist) or physical exercise. For equivalent 
heart rates, QT was longest and the QT-heart rate slope was smallest (indicating 
impaired QT reduction per unit increase in heart rate) for isoproterenol compared 
with either exercise or atropine, both of which gave similar results. This provided 
evidence that parasympathetic withdrawal has a substantial and dominant 
influence on QT shortening at elevated heart rates. Moreover, the authors noted
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that this parasympathetic modulation must occur directly on the ventricular 
myocardium since there were no chronotropic differences between the tested 
conditions in their study.
5.6.1.3 QT variability indices
Previous research therefore leads to the hypothesis that the apparent breakdown 
in validity of the Bazett correction formula during exercise might reflect differing 
autonomic modulation of the atrial and ventricular myocardium. The relative 
influence of the ANS on QT and heart rate was therefore examined in the present 
work by quantifying the previously described RR and QT variability indices, with 
particular emphasis on the QTVI.
To reiterate, the QTVI is expressed as the base-10 logarithm of the ratio between 
the squared coefficients of variance for the QT and RR intervals. The QTVI 
therefore compares the magnitude of temporal variability in these two 
parameters, whilst QTVN quantifies the extent of repolarisation lability (squared 
coefficients of variance of QT) without adjustment for heart rate variability 
(Haigney etal. 2004).
In this work, gender differences in both the magnitude and dynamic properties of 
the QTVI indices (QTaVI and QTeVI) were observed. QTaVI and QTeVI were 
lower (more negative) in males compared with females during pre-exercise rest 
and during moderate intensity exercise, indicating a more marked dominance of 
RR variability over QT variability in males compared with females. This suggests 
that there is a greater relative chronotropic (atrial myocardium) influence from 
the ANS during these conditions in males compared with females. Post-exercise
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recovery values of both QTVI indices were similar in males and females, 
suggesting similar relative levels of autonomic influence on the atrial and 
ventricular myocardium during this time.
There was a substantial and rapid increase in both QTVI indices within the first 
minute of exercise in males and females. This behaviour might be caused by the 
similarly large and rapid withdrawal of parasympathetic influence on heart rate 
that occurs during this time (Yamamoto etal. 1991, Tulppo etal. 1996). 
Subsequently, positive QTVI values were observed during the majority of 
exercise, indicating a shift towards dominance of QT variability over RR 
variability. It is possible that this may be explained by the persistent 
parasympathetic modulation of the ventricular myocardium, but not of the atrial 
myocardium, during these physiological conditions. It is also notable that Atiga et 
al. (1998) suggested a QTVI value of 0.1 or greater to be a discriminator for higher 
risk of arrhythmic events. In this work both QTVI indices exceeded 0.1 at work 
rates greater than 120 W (42 ± 7 %WRmax) in males and greater than 90 W (32 ± 8 
%WRmax) in females, equivalent to heart rates of 128 ± 14 bpm and 145 ± 6 bpm 
respectively. Whether this can be interpreted as indicating an elevated risk of 
arrhythmia during physical exercise at intensities greater than these values is a 
matter for further investigation.
Compared with pre-exercise values, both of the calculated QTVI indices (QTaVI 
and QTeVI) remained elevated until the tenth minute post-exercise in males and 
females. This indicates a sustained dominance of QT variability over RR 
variability, and it is possible that this is associated with a sustained imbalance of 
autonomic influence on the atrial and ventricular myocardium. This is in accord 
with the diminished parasympathetic modulation of HRV that is observed for 
several hours post-exercise (Hautala etal. 2001).
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5.6.1.4 Choice of QT interval measurement
To reiterate, the QT interval is commonly measured as the interval between the 
Qwave onset and either the apex of the T wave (QTa) or the end of the T wave 
(QTe). Several authors have indicated that QTa is an adequate index of ventricular 
repolarisation time as no meaningful information is lost from the Ta-Te interval, at 
least during rest (Merri etal. 1989, Kligfield etal. 1996, Bidoggia etal. 2000, 
Chauhan etal. 2002). However, other authors have suggested that there is 
variability in the Ta-Te interval in individuals who are exercising or who have 
cardiac disease (O’Donnell etal. 1985, Davey 1999). For example, Davey (1999) 
found significant differences in QTe but not in QTa between patients with heart 
failure and both controls and patients with left ventricular hypertrophy. It was 
concluded that QTe contained a variability component not present in QTa, 
suggesting that QTe should be used to quantify the ventricular repolarisation 
interval.
It is worthy of note that there were significant differences between QTaVI and 
QTeVI during the majority of the experimental protocol for males and females. It 
should therefore be remembered that QTa represents only a part of the complete 
ventricular depolarisation-repolarisation period and that, assuming equivalent 
reliability in their measurement, QTe might be the more valid index of this 
interval. Moreover, the results of this study suggest that the Ta-Te interval 
contains important information about the autonomic influence on the ventricular 
myocardium during rest and physical exercise. It is therefore advisable to 
calculate the QT variability indices during these physiological conditions using 
either QTe alone or both QTa and QTe.
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Chauhan et al. (2002) also noted that the QTe wave cannot be reliably determined 
at rapid heart rates owing to the fusion of the T wave and the subsequent P wave. 
In this work, it was found that both QTa and QTe intervals could be reliably 
measured by the Holter system’s detection algorithm, even for quite high heart 
rates. However, it was not possible to measure QT intervals using either method 
for heart rates greater than around 160 bpm (equivalent to between 75% and 85% 
of maximal work rates in males and females, respectively).
5.6.2 Study 2
5.6.2.1 Characterisation of cardiac ventricular performance indices
Cardiac performance indices were measured reliably and continuously during 
rest, exercise and recovery using the Task Force Monitor. These indices provided 
a comprehensive characterisation of the cardiac and haemodynamic responses to 
the progressive exercise protocol. Variability in electrocardiographic RR and QT 
intervals was reliably quantified throughout the protocol apart from during the 
final stage of exercise, during which time the substantially elevated heart rates 
made it impossible to measure the QT interval.
5.6.2.2 Quantification and interpretation of ventricular repolarisation variability
The QT interval is known to vary in part as a function of heart rate or RR interval 
(Porta etal. 1998). However, Almeida etal. (2006) found that the RR- 
independent contribution to QT variability in healthy subjects was substantial 
(greater than 40%). Previous studies had also observed that QT shortening during 
exercise has a substantial component that is not controlled by heart rate (Rickards 
& Norman 1981, Milne etal. 1982). A complete understanding of the temporal
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variability of electrical activity in the ventricular myocardium therefore requires 
consideration of both RR and QT variabilities.
5.6.2.2.1 QT variability
The magnitude of QT variability is of great clinical significance as it is related to 
the risk of SCD, caused by sustained ventricular tachycardia or fibrillation 
(Antzelevitch & Oliva 2006, Piccirillo etal. 2007). Temporal variability of the QT 
interval of the ECG is caused by transmural dispersion of myocardial 
repolarisation (Piccirillo etal. 2007): the duration of repolarisation varies 
between subendocardial, subepicardial and intermediate layer (M) cells, being 
delayed in the M cells owing to ion channel population differences (Rosen & 
Cohen 2004). This myocardial repolarisation inhomogeneity might be 
accentuated owing to pathological structural changes or notably as a result of 
ANS changes such as sympathetic hyperactivity or reduced vagal activity 
(Tomaselli & Zipes 2004, Piccirillo etal. 2007). Furthermore, since the ANS has a 
direct influence on the ventricular myocardium, it could influence ventricular 
repolarisation independently of SA node modulation (Magnano etal. 2002). 
Nevertheless, despite this understanding of the mechanistic origins and the 
diagnostic and prognostic utility of QT variability measures, there is no evident 
previous study that has assessed the relationship between QT variability and 
standard measures of ventricular performance.
5.6.2.2.2 The QT variability index (QTVI)
QTVI is a marker of temporal inhomogeneity in myocardial repolarisation 
(Piccirillo etal. 2007). Several studies have demonstrated that QTVI, in 
preference to other indices of either RR or QT variability, has utility as a risk 
factor or discriminator for cardiac pathologies related to diminished or abnormal
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ventricular function. Also, as previously reported, QTVI is highly sensitive to 
changes in physiological states including rest, exercise and recovery. For example, 
a substantial and rapid increase in QTVI within the first minute of exercise at 
relatively low work rates has been noted (section 5.5.1.2). Subsequently, elevated 
QTVI values were observed throughout a progressive exercise protocol and 
during an extended period of recovery, indicating a sustained shift towards 
dominance of QT variability over RR variability.
The potential clinical utility of QTVI, yet the lack of a clear functional 
interpretation of this index, led to the rationale for this section of the thesis. It 
was thought that it would be of great interest to determine the relationship 
between QTVI and standard measures of cardiac ventricular performance and to 
compare this relationship with that for other indices of cardiac (QT and RR) 
temporal variability. Since substantial differences in QTVI during exercise and 
recovery compared with during pre-exercise rest were observed in the first study 
of this chapter, it was considered important to investigate whether exercise alters 
these relationships.
5.6.2.3 Relationship between cardiac performance indices and RR and QT 
variability
Differences between the subsets of included predictor variables, and in their 
pre/post exercise magnitudes, were observed in several of the pre- and post­
exercise models. This suggests that exercise had a substantial influence on the 
relationship between measures of RR and QT variability and the indices of 
cardiac ventricular performance.
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On the basis of the reported regression models, RMSSDNN appears to reflect 
LVET and TPRI during rest and to reflect SVI following exercise. SDNN appears 
to reflect LVET during rest and both SVI and IC following exercise. The results 
suggest that RMSSDQT and SDQT are equivalent with regard to their 
relationships with the indices of cardiac ventricular performance: RMSSDQT and 
SDQT reflect SVI and IC during rest and reflect EDVI, IC and ACI following 
exercise. SVI and ACI (measures of cardiac output per contraction and the force 
of contraction, respectively) are the strongest predictors of QTVI, and notably the 
relationship between QTVI and these indices of cardiac ventricular performance 
is not altered following high-intensity exercise.
5.7 Limitations
The relationship between cardiac ventricular performance parameters and RR 
and QT variables during exercise was not quantified because the relatively short 
periods during which physiological steady states could have been assumed would 
have been an insufficient basis for performing meaningful regression analysis. 
Future work might attempt to evaluate such relationships by employing longer, 
single periods of exercise at uniform work rates.
It is also worthy of note that the majority of variables considered in this chapter 
remained substantially altered at the end of the recovery period (15 minutes post­
exercise) compared with those at rest. Future studies should therefore employ 
longer recovery periods to analyse the complete recovery behaviour of these 
variables.
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In the first study of this chapter, gender differences in both the magnitude and 
dynamic properties of the QTVI index during conditions of rest and exercise were 
observed. As a result of availability and time considerations, only males were 
considered in the second study of this chapter and a comparison of these results 
for females would be a useful future addition to this work.
It should be emphasised that the data reported in these studies were obtained 
from young, physically active, healthy subjects. The direct applicability of this 
work to clinical populations (such as those with cardiac pathology), and the 
influence of age and physical fitness thereon, remains questionable. In this 
context, the results of this chapter should be interpreted with caution.
5.8 Conclusions
5.8.1 Study 1
QT and RR interval variabilities have been quantified during rest and dynamic 
physical exercise. This work has shown that QTVI undergoes a rapid and 
substantial increase at the onset of exercise, and that it remains elevated 
throughout exercise and subsequent recovery. This reflects a sustained relative 
increase in QT variability compared with RR variability during this time. These 
changes might be explained by a simultaneous withdrawal of autonomic 
modulation of the atrial myocardium and an accentuation of autonomic 
modulation of the ventricular myocardium during exercise. This further suggests 
that differential autonomic control of the atrial and ventricular myocardium 
might be related to heart rate-dependent and heart rate-independent modulation 
of the QT interval.
186
It is also notable that both QTe and the non-logarithmic ratio of QT and RR 
variabilities (10Qrvi) displayed linear relationships with work rate, at least up to 
moderate exercise intensities, and this association requires further investigation. 
The magnitude of the increase in QTVI during exercise is also worthy of 
particular note: even moderately elevated heart rates were associated with QTVI 
values previously shown to represent a risk factor for the development of 
arrhythmia. Future investigations of QTVI should include an assessment of the 
clinical implications of elevated values for this parameter during physical 
exercise.
5.8.2 Study 2
In quantifying the relative variability of RR and QT intervals, the QTVI index 
appears to be strongly influenced by both SVI and ACI and this relationship is 
maintained following a period of high-intensity physical exercise. Each of the 
other regression models of electrocardiographic RR and QT interval magnitudes 
and variabilities was altered following the performance of physical exercise. 
QTVI therefore is a reasonably consistent measure of cardiac ventricular 
performance during pre- and post-exercise physiological conditions, and as such 
is a more useful index than other parameters based on RR or QT interval alone. 
These results therefore suggest that QTVI could have utility as an easily 
measured, non-invasive marker of cardiac performance that is robust to differing 
physiological conditions.
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Chapter 6 Conclusion
The work presented in this thesis was motivated by the need for general 
characterisation of physiological parameters throughout the full range of heart 
rates during exercise and post-exercise recovery. This included the assessment of 
the ability of available apparatus to measure these data reliably, along with the 
examination of which different (complementary) types of information is 
extractable from the data and establishment of their properties and sensitivities to 
differing physiological conditions. This was done:
• To provide a baseline of data for further comparison, as the work detailed 
here characterises the normal responses for young, healthy adults
• To validate the use of the apparatus and data analysis methods
• To provide examples of best practice
The work of chapter 3 aimed to characterise the Reynolds Lifecard Holter system. 
The results indicated that the magnitude of paired-lead bias and the associated 
LOA of the bias for this system are substantially greater for QT data compared 
with RR data in both males and females. The difference in paired-lead bias for RR 
and QT being related to differences in the orientation of the cardiac vector during 
these two phases of the cardiac cycle. The difference in LOA for RR and QT is 
likely related to the differing accuracy and precision with which these two 
parameters can be measured from the ECG. Although employed specifically to 
the Reynolds Lifecard Holter system, this methodology could similarly be used 
with other Holter systems. The need for the quantification of the between-lead 
bias and associated LOA for electrocardiographic RR and QT data in future 
investigations using multi-lead ambulatory ECG systems has therefore been 
highlighted. Interpretation of the results of such studies should take adequate
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account of the between-lead variation in these parameters, and should specify 
each subject’s physiological state.
The relationship between QT and RR intervals for the three different electrode 
lead configurations of the Reynolds Lifecard Holter system following dynamic 
physical exercise was then characterised and compared. It was found that the 
locations of the paired electrodes used to record the surface ECG, significantly 
affects the calculated magnitudes of QTa-RR hysteresis. This emphasises the need 
for ECG electrode placement standardisation in investigations of QTa-RR 
hysteresis. There was also evidence of differences in hysteresis between genders, 
highlighting the need for a set of standard ECG electrode locations for each 
gender. Standardised ECG recording methodologies could help to elucidate the 
hypothesised association between QTa-RR hysteresis and differential autonomic 
control of atrial and ventricular myocardia.
The results of chapter 4 indicated that the sample entropy of RR time-series data 
is sensitive to differing physiological conditions when an appropriate choice of 
parameters is used for its calculation. The work suggests that values of r=0.1-0.15 
and M=2 represent an optimal choice for the consistent estimation of SampEn for 
RR and QT data. However, it appears that the ability of SampEn to discriminate 
between resting and exercise conditions is poorer than that of the common linear 
measures of HRV. SampEn was also unable to differentiate between the work 
loads used.
SampEn of RR data was negatively correlated with normalised LF and LF/HF 
parameters in cardiac control, which confirms that the complexity of cardiac 
interval time-series is associated with ANS functional status. Changes in SampEn
189
for RR or QT data in terms of the altered ANS control of either the atrial or 
ventricular myocardium (or both) during discrete physiological states are 
interpreted as system decoupling from external inputs or a reduction in the 
influence of these inputs. Further investigations might usefully examine the 
utility of a combined analysis of SampEn for RR and QT data during specific types 
of pathology.
The DFA scaling exponent values for RR data in chapter 4 were in general 
agreement with those observed previously during rest and exercise. Post-exercise 
recovery values of the scaling exponents had not previously been documented; it 
was observed that recovery values reverted to pre-exercise values within the 
observation period. During rest and post-exercise recovery, the RR data displayed 
strong scaling characteristics tending towards those of brown noise (a=2). 
However, as exercise work loads increased, the RR data tended to demonstrate a 
1/f scaling behaviour (a=l).
Scaling exponent values for QT data had not previously been reported. It was 
observed that a  values for QT were significantly lower than those for RR data 
during all physiological states. Moreover, the a  values for QT approached 0.5 
during the heaviest exercise work loads, suggesting that the QT data had the 
characteristics of uncorrelated white noise during these periods.
Short-term (on) and long-term (0C2) values for RR data differed significantly 
during the resting period and the initial stages of exercise, but were comparable 
thereafter, whilst ai and 0C2 values for QT data differed only for parts of the rest 
and recovery stages. However, ai for RR was found to be the better discriminator 
between different physiological states. These differences suggest that it is
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preferable to report both on and on exponents for RR and QT data. However, to 
reiterate, the ability of a  to discriminate between resting and exercise conditions 
is poorer than that of the majority of common linear and non-linear measures of 
HRV. The on exponent for RR was found to be negatively correlated with various 
linear and non-linear indices of HRV, further confirming that the fractal 
characteristic of cardiac interval time-series data is associated with ANS 
functional status.
This work suggests that RR and QT have dissimilar fractal structures, possibly 
reflecting differences in the mechanisms of temporal modulation of these two 
aspects of cardiac electrical activity. Further investigations might usefully 
compare the fractal characteristics of both RR and QT data in cases of cardiac or 
neural pathology.
The results of chapter 5 indicated that QTVI undergoes a rapid and substantial 
increase at the onset of exercise, remaining elevated throughout exercise and 
recovery. This reflects a sustained relative increase in QT variability compared 
with RR variability during this time. These changes might be explained by a 
simultaneous withdrawal of autonomic modulation of the atrial myocardium and 
an accentuation of autonomic modulation of the ventricular myocardium during 
exercise. This further suggests that differential autonomic control of the atrial and 
ventricular myocardium might be related to heart rate-dependent and heart rate- 
independent modulation of the QT interval.
Both QTe and the non-logarithmic ratio of QT and RR variabilities (lO^™) 
presented linear relationships with work rate, up to moderate exercise intensities, 
although this association requires further investigation. Even moderately elevated
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heart rates were associated with QTVI values previously shown to represent a 
risk factor for the development of arrhythmia. Future investigations of QTVI 
should include an assessment of the clinical implications of elevated values for 
this parameter during physical exercise.
In quantifying the relative variability of RR and QT intervals, QTVI appears to be 
strongly influenced by both SVI and ACI, this relationship being maintained 
following a period of high-intensity physical exercise. Each of the other utilised 
regression models of electrocardiographic RR and QT interval magnitudes and 
variabilities was altered following physical exercise. QTVI therefore is a 
reasonably consistent measure of cardiac ventricular performance during pre- and 
post-exercise physiological conditions, and as such is a more useful index than 
other parameters based on RR or QT intervals alone. These results therefore 
suggest that QTVI could have utility as an easily measured, non-invasive marker 
of cardiac performance that is robust to differing physiological conditions.
As an expansion on the knowledge gained in this work, further investigations 
could be performed:
1. In older adults in order to assess the effect of aging on the degradation of 
physiology as reflected in the parameters
2. In children and adolescents to assess whether developmental changes are 
reflected in the parameters
3. In individuals with pathology
4. In athletes and exercising individuals in order to assess the relative 
influence of different training types (including the comparison of aerobic 
and anaerobic training effects) and over-training
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The above could potentially lead to information regarding SCD which is 
seemingly prevalent in active apparently healthy young adults.
For the first time this work has shown:
• That studies should take adequate account of the between-lead variation 
in RR and QT data, and should specify each subject’s physiological state
• That ECG electrode placement standardisation is necessary in 
investigations of QT-RR hysteresis, highlighting the need for a set of 
standard ECG electrode locations for each gender
• That RR and QT interval data series have dissimilar fractal structures, 
which requires further investigation in cases of cardiac or neural 
pathology
• That the QTVI could have utility as an easily measured, non-invasive 
marker of cardiac performance that is robust to differing physiological 
conditions
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Appendix I Basic central nervous system anatomy 
A l.l The central nervous system
The vertebrate nervous system coordinates musculature activity, monitors organ 
function, collects and also inhibits input from the senses and initiates appropriate 
reaction to stimuli, hence providing protection for the body. The basic unit of the 
nervous system is the neuron. All neurons have two fibre types which extend 
from the cell body, the dendrite carrying impulses toward the cell body and the 
axon carrying impulses away. Each neuron is part of relay system carrying 
information through the nervous system. The nervous system is initially divided 
into the central nervous system (CNS) and the peripheral nervous system (PNS). 
A neuron which transmits impulses towards the CNS is classed as a sensory 
neuron whilst neurons which transmit impulses away from the CNS are termed 
motor neurons. Individual neuron fibres exist in bundles which, if part of the 
PNS, are classed as nerves. A collection of cell bodies along the pathway of a 
nerve is known as a ganglion and these provide intermediary connections 
between different neurological structures in the body, such as the PNS and CNS. 
The PNS is then further subdivided. This is illustrated in Figure A l.l. The CNS 
represents the largest part of the nervous system and includes the brain and the 
spinal cord. Together with the PNS, it fundamentally controls behaviour.
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Figure A l.l Schematic diagram of the vertebrate nervous system 
A1.2 The brain
The brain has three main areas of interaction with the nervous system; the 
cerebrum, the cerebellum, and the brainstem.
The cerebrum's tasks include high-order thinking and learning, voluntary 
movement and the perception and interpretation of conscious sensations such as 
pain or heat. It is the largest part of the brain and consists of the left and right 
cerebral hemispheres. It is composed largely of white matter (myelin) with a thin 
outer layer of unmyelinated grey matter, the cerebral cortex. Within this cortex, 
higher brain functions of memory, reasoning and thought take place.
The cerebellum is beneath the cerebrum and manages learned automatic bodily 
functions through the coordination of muscular activity. It maintains balance and 
the equilibrium of the body through the subconscious control of muscle tone and
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posture. It is referred to as the small brain as its structure is similar to that of the 
cerebrum.
The brainstem has three major areas of interaction: the mesencephalon or 
midbrain, which functions as the “relay station” of the brain, transmitting 
messages between the spinal cord, the cerebrum and the cerebellum; the pons 
variolii, consisting of nerve fibres which bridge the space between the 
hemispheres of the cerebrum and also send messages to and from the spinal cord, 
the cerebrum and the medulla oblongata. This has four centres of control:
1. The cardiac control centre (composed of two neural pools, a cardio- 
acceleratory centre and a cardio-inhibitory centre) which regulates 
cardiac output
2. The respiratory control centre which regulates breathing by integrating 
afferent signals from mechanical and neuro-mechanical sources, 
(information from both these sources, combined with voluntary and 
involuntary CNS control, effects stimulation of the respiratory muscles)
3. The vasomotor centre controlling vasoconstriction and dilation
4. The reflex centre which responds to irritants and hence regulates reflex 
actions such as vomiting
Situated beneath the midbrain, the hypothalamus links the nervous system to the 
endocrine system via the pituitary gland. It has a role in the regulation of basal 
metabolic rate (energy expenditure whilst at rest), temperature and hydration, 
although “drives and emotions” such as pleasure and appetite are also controlled 
by the hypothalamus, through the synthesis and secretion of neuro-hormones.
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A1.3 The spinal cord
The spinal cord extends from the base of the medulla oblongata through the 
spinal vertebrae ending at the first lumbar vertebra. 31 pairs of spinal nerves exit 
the spinal cord along its length. The afferent and efferent nerve fibres associated 
with these nerves transmit signals to and from the brain. Efferent motor neurons 
innervate skeletal muscle via the anterior horn whilst afferent sensory nerve 
fibres enter the spinal cord via the posterior horn of the spinal cord. The grey 
core of the spinal cord is surrounded by a sheath of white matter containing these 
ascending and descending nerve tracts.
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Appendix II Clinical applications of HRV analysis 
A2.1 Introduction
Extensive effort has been made to date in describing changes in cardiovascular 
variability in a plethora of applications (both physiological and pathological) 
although this clinical research has continued in some cases without reflection and 
understanding of the fundamental causes of the variability and also without 
reference to the possibility that not all changes in cardiovascular variability result 
from changes in autonomic function (Malpas 2002). Although cardiovascular risk 
stratification using HRV has been researched widely in terms of myocardial 
infarction, angina pectoris, congestive heart failure, malignant arrhythmia, 
sudden cardiac death and essential hypertension, other non-cardiac pathologies 
have also been investigated with regard to potential HRV changes. Research areas 
include: obstructive sleep apnoea, endocrinological and metabolic disease, 
respiratory disease including asthma and COPD, diabetic autonomic neuropathy, 
end stage renal disease, Parkinson’s disease, Chagas’ disease, multiple sclerosis, 
perinatal pathology, sudden infant death syndrome and clinical depression. 
However, as HRV deals with RR interval variations, its measurement is limited to 
individuals in sinus rhythm and to those with a low number of ectopic beats, 
resulting in approximately 20 - 30% of high risk post-myocardial infarction 
patients being excluded from any HRV analysis (Sztajzel 2004). In addition, loss 
of spectral power of HRV may he used to confirm the cessation of brainstem 
function in clinical practice (Gang & Malik 2003). Altered HRV has also been 
associated with cirrhosis of the liver, eclampsia and tetanus, although assessment 
in these areas has not been systematically explored (Gang & Malik 2003). Several 
major areas of current research into the clinical influences on HRV are detailed in 
the following sections in order to demonstrate the variety of systemic conditions 
that can result in alterations in HRV.
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A2.2 Cardiovascular risk stratification
The major area of agreement in the clinical applicability of HRV analysis has 
been in the prediction of mortality and malignant arrhythmias in post acute 
myocardial infarction patients, which has been linked to lowered HRV (Kleiger 
etal. 2005). Although most studies have been conducted in the sub-acute phase of 
infarction, others have been performed up to a year post-event with HRV 
remaining significantly associated with subsequent mortality (Bigger etal. 1993). 
Myocardial ischaemia and autonomic nerve activity are closely related and 
moreover, sympathetic activation may precipitate ischaemia which in turn may 
lead to increased release of noradrenaline from cardiac sympathetic nerves 
resulting in a “vicious circle” (Forslund etal. 2002).
A2.2.1 Sudden cardiac death
Sudden cardiac death (SCD) is defined as an unexpected natural death resulting 
from cardiac aetiology preceded by a sudden loss of consciousness (Ranpuria et al. 
2008). The pathophysiology of SCD is not clearly understood, although there is 
around a seventeen-fold increase in risk during and immediately following 
physical exercise (Kannankeril & Goldberger 2002) and hence the case has been 
made for pre-exercise participation screening (Corrado etal. 2003). A possible 
mechanism for SCD could involve an abnormally depressed parasympathetic 
control, resulting in a failure to counteract the sympathetically mediated QT 
interval prolongation (Sundaram etal. 2008).
The significance of time domain HRV analysis in predicting SCD is controversial 
(Kudaiberdieva et al. 2007) particularly in individuals with congestive heart 
failure (Nolan etal. 1998). Prevalent LF power (suggesting sympathetic 
dominance) of the PSD has been shown to have prognostic significance in
199
predicting SCD in individuals with congestive heart failure however (Galinier et 
al. 2000, La Rovere et al. 2003, Guzzetti etal. 2005). The abnormal (narrow or 
complex) Poincar£ plot (section 2.5.4.2.2) has been described as a significant 
predictor of SCD in individuals with congestive heart failure (Brouwer etal. 1996, 
Makikallio etal. 2001). However, the positive predictive value of HRV analysis in 
SCD remains low (Lombardi etal. 2001, Kudaiberdieva etal. 2007).
A2.2.2 Hypertension
There is a decline in HRV relatively early in the development of hypertension 
and decreases in autonomic function precede the development of clinical 
hypertension (Schroeder etal. 2003). Abnormalities in the adrenergic regulation 
of either cardiac output or peripheral vascular resistance possibly represent the 
pathophysiological basis of the hypertensive state (Grassi & Mancia 2004). There 
is difficulty in determining the degree to which events in ANS dysfunction are a 
cause or a consequence of hypertension and further studies are needed to isolate 
the various contributions of sympathetic over-activity and parasympathetic 
withdrawal, as well as the role of various antihypertensive treatments on changes 
in HRV (Schroeder etal. 2003). HRV (and BRS) contribute importantly and 
additionally to risk stratification for hypertension, particularly in the presence of 
reduced left ventricular ejection fraction as increased mortality is associated with 
autonomic imbalance in hypertensive individuals (La Rovere etal. 2001).
A2.2.3 Myocardial infarction and coronary artery disease
HRV analysis has had its greatest cardiological use in post myocardial infarction 
(MI) risk stratification (Kleiger etal. 2005). ANS imbalance may trigger 
mechanical and electrical complications, leading to sudden death both in the 
acute and chronic phases of MI (Carpeggiani etal. 2005). 10% of individuals die
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within one year post-MI (Sanz etal. 1981); the majority of these are attributable 
to ventricular tachyarrhythmias, whilst the remainder result from re-infarction 
and heart failure (Rosenthal etal. 1985). Kleiger etal. (1987) presented the initial 
study which suggested the independent and long-term predictive value of HRV 
analysis after MI. Their study showed that reduced SDNN was linked with low 
ejection fraction, poor exercise performance, high New York Heart Association 
(NYHA) functional class (I-IV, the latter being most severe) and short RR 
intervals. Subsequent to this work, multiple studies (Pipilis etal. 1991, Bigger et 
al. 1993, Valkama etal. 1994) confirmed the value of HRV analysis in risk 
stratification post-infarction through a general decrease in spectral measures post 
event. The study conducted by Bigger etal. (1993), concluded that all frequency 
bands of the power spectrum are significant predictors of all-cause cardiac 
mortality, with the VLF band having most predictive value. Lombardi et al.
(1987) showed a predominance of sympathetic activity two weeks post-MI which 
progressively normalised over the following year, whilst Rothschild etal. (1988) 
showed a decrease in cardiac vagal tone post-MI which contributed to the 
relative sympathetic over-activity. The HRV normalisation in the 12 months 
following infarction has created controversy as there has been disagreement as to 
whether recovery is partial or complete (Di Micco et al. 2000) with some 
individuals exhibiting a progressive deterioration in HRV with eventual sudden 
death (Nakagawa etal. 1994). Cripps etal. (1991) suggested that the relative risk 
of sudden death or ventricular tachycardia was seven times greater in post-MI 
patients with reduced HRV than in those with normal HRV. Whilst the observed 
autonomic changes have a short term adaptive effect through the maintenance of 
blood pressure, their longer term consequences are clearly maladaptive, resulting 
in increased myocardial oxygen consumption, adverse cardiac remodelling and 
renin-angiotensin system activation (Frenneaux 2004).
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Coronary artery disease (CAD) arises from narrowed coronary arteries following 
the build up of plaque formed from fat, cholesterol, calcium and other substances 
(atherosclerosis) leading to reduced HRV (Casalo etal. 1995). Initial studies have 
suggested that CAD is independently associated with specific parasympathetic 
impairment which occurs without sympathetic dysfunction (Rich etal. 1988, 
Hayano etal. 1990, Hayano etal. 1991), with the severity of parasympathetic 
dysfunction being proportional to CAD severity (Nolan etal. 1994) and with 
elevated sympathetic activity (McCance etal. 1993). Several epidemiological 
studies (Okin etal. 2000, Robbins etal. 2003, Dekker etal. 2004) have indicated 
that QT interval prolongation predicts the risk of CAD. Likewise, cross-sectional 
studies have highlighted a positive association between QT interval prolongation 
and sub-clinical arterial disease (Maebuchi etal. 2008).
A2.2.4 Congestive heart failure
Congestive heart failure (CHF) is characterised by low cardiac output with 
sympathetic activation (Cohn etal. 1984), renin-angiotensin system activation 
(Cody 1984) and impaired baroreflex gain (Ferguson etal. 1992) ultimately 
leading to death. The mode of death is dependent on NYHA classification, 
individuals with less advanced CHF more often die suddenly, whilst those with 
NYHA class IV typically die from pump failure (Carson etal. 2005). CHF has an 
incidence in the general population of between 6-10% in individuals over 65 
years of age (Sandercock & Brodie 2006) and approximately 50-60% of affected 
individuals will die within five years of diagnosis (Cygankiewicz etal. 2008). 
Norepinephrine levels increase in individuals with CHF, this correlating with 
disease severity (Levine etal. 1982) and with the prognosis of heart failure 
(Rector etal. 1987), suggesting a close relationship between the ANS and CHF 
(Soejima etal. 2000). Numerous studies have shown reduced HRV in individuals 
with CHF (Saul etal. 1988, Casalo etal. 1989, Binkley & Cody 1992, Nolan etal.
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1992) resulting from increased sympathetic drive and/or reduced vagal activity, 
but little attention has been given to the relationship between HRV and CHF 
severity (Casalo et al. 1995).
The study by Saul etal. (1988) compared individuals with CHF of NYHA classes 
III and IV (that is with marked to severe limitations in physical activity) with 
normal control subjects, with reduced HRV being found in all PSD bandwidths. 
Soejima et al. (2000) highlighted a clear correlation between HRV, left 
ventricular function and NYHA classification. They also indicated that LF HRV 
showed a progressive decrease with worsening NYHA classification, but HF HRV 
decreased to NYHA class II and did not decrease thereafter. They concluded that 
in their study, abnormal HF HRV enabled only mid-term prognosis, whereas 
abnormal LF HRV enabled both mid- and long-term prognoses. Agreement on 
the prognostic role of HRV in SCD prediction in individuals with CHF however 
remains controversial, with the majority of studies indicating no prognostic 
significance owing to the difficulty in categorising the sudden or arrhythmic 
nature of death (Cygankiewicz etal. 2008).
Individuals with CHF have increased QT interval variability compared with age- 
matched healthy subjects (Berger etal. 1997) which predisposes to electrical 
instability of the myocardium and may favour certain arrhythmias (Cygankiewicz 
etal. 2008). Abnormal QT interval variability may help in the identification of 
individuals with high risk of SCD among asymptomatic patients with only mild to 
moderate left ventricular dysfunction (Piccirillo etal. 2007).
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A2.2.5 Cardiovascular surgery
HRV analysis has been utilised to evaluate ANS function post cardiovascular 
surgery, decreased HRV being an independent predictor of prolonged 
hospitalisation post surgery (Stein etal. 2001). Chase etal. (2004) reported that 
HRV can provide an improved method of assessing agitation in ICU patients, 
enabling improved sedation management through optimised drug delivery when 
compared with traditional methods.
A2.3 Neurological application
Cerebrovascular trauma represents one of the main causes of death and disability 
in Western countries. Furthermore, impaired cardiovascular autonomic 
regulation has been described in stroke patients, often complicating the 
determination of the clinical source of the pathology (D’Addio etal. 2006). 
Spectral and time domain methods have described HRV reduction post-stroke 
although some individuals with poor outcome have shown random complex HRV 
behaviour, which these techniques are unable to quantify (Korpelainen et al. 
1999). However, the level of autonomic imbalance in the months following acute 
ischemic stroke has not been thoroughly investigated and available data are 
incomplete (Lakusic etal. 2005). Transient autonomic dysfunction exists in 
individuals with acute medullary stroke, contrasting with those with non- 
medullary stroke owing to the role of the medulla oblongata in autonomic 
function (Meglic etal. 2001). The quantification of autonomic imbalance during 
the acute phase of stroke would allow the identification of individuals with 
further high risk of malignant arrhythmias and SCD (Lakusic etal. 2006).
Autonomic modulation of circulation is the primary response to traumatic 
haemorrhage and post-event individuals with adequate autonomic responses are
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better able to maintain peripheral resistance and arterial pressure compared with 
those whose autonomic responses are blunted (Cooke etal. 2006). Acute brain 
injury or trauma can also result in decreased HRV and BRS, indicating an 
“uncoupling” of the autonomic and cardiovascular systems proportional to the 
degree of neurological injury, especially at the low end of the LF and HF bands, 
whilst in brain dead individuals, all spectral components are virtually non­
existent (Papioannou etal. 2006). A positive correlation between autonomic 
cardiovascular control and the subsequent outcome post-trauma has also been 
shown (Haji-Michael etal. 2000).
A2.4 Renal disease
The end stage renal disease population has one of the highest mortality rates, 
even when adjusted for age, race, sex and co-morbid conditions (Gussak & Gussak
2007). Chronic kidney disease is a progressive condition that results in significant 
morbidity and mortality. As the kidneys maintain the homeostatic balance of 
bodily fluids through the filtration and secretion of metabolites, chronic kidney 
disease can affect almost every body system (Snively & Gutierrez 2004). 
Circulating angiotensin II physiologically connects the cardiovascular, endocrine 
and renal systems and also plays a role in disease development in some forms of 
hypertension, obesity and diabetes, each of these pathologies being linked with 
altered autonomic function. One of the major causes of death in end-stage renal 
disease patients under maintenance of haemodialysis is ventricular arrhythmias 
(Lung Wen etal. 2007) although there are numerous other factors implicated in 
the vulnerability of chronic dialysis patients to cardiovascular causes of death 
including sympathetic activation (Furgeson & Chonchol 2008).
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HRV significantly increases following dialysis (Lung Wen etal. 2007). Frequency 
domain analysis indicates that HF components are almost lost in individuals with 
chronic renal failure, with the LF mean power being around three times greater 
than HF (compared with healthy subjects where the power in both frequency 
bands is comparable (Lerma etal. 2004)). In this case, the LF/HF ratio at rest in 
chronic renal failure patients is around three times greater than in healthy 
subjects.
Decreasing the activity of the renin-angiotensin system by angiotensin 
converting enzyme inhibition or angiotensin II receptor blockade reduces 
sympathetic activity which is suggestive of a cause and effect relationship 
between cardiac disease and sympathetic over-activity in chronic renal disease 
patients (Neumann etal. 2007). However, the chronic interactions among the 
renin-angiotensin system, cardiac reflexes and arterial baroreflexes that impact on 
sympathetic nerve activity, and the link between the sympathetic nervous system 
and long term blood pressure regulation, need further research (Lohmeier et al. 
2001).
A2.5 Diabetes Mellitus
The American Diabetes Association has defined diabetes mellitus as a group of 
metabolic diseases characterised by hyperglycaemia resulting from defects in 
insulin1 secretion, insulin action or both. It is characterised by widespread 
neurological degeneration affecting the small nerve fibres of the sympathetic and 
parasympathetic branches of the ANS (Schroeder etal. 2005). Diabetes mellitus 
reduces life expectancy by between five and ten years, it is the most common
1 Insulin is a pancreatic hormone w hich affects metabolic rate through the regulation o f 
glucose uptake by cells from the blood.
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reason for renal replacement therapy worldwide, the most common cause of 
blindness in individuals under the age of 65 and the most common cause of non- 
traumatic amputation (Marshall & Flyvbjerg 2006).
Autoimmune-mediated destruction of insulin producing p-cells in the Islets of 
Langerhans in the pancreas characterises type 1 diabetes (also known as insulin 
dependent diabetes). Destruction of p-cells leads to progressive decline in the 
body’s insulin secretory capacity, with destruction of 80% of p-cells resulting in 
clinical symptoms. Currently this is considered a result of a combination of 
environmental factors, such as viral infections, superimposed on a genetic 
susceptibility (Fowler 2007).
Similar to type 1, type 2 diabetes (or non-insulin dependent diabetes) involves 
both genetic susceptibility and environmental initiators, the genetic component 
being greater than in type 1 diabetes (Fowler 2007). The prevalence of type 2 
diabetes is estimated at 2-6% in most European countries (Rana etal. 2005). 
Approximately 90% of diabetes incidence is type 2 and it results from a 
combination of insulin resistance or relative insulin deficiency with increased 
heptatic glucose production, insulin resistance is generally thought to precede 
insulin deficiency. Type 2 diabetes in mild cases can be unnoticed for several 
years. In this case secondary complications may result such as renal failure, 
diabetic autonomic neuropathy, diabetic retinopathy, cardiovascular disease, 
cerebrovascular disease and peripheral vascular disease leading to MI, stroke and 
amputation (Watkins 2003). In diabetic individuals, the risk of cardiovascular 
disease approaches that in non-diabetic people with previous MI and even with 
appropriate therapy, 70% of cardiovascular events still occur (Reckless 2006).
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A2.5.1 Diabetic autonomic neuropathy
A common and potentially serious complication of diabetes, although among the 
least recognised and understood, is diabetic autonomic neuropathy (DAN). This is 
initially an asymptomatic condition which has a significant negative impact on 
survival and quality or life, initially through abnormalities in heart rate control, 
as well as through defects in central and peripheral vascular dynamics (Vinik & 
Ziegler 2007). Of individuals with DAN, 25-50% die within 5-10 years of 
diagnosis and the 5-year mortality rate in these individuals, is three times higher 
than in those without DAN (Vinik & Erbas 2001). DAN can involve all parts of 
the ANS and manifests as dysfunction of one or more organ systems. The 
metabolic disorders of diabetes lead to widespread damage of peripheral nerves 
and small vessels. DAN initially manifests in longer nerves, and since the vagus 
nerve (cranial nerve X) accounts for approximately 75% of all parasympathetic 
activity, even the early effects of DAN are widespread.
The most studied form of DAN but over-looked in patient care is cardiovascular 
autonomic neuropathy (CAN) which can greatly affect daily activities and 
produce symptoms such as syncope (Vinik eta l. 2003). The earliest indicator of 
CAN is reduced HRV as it results from damage to the autonomic nerve fibres that 
innervate the heart and blood vessels leading to abnormalities in heart rate 
control and the 5-year mortality rate from this complication is five times higher 
for individuals with CAN than for those without (Vinik etal. 2003).
Whilst the earliest sign of CAN manifests via reduced HRV at the sub-clinical 
stage, at more advanced stages, resting tachycardia is evident owing to 
sympathetic dominance which follows vagus nerve damage (Schonauer et al. 
2008). Subsequent to this vagal dysfunction, the HF component of HRV is
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reduced (Makimattla etal. 2000). HRV in conjunction with complexity analysis 
has been suggested as a screening tool for CAN (Khandoker etal. 2009). These 
authors found that compared with conventional HRV indices and Poincare plot 
parameters, sample entropy of HRV was able to better distinguish diabetic 
individuals with CAN from diabetics free of CAN. They suggested that the 
association between variability and complexity organisation of heart beat 
fluctuations may be specific to CAN and that the reduced sample entropy of heart 
rate complexity in individuals with CAN suggests a reduced responsiveness of 
feedback interactions. The transitions to strongly periodic dynamics in 
individuals with CAN shown in that study are similar to those observed in 
Parkinson’s disease, obstructive sleep apnoea, SCD, epilepsy and foetal distress 
syndrome (Vaillancourt & Newell 2002). Type 1 diabetic individuals with CAN 
may also exhibit QTc interval prolongation and further autonomic abnormalities 
such as impaired BRS (Lee etal. 2004), although exercise improves BRS sensitivity 
in type 2 diabetic subjects in addition to improving glucose control (Loimaala et 
al. 2003).
A2.6 Obesity
Obesity is a condition characterised by excess body mass with additional co- 
morbidities of hyperinsulinemia and insulin resistance causing individuals to 
suffer from increased mortality and morbidity risk resulting from cardiovascular 
complications (Avsar etal. 2007). Obesity can be defined in absolute terms when 
referring to the body mass index (BMI) with the World Health Organisation 
guidelines defining those with BMI  ^30 kg m 2 as obese (Wolk etal. 2003). 
Obesity in individuals with established CAD worsens the prognosis, is associated 
with acute coronary syndromes and is related to ANS dysfunction 
(Piestrzeniewicz etal. 2008). Studies of resting muscle sympathetic nerve activity, 
norepinephrine spill-over from the kidney and plasma norepinephrine indicate
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greater sympathetic activation with increasing body weight (Zahorska- 
Markiewicz etal. 1993, Gao etal. 1996, Piccirillo etal. 1996) and that 
sympathetic activity is increased in obese subjects compared with non-obese 
controls (Peterson etal. 1988, Rossi etal. 1989, Piccirillo etal. 1996, Goodfriend 
& Calhoun 2004). In addition, decreased parasympathetic activity has been 
reported in obesity (Aronne etal. 1995). This sympathetic hyperactivity then 
impacts on further cardiovascular effects such as elevated blood pressure, heart 
rate and hence cardiac output, as well as renal effects.
Obese individuals are also more prone to malignant arrhythmias than the non- 
obese as shown by PSD analysis, obesity being a strong predictor of SCD (Avsar et 
al. 2007). However, weight gain without co-morbidities may not affect cardiac 
autonomic function; the main reason for cardiac autonomic dysfunction in 
obesity may be the concomitant disorders. For the overweight or obese, higher 
levels of vigorous activity are associated with low resting heart rates and HRV 
levels similar to those in the non-obese who do not participate in vigorous 
activity, although the positive effects of vigorous activity do not surpass the 
advantages of a lowered BMI (Rennie etal. 2003).
A2.7 Sleep apnoea
Sleep is a dynamic complex process, the stages of which are characterised by 
autonomic influences on cardiac rhythm and haemodynamics. Sleep studies of 
young individuals free of cardiac disease show sinus pauses of up to two seconds 
in duration in association with sinus arrhythmia, the incidence being increased 
with increasing levels of training but decreased in the elderly (Gula etal. 2004). 
These arrhythmias reflect the changes in autonomic tone that occur during sleep. 
During non-REM (rapid eye movement) sleep there is an increase in
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parasympathetic tone with a reduction in sympathetic tone whilst during REM 
sleep there is a decrease in parasympathetic tone with surges of sympathetic 
activity resulting in decreased baroreceptor regulation and control (Gula et al. 
2004). These authors reported that the highest incidence of non-fatal MI, 
implanted defibrillator discharges and SCD occur in a non-uniform manner 
throughout the night with a surge in each of these events occurring between 5.00 
and 6.00AM, coinciding with an increased incidence of REM sleep.
Sleep apnoea is characterised as obstructive or central and is reported to be 
present in 25% of middle-aged men and 10% of middle aged women. Obstructive 
sleep apnoea (OSA) manifests as a complete or partial obstruction of the pharynx 
resulting from the relaxation of the musculature, which causes apnoea (complete 
collapse) or hypopnoea (partial collapse) during sleep. Central sleep apnoea (CSA) 
results from a cessation of voluntary respiratory drive from the respiratory 
control centre of the hypothalamus. Apnoeas and hypopnoeas are often 
accompanied by arterial hypoxia, a rise in carbon dioxide levels and increased 
sympathetic discharge leading to a repetitive interruption of nocturnal sleep 
which results in increased cardiac output and fatigue (Chakravorty et al. 2006). 
OSA has numerous co-morbidities including obesity, diabetes, stroke, CHF, 
cardiac arrhythmia and gastric reflux (Park etal. 2008). It is closely related to 
CAD and is an independent risk factor for hypertension (Peppard et al. 2000). 
Sudden death amongst individuals with OSA occurs predominantly at night in 
contrast to the general population; almost 50% of this group develop cardiac 
arrhythmias of some kind during sleep (Baumert e t al. 2008b).
HRV parameter changes have been reported in individuals with OSA (Park etal.
2008) and HRV analysis has been proposed as a screening tool for OSA (Roche et 
al. 1999b). Generally, a decreased HF component and increased LF component,
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reflecting decreased parasympathetic and increased sympathetic cardiac 
modulation has been observed (Narkiewicz etal. 1998, Gula etal. 2003, Ay din et 
al. 2004, Yang etal. 2005) and the LF/HF ratio may be of use in the estimation of 
OSA severity (Park etal. 2008). Continuous positive airway pressure (CPAP) 
therapy has been shown to restore these indices acutely (Khoo etal. 1999) and 
chronically (Roche etal. 1999a).
A2.8 Respiratory disease 
A2.8.1 Asthma
The term “asthma” encompasses several distinct disease phenotypes leading to 
differences in diagnostic classification, the most widely accepted definition being 
a chronic inflammatory disorder of the airways usually associated with 
widespread but variable airflow obstruction and an increase in airway response to 
a variety of stimuli (Lewis etal. 2006). Clinically it is defined as a condition in 
which any of the following are manifest: symptoms prior to treatment are 
continuous and punctuated by frequent exacerbations or frequent nocturnal 
symptoms; impairment of lung function demonstrated by spirometry; or there is 
limitation of daily activities by asthma symptoms (Stirling & Chung 2001).
Individuals with asthma undergo episodes of exaggerated bronchoconstriction in 
response to a wide variety of exogenous and endogenous stimuli (for example cold 
air, organic/inorganic allergens including dust or exercise). This hyper-reactivity 
is generally co-existent with airway inflammation, the pathophysiological 
mechanism underlying these changes being not fully understood. It is likely that 
this mechanism is associated with the abnormal ANS control observed in 
asthmatic subjects (Kaliner etal. 1982), the parasympathetic component of the 
ANS appearing to be implicated. The parasympathetic nervous system is involved
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in the bronchoconstriction that occurs during physical exercise in both asthmatic 
and non-asthmatic subjects (Warren etal. 1984) and the bronchoconstriction 
response to altered airway temperature and/or airway surface osmolarity 
(McFadden etal. 1986). In addition, the existence of altered autonomic function 
following exercise in asthmatics compared with normal controls has been 
suggested (Fujii etal. 2000). Cardiac vagal activity also appears to be increased in 
asthma, as demonstrated by the bradycardic response to anticholinergic drugs, 
methacholine and antigen challenge seen in asthmatic subjects (Crimi etal. 1992). 
It has therefore been suggested that there could be an intrinsic relationship 
between cardiac and bronchial autonomic control, and that this relationship 
might be altered in asthmatic individuals (Kallenbach etal. 1985). However, vagal
I regulation of resting bronchomotor tone depends on reflexes initiated in irritant
airway receptors (Jammes & Mei 1979), whilst vagal activity to the heart occurs
I in response to arterial baroreceptors (Kollai etal. 1994). This apparent
independence of vagal control suggests that bronchial and cardiac vagal activities
j
| would be unrelated. In accordance with this concept of system-independent ANS
j
; control, some authors have reported a lack of association between changes in
ANS control in the cardiac and respiratory systems. For example, Horvath et al. 
(1995) found no correlation between bronchial and cardiac vagal tone (assessed 
using airway resistance and heart beat period) in non-atopic healthy adults. 
However, there is also a considerable body of evidence suggesting that numerous 
cardiovascular parameters are altered as a result of either pathophysiological 
changes or the administration of therapeutic medication in asthma. This 
autonomic and resultant cardiac dysfunction may even contribute to some sudden 
and often unexpected deaths in individuals with asthma (Lewis e t al. 2006).
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A2.8.2 Chronic obstructive pulmonary disease
According to the definition from the European Respiratory Society, chronic 
obstructive pulmonary disease (COPD) is a disease characterised by reduced 
maximum expiratory flow and slow, forced emptying of the lungs owing to 
varying combinations of diseases of the airways and emphysema resulting from 
respiratory pollutants, mainly tobacco smoke (Agusti etal. 2005). Whilst asthma 
and COPD are both characterised by airflow limitation, asthma is usually episodic 
in nature, does not progress, begins in childhood and exhibits a good response to 
bronchodilators and corticosteroids. COPD by contrast has a slow, progressive 
onset with little variability in symptoms, most individuals being diagnosed after 
the age of 60 and showing a poor response to bronchodilators and corticosteroids 
(Barnes 2006). COPD is recognised as having local respiratory effects and wider 
systemic influences (Fabbri & Rabe 2007). COPD is an independent risk factor for 
cardiovascular disease and further co-morbidities include hypertension, diabetes, 
cancer and pulmonary vascular disease, with sufferers mainly dying of non- 
respiratory disorders such as cardiovascular diseases or cancer (Fabbri & Rabe 
2007).
Impaired autonomic regulation in COPD patients via sympathetic activation and 
parasympathetic withdrawal are commonly observed during acute exacerbations 
and these are associated with a worse prognosis in this group (Skyba et al. 2007). 
One explanation for the high levels of sympathetic activation in COPD patients is 
an increased arterial chemoreflex activation of sympathetic outflow which may 
have important consequences for respiratory muscle function, pulmonary 
circulation and right heart failure in these individuals (Heindl etal. 2001). In 
addition to the consistent evidence of augmented sympathetic nervous traffic, 
there is evidence of elevated catecholamine level and renin-angiotensin system
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activity in COPD patients which is in keeping with the similar situation which 
exists in individuals with heart failure.
BRS is reduced in individuals with COPD although the exact mechanism for this 
remains unclear. Exercise training is known to improve BRS in healthy subjects 
(Costes et al. 2004) and these workers reported that exercise conditioning in 
COPD patients with poor initial exercise tolerance is a strong stimulus in 
increasing the baroreflex gain, although it remains undetermined whether the 
increase reduces the incidence of cardiovascular events. There are two proposed 
mechanisms for the alteration of the exercise autonomic response in COPD 
patients (Bartels etal. 2003). The first is a lack of ability to achieve a sympathetic 
response as the baseline sympathetic tone is already elevated, and the second is 
that there is an increase in HF power indicating an abnormal level of 
parasympathetic tone, both implying that an increase in heart rate would be 
difficult. Bartels et al. (2003) demonstrated an increase in parasympathetic 
activity during exercise in COPD patients, in clear contrast to a healthy control 
group. They also showed a lack of alteration of sympathetic tone during exercise 
in the COPD group, in direct opposition to the exercise response in the healthy 
population. This might have a significant bearing on the ability to perform 
exercise and on the response to a conditioning programme in COPD patients.
A2.9 Thyroid dysfunction
The thyroid gland is one of the largest endocrine glands in the body and is under 
the control of the hypothalamus and pituitary gland. It primarily controls 
metabolic rate, protein synthesis and systemic sensitivity to other hormones. 
Thyroid hormones affect cardiac tissue and the peripheral vasculature by direct 
action on these tissues and also indirectly, at least in part, from changes at the
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ANS level (Cacciatori etal. 2000). Cacciatori etal. (1996) evaluated the impact of 
hyperthyroidism on the cardiovascular system by PSD analysis during “Ewing 
battery” intervention, finding that hyperthyroid patients have reduced vagal 
influence at the SA node and consequently a relative hypersympathetic tone. This 
was in agreement with Northcote etal. (1986). Pitzalis etal. (1998) however 
found no association between hyperthyroidism and HRV.
Flynn et al. (2006) described all-cause mortality and vascular mortality and 
morbidity in individuals after treatment for hypothyroidism and 
hyperthyroidism. They advocated an increased use of statins and ACE inhibitors 
in this group as amongst individuals with treated and stabilised thyroid disease 
there may be an increased risk of specific non-fatal vascular events, and ischemic 
heart disease and dysrhythmias in the case of both hypothyroidism and 
hyperthyroidism. The impact of thyroid dysfunction on the QT interval has not 
however been investigated extensively (Dorr e t al. 2006) and as yet there are 
inconsistent findings, although QTc interval prolongation has been associated 
with hyperthyroidism (Colzani etal. 2001, Owecki etal. 2006) and also with 
hypothyroidism (Fazio etal. 1992). Hyperthyroidism is also associated with an 
age dependent increase in atrial fibrillation which commonly normalises post 
treatment. Wustmann etal. (2008) studied potential atrial fibrillation triggers in 
individuals with hyperthyroidism using time and frequency domain analysis and 
heart rate turbulence analysis with the finding that elevated thyroid hormones 
increase electrical atrial activity in young individuals without cardiac disease, 
which in some cases may trigger atrial fibrillation.
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A2.10 Depression and Schizophrenia
Depression is a risk factor for cardiac morbidity and mortality in individuals with 
coronary heart disease and major depression is associated with a four-fold 
increase in the risk of mortality during the first six months after acute MI. The 
prognostic significance of this is comparable to that of left ventricular dysfunction 
and history of ML Elevated sympathetic activity and hypothalamus dysregulation 
have been identified in otherwise healthy individuals with major depression 
(Carney etal. 2001). QT interval variability is significantly higher in depressed 
post-MI patients when compared with non-depressed controls, the former 
showing more predisposition to SCD resulting from abnormalities in ventricular 
repolarisation which arise from increased sympathetic activity (Carney et al. 
2003).
Life expectancy is reduced by around 20% in schizophrenic individuals and 
besides suicide, cardiovascular disease has been reported to play a role, with 
decreased vagal activity being identified in acute schizophrenia, altering 
cardiovascular regulation and increasing cardiac mortality via decreased BRS (Bar 
etal. 2007). These workers reported that the reduction in BRS in acute 
schizophrenia leads to a severe impairment of blood pressure and heart rate 
regulation in acute psychotic individuals and that, taken into account with other 
risk factors associated with this group, this might play a significant role in 
cardiovascular morbidity and mortality in this population. Coexistent with 
increased sympathetic activity, untreated schizophrenics have a reported 
increased frequency of diabetes, dyslipidemia, hypertension and obesity and a 
further worsening of vascular risk factors has been assigned as a side effect of 
neuroleptic drug treatment (Scigliano etal. 2008).
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A 2.ll Parkinson's disease
Parkinson’s disease is a movement disorder characterised by loss of dopaminergic 
neurons in the CNS. Cardiac sympathetic denervation appears to be characteristic 
of most Parkinson’s disease patients, reflecting an abnormality of catecholamine 
function in the brain and the periphery (Goldstein etal. 2000). Reduced 
autonomic activity induced by the disease is associated with a decreased 
frequency of vascular risk factors and the occurrence of vascular disease is further 
reduced by treatment with dopaminergic drugs (Scigliano etal. 2008).
The incidence of autonomic involvement in the mechanism of orthostatic 
hypotension, which is common in Parkinson’s disease patients, has not been 
systematically explored (Biaggioni 2007). Abnormalities in cardiovascular 
autonomic control might underlie the mechanisms that lead to the decrease of 
arterial pressure during standing although drugs used to control symptoms in 
Parkinson’s disease may promote orthostatic hypotension (Barbie etal. 2006). 
Spectral analysis may provide a research tool to determine the incidence of 
autonomic abnormalities in early Parkinson’s disease (Biaggioni 2007) and is one 
of the most promising techniques for the evaluation of Parkinson’s disease 
evolution (Garcia-Sanchez etal. 2006). Haapaniemi etal. (2001) examined tonic 
autonomic cardiovascular regulation PSD analysis in individuals with untreated 
Parkinson’s disease with the conclusion that the disease causes dysfunction of the 
diurnal autonomic cardiovascular regulation, with dysfunction becoming more 
pronounced with disease severity.
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